data_1aty_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aty _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.632 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 66.2 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.919 ' CD2' ' HA ' ' A' ' 73' ' ' TYR . 40.7 t80 -70.96 20.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.627 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 3.5 ttm -87.91 -65.82 0.98 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.67 -38.51 89.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HA ' ' HB3' ' A' ' 16' ' ' MET . . . -68.97 -23.47 64.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.724 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -52.58 -45.27 66.4 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.707 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -57.05 -55.28 21.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.753 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -33.5 -85.46 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.765 ' HB2' ' CB ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.04 -73.59 0.26 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 119.718 -1.864 . . . . 0.0 107.992 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.689 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -19.23 -52.52 0.01 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.707 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.3 tt -61.61 -71.53 0.15 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.847 -1.973 . . . . 0.0 105.917 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.52 -64.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.001 -1.48 . . . . 0.0 108.832 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.769 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -67.57 -56.53 9.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -57.73 -22.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 O-C-N 118.334 -2.729 . . . . 0.0 104.566 177.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' A' ' 21' ' ' ALA . . . -72.12 -35.31 60.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -82.84 -79.75 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.643 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.296 -1.722 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.6 ' CB ' ' CD ' ' A' ' 64' ' ' PRO 0.322 0.8 OUTLIER . . . . . 0 C--O 1.251 1.14 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 . . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.679 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . 41.4 Cg_endo -70.86 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 103.322 -3.376 . . . . 0.0 103.322 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.769 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -3.15 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 CA-C-O 124.0 1.857 . . . . 0.0 109.062 175.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.761 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -55.66 -69.67 0.13 Allowed 'Isoleucine or valine' 1 C--N 1.244 -4.021 0 CA-C-N 111.74 -2.482 . . . . 0.0 109.573 -179.934 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.672 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -81.8 -49.71 10.08 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 120.655 1.57 . . . . 0.0 110.823 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.679 ' HB ' ' CB ' ' A' ' 64' ' ' PRO . 4.3 t -84.43 -36.13 11.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 O-C-N 119.772 -1.83 . . . . 0.0 108.763 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.695 ' CA ' ' CG ' ' A' ' 17' ' ' MET . . . -64.08 -24.78 68.99 Favored Glycine 0 CA--C 1.481 -2.071 1 N-CA-C 100.998 -4.841 . . . . 0.0 100.998 171.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -57.02 -51.47 69.12 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 173.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.771 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -95.5 12.85 67.4 Favored Glycine 0 N--CA 1.497 2.766 0 C-N-CA 116.543 -2.741 . . . . 0.0 116.492 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.869 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 3.8 mm? -102.46 -47.51 4.44 Favored 'General case' 1 C--N 1.243 -4.025 1 N-CA-C 97.184 -5.117 . . . . 0.0 97.184 170.802 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.919 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -54.05 -28.15 36.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 170.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.771 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 47.8 t -82.72 -30.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.786 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.03 -37.04 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.724 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -108.85 -30.34 8.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -85.33 40.45 0.83 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.536 HG11 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.551 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.614 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.923 ' CD2' ' HA ' ' A' ' 73' ' ' TYR . 33.1 t80 -72.86 23.57 0.06 Allowed 'General case' 0 C--O 1.196 -1.755 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.283 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.591 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 47.4 mtp -87.66 -64.9 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -66.34 -44.05 84.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 16' ' ' MET . . . -63.97 -21.89 66.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 117.067 -1.853 . . . . 0.0 106.207 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.699 ' CB ' ' O ' ' A' ' 10' ' ' TYR . . . -58.82 -47.99 82.88 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 175.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -59.74 -35.2 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.877 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.49 -86.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.691 0.758 . . . . 0.0 109.815 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.743 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 4.1 tpp -88.76 6.74 37.32 Favored 'General case' 0 C--N 1.288 -2.083 0 O-C-N 120.998 -1.064 . . . . 0.0 110.853 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -106.59 -51.43 0.8 Allowed Glycine 0 C--N 1.266 -3.316 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.1 tt -59.3 -50.08 75.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' CB ' ' SD ' ' A' ' 65' ' ' MET . . . -61.86 -44.12 97.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.513 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 65' ' ' MET 0.264 . . -90.88 -59.76 2.09 Favored 'General case' 0 C--O 1.19 -2.048 0 C-N-CA 117.608 -1.637 . . . . 0.0 111.772 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -44.35 -31.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 118.915 -2.366 . . . . 0.0 105.544 174.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -69.26 -48.68 44.32 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 174.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -83.93 -73.68 0.41 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.3 -1.549 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.664 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.643 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.691 ' HG2' ' N ' ' A' ' 65' ' ' MET 0.376 76.8 Cg_endo -78.9 -21.76 9.33 Favored 'Trans proline' 0 C--O 1.202 -1.299 0 N-CA-C 102.938 -3.524 . . . . 0.0 102.938 173.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.841 ' HB3' ' HB3' ' A' ' 21' ' ' ALA 0.286 1.8 mmt -81.1 -56.02 4.37 Favored 'General case' 0 C--O 1.2 -1.524 0 CA-C-N 111.102 -2.772 . . . . 0.0 108.89 -173.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.729 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 6.6 mt -75.99 -36.63 32.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 C-N-CA 116.828 -1.949 . . . . 0.0 108.228 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.691 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.6 t -83.95 -55.05 4.44 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.79 1.281 . . . . 0.0 109.551 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 64' ' ' PRO . 6.1 t -86.63 -22.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 C-N-CA 116.46 -2.096 . . . . 0.0 107.57 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -73.17 -24.4 75.67 Favored Glycine 0 C--O 1.191 -2.55 1 N-CA-C 99.178 -5.569 . . . . 0.0 99.178 169.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 5.4 tp -56.75 -45.29 82.11 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 115.895 -2.322 . . . . 0.0 105.066 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.658 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -90.17 -2.71 73.79 Favored Glycine 0 CA--C 1.466 -3.009 0 C-N-CA 117.694 -2.193 . . . . 0.0 115.731 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.874 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -98.77 -41.04 7.84 Favored 'General case' 0 C--N 1.25 -3.727 1 N-CA-C 98.705 -4.554 . . . . 0.0 98.705 173.833 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.923 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -51.1 -29.6 13.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 101.816 -3.402 . . . . 0.0 101.816 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.658 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 57.3 t -81.82 -32.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.782 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -31.6 -36.75 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.758 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -108.43 -31.52 7.79 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -86.9 46.16 1.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.596 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.424 0.631 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.854 ' HB2' ' CB ' ' A' ' 75' ' ' MET . 39.4 t80 -77.76 28.38 0.17 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.826 -1.149 . . . . 0.0 111.238 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.624 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 9.8 mmt -91.66 -63.79 1.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -76.73 -20.58 56.36 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HA ' ' CZ ' ' A' ' 10' ' ' TYR . . . -52.43 -43.31 64.78 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.702 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 2.2 t -65.33 -51.17 67.86 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.789 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 1.5 mmt -27.29 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 CA-C-O 123.895 1.807 . . . . 0.0 106.966 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.783 ' HG3' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.41 -71.01 0.47 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 109.425 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.687 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.87 -48.45 0.02 OUTLIER Glycine 0 C--N 1.286 -2.211 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.702 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.9 tt -64.15 -71.47 0.17 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -60.5 -69.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.813 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.788 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -56.56 -41.7 77.32 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -74.04 -30.07 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 118.064 -2.898 . . . . 0.0 104.644 175.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.98 -11.86 64.11 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.636 -2.586 . . . . 0.0 106.636 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.664 ' HB1' ' HA ' ' A' ' 21' ' ' ALA . . . -107.68 -92.21 0.41 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.296 -1.761 0 O-C-N 121.416 -0.803 . . . . 0.0 109.48 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.603 ' CB ' ' CD ' ' A' ' 64' ' ' PRO 0.311 0.7 OUTLIER . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.738 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 44.4 Cg_endo -72.82 -62.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 N-CA-C 106.095 -2.31 . . . . 0.0 106.095 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.788 ' CB ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -18.02 -56.03 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.334 0 CA-C-O 123.927 1.823 . . . . 0.0 108.299 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.75 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.91 -73.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.892 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.024 175.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.679 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 69.2 m -77.83 -50.62 11.93 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.217 1.008 . . . . 0.0 111.785 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.1 t -86.39 -28.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 O-C-N 119.681 -1.887 . . . . 0.0 109.071 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.783 ' CA ' ' HG3' ' A' ' 17' ' ' MET . . . -68.79 -25.38 75.21 Favored Glycine 0 CA--C 1.489 -1.557 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 170.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.75 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -56.86 -56.01 27.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.889 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -88.87 11.55 68.64 Favored Glycine 0 N--CA 1.514 3.899 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.425 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.846 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . 1.4 mp -109.97 -64.11 1.3 Allowed 'General case' 1 C--N 1.241 -4.123 0 N-CA-C 100.328 -3.952 . . . . 0.0 100.328 174.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.788 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 24.7 m-85 -47.52 -27.69 1.89 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.889 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 45.6 t -88.61 -27.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.069 -1.644 . . . . 0.0 107.065 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.854 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.72 -36.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.264 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.708 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -109.04 -31.53 7.59 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.592 ' CB ' ' HA ' ' A' ' 74' ' ' VAL . . . -86.24 45.49 1.24 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.681 -1.608 . . . . 0.0 106.755 177.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.424 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.661 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 1.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.879 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.5 t80 -60.36 7.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.825 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.552 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -83.67 -68.58 0.7 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 119.267 -2.146 . . . . 0.0 105.868 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.14 -35.4 80.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.729 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.6 -26.12 64.29 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.672 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -53.17 -46.56 68.97 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.669 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 24.5 t -61.26 -44.51 98.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.729 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -46.28 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.67 -1.269 . . . . 0.0 110.104 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.94 ' CG ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -65.24 -22.86 66.93 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.528 -176.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.739 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -91.15 -69.01 1.18 Allowed Glycine 0 C--O 1.191 -2.558 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.725 ' C ' ' O ' ' A' ' 18' ' ' GLY . 3.0 tp -35.25 -48.75 0.47 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.106 -2.408 . . . . 0.0 105.448 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -63.91 -52.86 57.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.838 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -75.77 -60.91 2.11 Favored 'General case' 0 C--O 1.193 -1.911 0 O-C-N 120.716 -1.24 . . . . 0.0 113.382 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.721 ' N ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mm -51.0 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.46 -42.44 89.17 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 104.666 -3.374 . . . . 0.0 104.666 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -89.16 15.18 9.25 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 113.755 -1.222 . . . . 0.0 109.533 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.288 -2.092 0 O-C-N 121.608 -0.682 . . . . 0.0 109.747 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.753 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.328 0.3 OUTLIER . . . . . 0 C--O 1.252 1.211 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 . . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.5 Cg_endo -68.59 -92.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.928 0 N-CA-C 105.094 -2.695 . . . . 0.0 105.094 169.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.838 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 5.93 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.554 0 CA-C-O 124.599 2.143 . . . . 0.0 109.876 179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.7 -78.48 0.02 OUTLIER 'Isoleucine or valine' 1 C--N 1.211 -5.416 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.073 178.904 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.701 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 m -78.83 -45.31 21.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 119.815 -1.803 . . . . 0.0 110.266 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.94 ' O ' ' CG ' ' A' ' 17' ' ' MET 0.259 0.6 OUTLIER -95.34 -12.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 0 C-N-CA 116.868 -1.933 . . . . 0.0 108.152 -178.05 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.33 -34.26 74.38 Favored Glycine 0 CA--C 1.492 -1.396 1 N-CA-C 98.218 -5.953 . . . . 0.0 98.218 167.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -49.32 -46.66 47.06 Favored 'General case' 0 C--O 1.179 -2.639 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 171.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.27 -13.97 82.32 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-O 116.414 -2.325 . . . . 0.0 115.376 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.879 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 1.5 pt? -84.62 -59.06 2.48 Favored 'General case' 0 C--N 1.293 -1.853 2 CA-C-N 124.902 4.351 . . . . 0.0 99.92 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.753 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -59.73 -14.44 14.39 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.782 177.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.696 ' CB ' ' O ' ' A' ' 70' ' ' LEU . 93.5 t -109.1 -13.05 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 119.055 -2.278 . . . . 0.0 106.002 173.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.776 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -50.65 -30.92 14.74 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 174.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.79 -34.59 6.41 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.574 175.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.573 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -77.18 19.56 0.32 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.333 -1.747 . . . . 0.0 108.454 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.584 ' N ' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.624 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.835 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 7.2 t80 -61.78 5.98 0.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.835 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.603 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -87.24 -75.97 0.38 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.519 -1.363 . . . . 0.0 107.54 177.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.12 -35.85 76.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.906 ' O ' ' HB3' ' A' ' 16' ' ' MET . . . -69.97 -31.53 69.29 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.668 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -42.51 -40.92 2.79 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.649 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 2.5 t -59.83 -64.83 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.906 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -13.4 -97.54 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.346 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.945 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.885 ' HB2' ' CG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.46 -84.08 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.677 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -11.12 -62.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.087 -2.405 . . . . 0.0 107.087 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -56.18 -75.79 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -53.95 -67.12 0.29 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.822 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -68.44 -53.04 26.18 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -59.14 -22.72 22.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 114.241 -2.984 . . . . 0.0 104.541 177.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -72.06 -35.54 61.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -95.48 -78.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.295 -1.802 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.892 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.624 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.668 ' HG2' ' N ' ' A' ' 65' ' ' MET 0.371 80.8 Cg_endo -81.41 -22.4 5.72 Favored 'Trans proline' 0 C--O 1.208 -0.977 1 N-CA-C 101.441 -4.1 . . . . 0.0 101.441 173.169 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.865 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 mmt -77.68 -26.51 50.34 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 110.829 -2.896 . . . . 0.0 108.881 -173.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.695 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 70.0 mt -109.61 -19.48 6.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 117.786 -1.565 . . . . 0.0 107.928 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.662 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.6 m -83.2 -40.63 19.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 72' ' ' LEU . 2.9 t -95.38 -28.94 4.0 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.865 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -62.64 -26.81 68.86 Favored Glycine 0 N--CA 1.495 2.626 1 N-CA-C 100.09 -5.204 . . . . 0.0 100.09 170.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -57.45 -55.85 29.45 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.866 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.53 27.34 10.88 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 118.438 -1.839 . . . . 0.0 113.61 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.885 ' CG ' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -112.06 -64.53 1.28 Allowed 'General case' 1 C--N 1.242 -4.079 1 N-CA-C 98.678 -4.564 . . . . 0.0 98.678 170.617 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.757 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -57.81 -20.41 35.51 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 171.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.866 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 65.8 t -100.9 -17.83 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 118.653 -2.53 . . . . 0.0 105.164 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.748 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -38.85 -38.86 0.46 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 174.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.716 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -109.53 -27.65 9.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.834 176.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.573 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 116.802 -1.959 . . . . 0.0 106.284 175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.566 HG11 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.233 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.527 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.882 0.849 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.884 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -85.09 40.07 0.8 Allowed 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 116.761 -1.976 . . . . 0.0 111.162 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.596 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.49 -63.37 1.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 101.195 -3.631 . . . . 0.0 101.195 172.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -68.87 -43.13 75.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.74 ' CB ' ' HA ' ' A' ' 10' ' ' TYR . . . -67.42 -17.98 64.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 116.605 -2.038 . . . . 0.0 105.931 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.684 ' CB ' ' O ' ' A' ' 10' ' ' TYR . . . -58.01 -48.96 78.46 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.2 t -55.25 -48.09 76.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.672 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -45.34 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.865 -1.147 . . . . 0.0 110.178 178.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.918 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.39 -17.7 64.93 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.892 0.853 . . . . 0.0 112.053 -176.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.74 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -93.1 -67.91 1.09 Allowed Glycine 0 C--O 1.19 -2.624 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -35.52 -48.93 0.53 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 121.278 2.539 . . . . 0.0 105.08 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -63.5 -54.17 40.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.871 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -74.51 -63.78 1.17 Allowed 'General case' 0 C--O 1.189 -2.095 0 O-C-N 120.76 -1.212 . . . . 0.0 113.377 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -49.66 -27.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.0 -44.5 88.51 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 104.493 -3.443 . . . . 0.0 104.493 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -85.79 12.08 9.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.619 -1.29 . . . . 0.0 109.8 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.288 -2.088 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.897 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.775 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.334 1.2 mp . . . . . 0 C--O 1.251 1.172 0 N-CA-C 102.217 -3.253 . . . . 0.0 102.217 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.775 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.3 Cg_endo -67.88 -92.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 N-CA-C 105.086 -2.698 . . . . 0.0 105.086 169.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.871 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 6.26 -72.46 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 124.626 2.155 . . . . 0.0 109.794 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.24 -79.62 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.214 -5.291 0 CA-C-N 112.29 -2.232 . . . . 0.0 108.961 178.633 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 19.7 t -77.18 -46.59 22.84 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.04 -1.662 . . . . 0.0 110.336 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.89 ' O ' ' CG ' ' A' ' 17' ' ' MET 0.26 0.6 OUTLIER -95.18 -11.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 C-N-CA 116.884 -1.926 . . . . 0.0 108.593 -177.62 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.759 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.49 -35.04 74.66 Favored Glycine 0 CA--C 1.498 -1.006 1 N-CA-C 97.78 -6.128 . . . . 0.0 97.78 167.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.689 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -50.62 -43.47 56.87 Favored 'General case' 0 C--O 1.185 -2.31 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 171.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.753 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.07 -17.76 80.22 Favored Glycine 0 N--CA 1.5 2.916 0 CA-C-O 116.403 -2.331 . . . . 0.0 115.387 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.918 ' HB3' ' CB ' ' A' ' 17' ' ' MET . 1.4 pt? -84.79 -59.94 2.2 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 99.979 -4.082 . . . . 0.0 99.979 175.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.73 ' N ' ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -54.25 -18.32 3.81 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.697 1.236 . . . . 0.0 108.338 177.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.645 ' CB ' ' O ' ' A' ' 70' ' ' LEU . 69.1 t -105.25 -17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 118.328 -2.732 . . . . 0.0 105.998 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.753 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -48.28 -34.12 9.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.714 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.62 -26.45 10.86 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.785 -1.166 . . . . 0.0 108.21 174.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.663 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -89.63 49.15 1.69 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.625 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.304 0.573 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.898 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 49.2 t80 -72.02 23.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 111.903 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.567 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -89.41 -65.7 0.99 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 174.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.524 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -64.98 -40.46 95.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.772 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.07 -21.39 64.08 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 116.953 -1.899 . . . . 0.0 106.432 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.678 ' HA ' ' CZ ' ' A' ' 10' ' ' TYR . . . -53.91 -44.91 70.96 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 102.381 -3.192 . . . . 0.0 102.381 174.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.745 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.14 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.395 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.772 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -37.56 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.758 ' HB2' ' CB ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -73.3 -74.2 0.18 Allowed 'General case' 0 C--N 1.285 -2.213 0 O-C-N 119.895 -1.753 . . . . 0.0 108.088 178.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.668 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.45 -49.84 0.02 OUTLIER Glycine 0 C--N 1.28 -2.565 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tp -62.03 -68.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -59.38 -69.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 117.915 -1.514 . . . . 0.0 108.368 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.727 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -57.66 -48.07 80.51 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -72.07 -24.83 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 116.661 -2.016 . . . . 0.0 105.564 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.65 -20.75 77.54 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 20' ' ' ALA . . . -101.96 -10.79 19.47 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.9 -1.15 . . . . 0.0 109.446 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.289 -2.029 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.508 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.322 0.2 OUTLIER . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 . . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.643 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 38.1 Cg_endo -70.38 -63.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.254 -2.249 . . . . 0.0 106.254 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.727 ' CB ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -17.2 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 123.736 1.732 . . . . 0.0 107.904 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.77 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -56.39 -77.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.574 0 CA-C-N 111.557 -2.565 . . . . 0.0 109.352 176.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 5.3 p -78.4 -48.77 14.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 122.246 1.022 . . . . 0.0 111.469 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.1 t -82.98 -43.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.891 0 O-C-N 119.937 -1.727 . . . . 0.0 108.075 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -58.06 -25.68 57.17 Favored Glycine 0 CA--C 1.483 -1.919 1 N-CA-C 101.834 -4.506 . . . . 0.0 101.834 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.77 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -56.38 -58.11 9.39 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 116.157 -2.217 . . . . 0.0 105.299 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.748 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.54 18.15 55.72 Favored Glycine 0 CA--C 1.464 -3.111 0 C-N-CA 116.767 -2.635 . . . . 0.0 115.203 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.898 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.5 -49.14 3.3 Favored 'General case' 0 C--N 1.246 -3.897 1 N-CA-C 98.3 -4.704 . . . . 0.0 98.3 172.03 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.885 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -53.52 -26.72 22.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 170.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.748 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 21.2 t -85.76 -30.47 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.844 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -31.8 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 175.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.727 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.01 -31.42 7.64 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.556 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -84.75 39.06 0.73 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.021 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.548 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.667 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 6.9 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.855 ' HB2' ' CB ' ' A' ' 75' ' ' MET . 38.1 t80 -73.65 25.21 0.07 Allowed 'General case' 0 C--O 1.202 -1.443 0 O-C-N 121.073 -1.017 . . . . 0.0 111.037 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.562 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -89.14 -65.25 1.04 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -66.01 -40.03 90.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.673 ' CB ' ' HA ' ' A' ' 10' ' ' TYR . . . -69.01 -22.4 64.07 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -54.99 -44.47 74.52 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 101.947 -3.353 . . . . 0.0 101.947 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.724 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 3.1 t -60.5 -48.31 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.694 ' HG3' ' CD1' ' A' ' 72' ' ' LEU . 3.2 ptp -42.09 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.995 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.856 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.24 -70.45 0.44 Allowed 'General case' 0 C--O 1.187 -2.221 0 O-C-N 118.57 -2.581 . . . . 0.0 107.924 177.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -20.03 -56.39 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 4.3 tt -55.28 -68.08 0.22 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.848 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.0 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.102 -1.439 . . . . 0.0 107.971 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 65' ' ' MET . . . -53.89 -70.41 0.1 Allowed 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.125 -0.984 . . . . 0.0 112.043 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -45.39 -25.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 118.883 -2.386 . . . . 0.0 106.965 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -62.89 -59.51 9.03 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.854 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -84.07 -70.54 0.56 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 175.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.852 0.358 . . . . 0.0 110.54 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.623 ' CG2' ' HD3' ' A' ' 64' ' ' PRO . 1.3 mp . . . . . 0 CA--C 1.547 0.845 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.73 ' HG2' ' N ' ' A' ' 65' ' ' MET 0.382 94.3 Cg_endo -82.87 -25.47 2.86 Favored 'Trans proline' 0 C--O 1.201 -1.345 0 N-CA-C 103.744 -3.214 . . . . 0.0 103.744 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.879 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 8.1 mmt -55.34 -56.46 19.8 Favored 'General case' 0 C--O 1.185 -2.335 0 CA-C-N 112.78 -2.009 . . . . 0.0 108.986 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.682 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 80.6 mt -107.94 -8.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 117.37 -1.732 . . . . 0.0 110.289 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.724 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 11.9 t -85.28 -48.84 8.69 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.982 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.3 t -86.12 -34.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 C-N-CA 116.55 -2.06 . . . . 0.0 105.693 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.879 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -64.75 -19.06 64.8 Favored Glycine 0 CA--C 1.48 -2.154 1 N-CA-C 101.99 -4.444 . . . . 0.0 101.99 171.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.8 OUTLIER -55.67 -54.93 38.17 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 102.912 -2.996 . . . . 0.0 102.912 174.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.723 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -86.7 3.66 86.85 Favored Glycine 0 N--CA 1.515 3.9 0 C-N-CA 118.752 -1.69 . . . . 0.0 114.41 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.982 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 6.8 mt -107.76 -61.74 1.53 Allowed 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 101.462 -3.533 . . . . 0.0 101.462 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 82.5 m-85 -47.41 -28.46 2.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 171.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.723 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 46.1 t -87.37 -28.78 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.855 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -31.62 -37.89 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.701 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.17 -31.76 8.11 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -86.3 46.09 1.3 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.578 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.939 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 t80 -59.26 3.99 0.04 OUTLIER 'General case' 0 C--O 1.19 -2.027 0 O-C-N 121.468 -0.77 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.564 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 3.8 mmt -84.73 -74.84 0.37 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 118.762 -2.461 . . . . 0.0 107.085 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 15' ' ' VAL . . . -60.76 -36.35 78.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.73 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.18 -26.33 64.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.657 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -50.81 -43.72 58.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 102.901 -2.999 . . . . 0.0 102.901 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 2.4 t -61.79 -51.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.73 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 2.3 tpp -40.43 -91.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.815 1.293 . . . . 0.0 110.141 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.893 ' CG ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -67.15 -19.13 65.55 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.379 -175.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.728 ' O ' ' C ' ' A' ' 19' ' ' LEU . . . -95.42 -71.8 1.12 Allowed Glycine 0 C--O 1.194 -2.366 0 N-CA-C 107.067 -2.413 . . . . 0.0 107.067 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -31.55 -49.15 0.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 120.396 2.098 . . . . 0.0 105.761 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 18' ' ' GLY . . . -65.54 -61.04 2.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.84 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -66.0 -62.31 1.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.28 -1.368 . . . . 0.0 113.042 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -56.12 -23.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.09 -38.42 92.37 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 103.766 -3.734 . . . . 0.0 103.766 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -89.41 3.56 51.87 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.253 -1.473 . . . . 0.0 110.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.286 -2.173 0 O-C-N 121.709 -0.619 . . . . 0.0 109.641 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.754 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.325 0.5 OUTLIER . . . . . 0 C--O 1.256 1.424 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 . . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.754 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 30.0 Cg_endo -66.08 -85.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 104.734 -2.833 . . . . 0.0 104.734 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.84 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 0.87 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.342 0 CA-C-O 123.327 1.536 . . . . 0.0 108.666 178.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.636 HG13 ' O ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -42.88 -84.51 0.0 OUTLIER 'Isoleucine or valine' 1 C--N 1.228 -4.682 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.054 174.688 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.698 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.8 t -81.19 -43.45 19.29 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.455 -1.403 . . . . 0.0 112.103 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.893 ' O ' ' CG ' ' A' ' 17' ' ' MET 0.256 0.6 OUTLIER -93.98 -14.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.423 0 C-N-CA 116.902 -1.919 . . . . 0.0 106.75 -178.08 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.798 ' HA2' ' CD2' ' A' ' 72' ' ' LEU . . . -68.38 -37.78 86.35 Favored Glycine 0 C--N 1.302 -1.343 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 167.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.698 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -50.5 -44.27 55.91 Favored 'General case' 0 C--O 1.183 -2.438 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 172.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.791 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -78.99 -10.07 86.52 Favored Glycine 0 N--CA 1.506 3.347 0 CA-C-O 117.0 -2.0 . . . . 0.0 115.093 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.939 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 2.4 pt? -86.39 -56.99 3.18 Favored 'General case' 0 C--N 1.284 -2.259 1 N-CA-C 98.9 -4.481 . . . . 0.0 98.9 174.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.785 ' N ' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -60.69 -14.32 20.16 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.625 1.202 . . . . 0.0 108.329 176.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.674 ' CB ' ' O ' ' A' ' 70' ' ' LEU . 98.1 t -111.94 -8.5 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 119.125 -2.234 . . . . 0.0 106.053 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.791 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -54.43 -30.03 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 100.717 -3.808 . . . . 0.0 100.717 173.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -108.95 -38.4 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.845 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . . . -67.87 1.09 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.519 -1.672 . . . . 0.0 108.845 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.632 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 66.2 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.919 ' CD2' ' HA ' ' A' ' 73' ' ' TYR . 40.7 t80 -70.96 20.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.627 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 3.5 ttm -87.91 -65.82 0.98 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.67 -38.51 89.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HA ' ' HB3' ' A' ' 16' ' ' MET . . . -68.97 -23.47 64.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.724 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -52.58 -45.27 66.4 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.707 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -57.05 -55.28 21.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.753 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -33.5 -85.46 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.765 ' HB2' ' CB ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.04 -73.59 0.26 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 119.718 -1.864 . . . . 0.0 107.992 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.689 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -19.23 -52.52 0.01 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.707 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.3 tt -61.61 -71.53 0.15 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.847 -1.973 . . . . 0.0 105.917 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.52 -64.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.001 -1.48 . . . . 0.0 108.832 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.769 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -67.57 -56.53 9.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -57.73 -22.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 O-C-N 118.334 -2.729 . . . . 0.0 104.566 177.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' A' ' 21' ' ' ALA . . . -72.12 -35.31 60.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.749 ' HB3' ' N ' ' A' ' 62' ' ' ALA . . . -82.84 -79.75 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.643 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -40.11 -58.33 1.48 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.513 ' CG1' HG22 ' A' ' 22' ' ' ILE . 3.5 mm . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.297 0.57 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 53' ' ' PHE . 79.8 t80 -68.32 -9.46 48.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.547 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 50.8 t80 -45.12 -26.07 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.547 ' CG1' ' O ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 171.01 -20.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 56' ' ' VAL . 94.5 t -84.39 23.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.931 -1.105 . . . . 0.0 110.277 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.566 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -69.98 -40.49 75.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.851 -1.156 . . . . 0.0 109.507 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.05 -22.94 30.16 Favored Glycine 0 C--N 1.298 -1.545 0 N-CA-C 106.871 -2.492 . . . . 0.0 106.871 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.521 ' CB ' HG11 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -98.54 -23.37 15.55 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.612 ' O ' ' CB ' ' A' ' 61' ' ' ASP . 9.5 t -57.89 -62.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 109.198 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.653 ' C ' ' CB ' ' A' ' 24' ' ' ALA . 75.1 m-20 105.05 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 122.574 0.35 . . . . 0.0 110.553 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.86 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . -93.74 -30.12 15.04 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 116.267 -2.173 . . . . 0.0 106.921 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.688 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.322 0.8 OUTLIER -21.06 -56.03 0.08 OUTLIER Pre-proline 0 C--N 1.286 -2.156 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 172.63 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.679 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . 41.4 Cg_endo -70.86 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 103.322 -3.376 . . . . 0.0 103.322 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.86 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -3.15 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 CA-C-O 124.0 1.857 . . . . 0.0 109.062 175.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.761 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -55.66 -69.67 0.13 Allowed 'Isoleucine or valine' 1 C--N 1.244 -4.021 0 CA-C-N 111.74 -2.482 . . . . 0.0 109.573 -179.934 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.672 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -81.8 -49.71 10.08 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 120.655 1.57 . . . . 0.0 110.823 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.679 ' HB ' ' CB ' ' A' ' 64' ' ' PRO . 4.3 t -84.43 -36.13 11.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 O-C-N 119.772 -1.83 . . . . 0.0 108.763 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.695 ' CA ' ' CG ' ' A' ' 17' ' ' MET . . . -64.08 -24.78 68.99 Favored Glycine 0 CA--C 1.481 -2.071 1 N-CA-C 100.998 -4.841 . . . . 0.0 100.998 171.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.761 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -57.02 -51.47 69.12 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 173.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.771 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -95.5 12.85 67.4 Favored Glycine 0 N--CA 1.497 2.766 0 C-N-CA 116.543 -2.741 . . . . 0.0 116.492 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.869 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 3.8 mm? -102.46 -47.51 4.44 Favored 'General case' 1 C--N 1.243 -4.025 1 N-CA-C 97.184 -5.117 . . . . 0.0 97.184 170.802 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.919 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -54.05 -28.15 36.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 170.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.771 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 47.8 t -82.72 -30.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.786 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.03 -37.04 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.724 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -108.85 -30.34 8.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -85.33 40.45 0.83 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.536 HG11 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -94.85 37.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.551 -178.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.521 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.614 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.923 ' CD2' ' HA ' ' A' ' 73' ' ' TYR . 33.1 t80 -72.86 23.57 0.06 Allowed 'General case' 0 C--O 1.196 -1.755 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.283 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.591 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 47.4 mtp -87.66 -64.9 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -66.34 -44.05 84.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.877 ' HA ' ' HB3' ' A' ' 16' ' ' MET . . . -63.97 -21.89 66.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 117.067 -1.853 . . . . 0.0 106.207 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.699 ' CB ' ' O ' ' A' ' 10' ' ' TYR . . . -58.82 -47.99 82.88 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 175.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -59.74 -35.2 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.877 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -51.49 -86.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.691 0.758 . . . . 0.0 109.815 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.743 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 4.1 tpp -88.76 6.74 37.32 Favored 'General case' 0 C--N 1.288 -2.083 0 O-C-N 120.998 -1.064 . . . . 0.0 110.853 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -106.59 -51.43 0.8 Allowed Glycine 0 C--N 1.266 -3.316 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.1 tt -59.3 -50.08 75.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' CB ' ' SD ' ' A' ' 65' ' ' MET . . . -61.86 -44.12 97.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.513 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 65' ' ' MET 0.264 . . -90.88 -59.76 2.09 Favored 'General case' 0 C--O 1.19 -2.048 0 C-N-CA 117.608 -1.637 . . . . 0.0 111.772 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -44.35 -31.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 118.915 -2.366 . . . . 0.0 105.544 174.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -69.26 -48.68 44.32 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 174.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.621 ' CB ' ' HB2' ' A' ' 61' ' ' ASP . . . -83.93 -73.68 0.41 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -47.13 -49.07 22.86 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.664 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.548 ' CA ' ' O ' ' A' ' 22' ' ' ILE . 3.1 tt . . . . . 0 N--CA 1.494 1.734 0 O-C-N 120.705 -1.247 . . . . 0.0 109.755 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' CZ ' ' CG1' ' A' ' 55' ' ' ILE . 16.3 p90 27.55 54.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.571 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 3.8 t80 84.19 -46.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' CG1' ' CZ ' ' A' ' 53' ' ' PHE . 39.8 mm -69.58 -4.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.516 ' HA ' ' N ' ' A' ' 52' ' ' GLN . 4.6 p -45.78 -32.81 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 0.0 108.892 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.56 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -83.23 -38.91 21.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' MET . . . -51.82 -24.58 13.68 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 57' ' ' MET . 0.4 OUTLIER -103.85 -23.45 13.38 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 61' ' ' ASP . 3.4 t -99.44 -77.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 108.971 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.621 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 4.6 m-20 -166.17 -104.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.593 -1.317 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.648 ' CA ' ' HB2' ' A' ' 65' ' ' MET . . . 57.71 40.9 26.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.643 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -131.74 -63.28 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 111.003 -2.817 . . . . 0.0 104.269 -178.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.691 ' HG2' ' N ' ' A' ' 65' ' ' MET 0.376 76.8 Cg_endo -78.9 -21.76 9.33 Favored 'Trans proline' 0 C--O 1.202 -1.299 0 N-CA-C 102.938 -3.524 . . . . 0.0 102.938 173.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.841 ' HB3' ' HB3' ' A' ' 21' ' ' ALA 0.286 1.8 mmt -81.1 -56.02 4.37 Favored 'General case' 0 C--O 1.2 -1.524 0 CA-C-N 111.102 -2.772 . . . . 0.0 108.89 -173.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.729 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 6.6 mt -75.99 -36.63 32.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 C-N-CA 116.828 -1.949 . . . . 0.0 108.228 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.691 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.6 t -83.95 -55.05 4.44 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.79 1.281 . . . . 0.0 109.551 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.676 ' HB ' ' O ' ' A' ' 64' ' ' PRO . 6.1 t -86.63 -22.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 C-N-CA 116.46 -2.096 . . . . 0.0 107.57 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -73.17 -24.4 75.67 Favored Glycine 0 C--O 1.191 -2.55 1 N-CA-C 99.178 -5.569 . . . . 0.0 99.178 169.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.729 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 5.4 tp -56.75 -45.29 82.11 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 115.895 -2.322 . . . . 0.0 105.066 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.658 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -90.17 -2.71 73.79 Favored Glycine 0 CA--C 1.466 -3.009 0 C-N-CA 117.694 -2.193 . . . . 0.0 115.731 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.874 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -98.77 -41.04 7.84 Favored 'General case' 0 C--N 1.25 -3.727 1 N-CA-C 98.705 -4.554 . . . . 0.0 98.705 173.833 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.923 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -51.1 -29.6 13.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 101.816 -3.402 . . . . 0.0 101.816 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.658 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 57.3 t -81.82 -32.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.782 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -31.6 -36.75 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.758 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -108.43 -31.52 7.79 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -86.9 46.16 1.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -99.7 77.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.596 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.499 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.59 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.424 0.631 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.854 ' HB2' ' CB ' ' A' ' 75' ' ' MET . 39.4 t80 -77.76 28.38 0.17 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.826 -1.149 . . . . 0.0 111.238 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.624 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 9.8 mmt -91.66 -63.79 1.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.789 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -76.73 -20.58 56.36 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HA ' ' CZ ' ' A' ' 10' ' ' TYR . . . -52.43 -43.31 64.78 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.702 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 2.2 t -65.33 -51.17 67.86 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.789 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 1.5 mmt -27.29 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 CA-C-O 123.895 1.807 . . . . 0.0 106.966 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.783 ' HG3' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.41 -71.01 0.47 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 109.425 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.687 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.87 -48.45 0.02 OUTLIER Glycine 0 C--N 1.286 -2.211 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.702 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.9 tt -64.15 -71.47 0.17 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -60.5 -69.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.813 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.788 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -56.56 -41.7 77.32 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -74.04 -30.07 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 118.064 -2.898 . . . . 0.0 104.644 175.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' A' ' 59' ' ' LEU . . . -68.98 -11.86 64.11 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.636 -2.586 . . . . 0.0 106.636 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.816 ' CB ' ' N ' ' A' ' 62' ' ' ALA . . . -107.68 -92.21 0.41 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.651 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -41.69 -34.95 0.68 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.416 -0.803 . . . . 0.0 109.48 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.565 ' CA ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.765 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.547 ' HA ' ' CA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 22.3 p90 28.41 53.46 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 1.3 t80 83.74 -45.73 0.11 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.294 -0.879 . . . . 0.0 108.736 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.647 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.03 -4.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 60' ' ' VAL . 9.9 p -51.31 -26.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 108.965 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.571 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 14.8 mmt 63.42 29.29 15.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 57' ' ' MET . . . 44.67 29.43 1.92 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -174.18 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 172.38 -44.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.992 0.901 . . . . 0.0 109.173 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.61 ' C ' ' HB3' ' A' ' 24' ' ' ALA . 36.0 m-20 -159.29 -111.24 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.288 1.042 . . . . 0.0 108.714 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.816 ' N ' ' CB ' ' A' ' 24' ' ' ALA . . . 89.15 -53.73 0.03 OUTLIER 'General case' 0 C--O 1.181 -2.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.704 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.311 0.7 OUTLIER -18.36 -55.96 0.05 OUTLIER Pre-proline 0 C--N 1.285 -2.221 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.102 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.738 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 44.4 Cg_endo -72.82 -62.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 N-CA-C 106.095 -2.31 . . . . 0.0 106.095 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.788 ' CB ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -18.02 -56.03 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.334 0 CA-C-O 123.927 1.823 . . . . 0.0 108.299 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.804 HG13 ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.91 -73.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.892 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.024 175.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.679 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 69.2 m -77.83 -50.62 11.93 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.217 1.008 . . . . 0.0 111.785 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.1 t -86.39 -28.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 O-C-N 119.681 -1.887 . . . . 0.0 109.071 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.783 ' CA ' ' HG3' ' A' ' 17' ' ' MET . . . -68.79 -25.38 75.21 Favored Glycine 0 CA--C 1.489 -1.557 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 170.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.75 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -56.86 -56.01 27.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.889 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -88.87 11.55 68.64 Favored Glycine 0 N--CA 1.514 3.899 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.425 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.846 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . 1.4 mp -109.97 -64.11 1.3 Allowed 'General case' 1 C--N 1.241 -4.123 0 N-CA-C 100.328 -3.952 . . . . 0.0 100.328 174.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.788 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 24.7 m-85 -47.52 -27.69 1.89 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.889 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 45.6 t -88.61 -27.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.069 -1.644 . . . . 0.0 107.065 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.854 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.72 -36.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.264 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.708 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -109.04 -31.53 7.59 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.592 ' CB ' ' HA ' ' A' ' 74' ' ' VAL . . . -86.24 45.49 1.24 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.681 -1.608 . . . . 0.0 106.755 177.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -95.63 52.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.424 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.462 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.661 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 1.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.879 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.5 t80 -60.36 7.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.825 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.552 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -83.67 -68.58 0.7 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 119.267 -2.146 . . . . 0.0 105.868 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.14 -35.4 80.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.729 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.6 -26.12 64.29 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.672 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -53.17 -46.56 68.97 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.669 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 24.5 t -61.26 -44.51 98.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.729 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -46.28 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.67 -1.269 . . . . 0.0 110.104 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.94 ' CG ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -65.24 -22.86 66.93 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.528 -176.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.739 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -91.15 -69.01 1.18 Allowed Glycine 0 C--O 1.191 -2.558 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.725 ' C ' ' O ' ' A' ' 18' ' ' GLY . 3.0 tp -35.25 -48.75 0.47 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.106 -2.408 . . . . 0.0 105.448 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' CB ' ' A' ' 61' ' ' ASP . . . -63.91 -52.86 57.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.838 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -75.77 -60.91 2.11 Favored 'General case' 0 C--O 1.193 -1.911 0 O-C-N 120.716 -1.24 . . . . 0.0 113.382 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.721 ' N ' ' O ' ' A' ' 18' ' ' GLY . 1.3 mm -51.0 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.46 -42.44 89.17 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 104.666 -3.374 . . . . 0.0 104.666 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.873 ' CB ' ' N ' ' A' ' 62' ' ' ALA . . . -89.16 15.18 9.25 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 113.755 -1.222 . . . . 0.0 109.533 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -164.06 39.14 0.08 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.608 -0.682 . . . . 0.0 109.747 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ILE . 21.1 tt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.593 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.588 0.708 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 52' ' ' GLN . 6.3 t80 -61.87 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.617 -1.302 . . . . 0.0 108.941 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 55' ' ' ILE . 3.2 m-30 47.69 25.47 0.69 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.298 -1.501 . . . . 0.0 106.976 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.544 ' CB ' ' O ' ' A' ' 54' ' ' PHE . 2.3 mt 87.64 41.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 87.8 t 62.41 29.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.609 -1.307 . . . . 0.0 110.357 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.541 ' HG2' ' CB ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -77.85 -41.99 35.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.648 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' N ' ' HE1' ' A' ' 57' ' ' MET . . . -55.44 -22.39 30.85 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 106.602 -2.599 . . . . 0.0 106.602 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 0.3 OUTLIER -101.24 -21.55 14.88 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 61' ' ' ASP . 2.2 t -101.0 -81.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.716 ' C ' ' HB3' ' A' ' 24' ' ' ALA . 17.9 m-20 -158.23 -140.04 0.07 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.873 ' N ' ' CB ' ' A' ' 24' ' ' ALA . . . 85.09 -31.45 0.06 Allowed 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.753 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.328 0.3 OUTLIER -34.6 -48.58 0.95 Allowed Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 168.899 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.5 Cg_endo -68.59 -92.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.928 0 N-CA-C 105.094 -2.695 . . . . 0.0 105.094 169.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.857 ' CB ' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 5.93 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.554 0 CA-C-O 124.599 2.143 . . . . 0.0 109.876 179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.7 -78.48 0.02 OUTLIER 'Isoleucine or valine' 1 C--N 1.211 -5.416 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.073 178.904 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.701 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 m -78.83 -45.31 21.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 119.815 -1.803 . . . . 0.0 110.266 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.94 ' O ' ' CG ' ' A' ' 17' ' ' MET 0.259 0.6 OUTLIER -95.34 -12.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 0 C-N-CA 116.868 -1.933 . . . . 0.0 108.152 -178.05 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.33 -34.26 74.38 Favored Glycine 0 CA--C 1.492 -1.396 1 N-CA-C 98.218 -5.953 . . . . 0.0 98.218 167.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -49.32 -46.66 47.06 Favored 'General case' 0 C--O 1.179 -2.639 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 171.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.27 -13.97 82.32 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-O 116.414 -2.325 . . . . 0.0 115.376 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.879 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 1.5 pt? -84.62 -59.06 2.48 Favored 'General case' 0 C--N 1.293 -1.853 2 CA-C-N 124.902 4.351 . . . . 0.0 99.92 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.753 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -59.73 -14.44 14.39 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.782 177.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.696 ' CB ' ' O ' ' A' ' 70' ' ' LEU . 93.5 t -109.1 -13.05 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 119.055 -2.278 . . . . 0.0 106.002 173.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.776 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -50.65 -30.92 14.74 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 174.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.79 -34.59 6.41 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.574 175.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.573 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -77.18 19.56 0.32 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.333 -1.747 . . . . 0.0 108.454 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.584 ' N ' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -68.41 -43.6 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.48 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.624 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.835 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 7.2 t80 -61.78 5.98 0.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.835 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.603 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -87.24 -75.97 0.38 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.519 -1.363 . . . . 0.0 107.54 177.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.12 -35.85 76.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.906 ' O ' ' HB3' ' A' ' 16' ' ' MET . . . -69.97 -31.53 69.29 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.668 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -42.51 -40.92 2.79 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.649 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 2.5 t -59.83 -64.83 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.906 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -13.4 -97.54 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.346 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.945 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.885 ' HB2' ' CG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.46 -84.08 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.677 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -11.12 -62.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.087 -2.405 . . . . 0.0 107.087 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -56.18 -75.79 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -53.95 -67.12 0.29 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.822 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -68.44 -53.04 26.18 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -59.14 -22.72 22.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 114.241 -2.984 . . . . 0.0 104.541 177.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -72.06 -35.54 61.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' A' ' 61' ' ' ASP . . . -95.48 -78.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -43.81 -22.16 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.892 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.53 ' HB ' ' CA ' ' A' ' 22' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.497 1.895 0 O-C-N 120.176 -1.578 . . . . 0.0 109.806 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.62 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 5.8 pt20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.602 0.715 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 54' ' ' PHE . 3.7 t80 -58.66 -170.04 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.747 -1.581 . . . . 0.0 108.249 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.618 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 10.1 t80 86.99 -7.4 0.67 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' CB ' ' O ' ' A' ' 54' ' ' PHE . 1.7 tt 150.81 0.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.682 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 52' ' ' GLN . 1.9 p -46.59 -39.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 120.037 -1.665 . . . . 0.0 108.128 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.643 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -88.98 -25.56 21.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.129 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 57' ' ' MET . . . -51.54 -27.82 19.5 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.507 -3.037 . . . . 0.0 105.507 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -107.43 -26.98 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.171 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.643 ' HB ' ' HA ' ' A' ' 57' ' ' MET . 94.4 t -104.17 -114.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.672 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 154.0 -91.09 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.927 -1.108 . . . . 0.0 109.399 178.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.671 ' N ' ' HB2' ' A' ' 65' ' ' MET . . . 47.11 32.87 2.14 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 124.174 1.94 . . . . 0.0 106.01 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.624 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 mt -109.71 -66.58 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.131 0 CA-C-N 111.822 -2.445 . . . . 0.0 104.496 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.668 ' HG2' ' N ' ' A' ' 65' ' ' MET 0.371 80.8 Cg_endo -81.41 -22.4 5.72 Favored 'Trans proline' 0 C--O 1.208 -0.977 1 N-CA-C 101.441 -4.1 . . . . 0.0 101.441 173.169 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.865 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 1.4 mmt -77.68 -26.51 50.34 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 110.829 -2.896 . . . . 0.0 108.881 -173.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.695 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 70.0 mt -109.61 -19.48 6.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 117.786 -1.565 . . . . 0.0 107.928 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.662 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.6 m -83.2 -40.63 19.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 72' ' ' LEU . 2.9 t -95.38 -28.94 4.0 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.865 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -62.64 -26.81 68.86 Favored Glycine 0 N--CA 1.495 2.626 1 N-CA-C 100.09 -5.204 . . . . 0.0 100.09 170.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -57.45 -55.85 29.45 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.866 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.53 27.34 10.88 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 118.438 -1.839 . . . . 0.0 113.61 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.885 ' CG ' ' HB2' ' A' ' 17' ' ' MET . 0.0 OUTLIER -112.06 -64.53 1.28 Allowed 'General case' 1 C--N 1.242 -4.079 1 N-CA-C 98.678 -4.564 . . . . 0.0 98.678 170.617 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.757 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -57.81 -20.41 35.51 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 171.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.866 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 65.8 t -100.9 -17.83 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 118.653 -2.53 . . . . 0.0 105.164 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.748 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -38.85 -38.86 0.46 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 174.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.716 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -109.53 -27.65 9.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.834 176.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.573 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 116.802 -1.959 . . . . 0.0 106.284 175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.566 HG11 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -91.28 -44.22 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.233 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.841 -1.076 . . . . 0.0 109.545 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.882 0.849 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.884 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -85.09 40.07 0.8 Allowed 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 116.761 -1.976 . . . . 0.0 111.162 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.596 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.49 -63.37 1.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 101.195 -3.631 . . . . 0.0 101.195 172.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -68.87 -43.13 75.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.74 ' CB ' ' HA ' ' A' ' 10' ' ' TYR . . . -67.42 -17.98 64.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 116.605 -2.038 . . . . 0.0 105.931 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.684 ' CB ' ' O ' ' A' ' 10' ' ' TYR . . . -58.01 -48.96 78.46 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.2 t -55.25 -48.09 76.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.672 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -45.34 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.865 -1.147 . . . . 0.0 110.178 178.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.918 ' CB ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.39 -17.7 64.93 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.892 0.853 . . . . 0.0 112.053 -176.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.74 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -93.1 -67.91 1.09 Allowed Glycine 0 C--O 1.19 -2.624 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -35.52 -48.93 0.53 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 121.278 2.539 . . . . 0.0 105.08 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' O ' ' CB ' ' A' ' 61' ' ' ASP . . . -63.5 -54.17 40.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.871 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -74.51 -63.78 1.17 Allowed 'General case' 0 C--O 1.189 -2.095 0 O-C-N 120.76 -1.212 . . . . 0.0 113.377 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -49.66 -27.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.0 -44.5 88.51 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 104.493 -3.443 . . . . 0.0 104.493 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.878 ' CB ' ' N ' ' A' ' 62' ' ' ALA . . . -85.79 12.08 9.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.619 -1.29 . . . . 0.0 109.8 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.684 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -141.04 9.9 2.14 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.897 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 109.249 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.617 ' CG ' ' N ' ' A' ' 54' ' ' PHE . 29.5 p90 -10.74 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' N ' ' CG ' ' A' ' 53' ' ' PHE . 40.4 t80 -139.06 -40.01 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.666 -1.271 . . . . 0.0 108.122 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.539 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 5.8 tt -63.09 -10.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.549 ' N ' ' HB3' ' A' ' 52' ' ' GLN . 8.6 p -61.79 -40.37 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.295 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.526 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 1.5 mtm -79.82 -41.13 27.04 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.33 -23.0 32.42 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -99.97 -23.42 14.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -96.97 -74.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.69 ' C ' ' HB3' ' A' ' 24' ' ' ALA . 25.0 m-20 -160.51 -137.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.882 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . 83.64 -34.12 0.07 Allowed 'General case' 0 CA--C 1.473 -1.998 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.775 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.334 1.2 mp -33.55 -49.08 0.73 Allowed Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 102.217 -3.253 . . . . 0.0 102.217 168.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.775 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.3 Cg_endo -67.88 -92.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 N-CA-C 105.086 -2.698 . . . . 0.0 105.086 169.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.882 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 6.26 -72.46 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 124.626 2.155 . . . . 0.0 109.794 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.24 -79.62 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.214 -5.291 0 CA-C-N 112.29 -2.232 . . . . 0.0 108.961 178.633 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 19.7 t -77.18 -46.59 22.84 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.04 -1.662 . . . . 0.0 110.336 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.89 ' O ' ' CG ' ' A' ' 17' ' ' MET 0.26 0.6 OUTLIER -95.18 -11.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 C-N-CA 116.884 -1.926 . . . . 0.0 108.593 -177.62 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.759 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.49 -35.04 74.66 Favored Glycine 0 CA--C 1.498 -1.006 1 N-CA-C 97.78 -6.128 . . . . 0.0 97.78 167.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.689 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -50.62 -43.47 56.87 Favored 'General case' 0 C--O 1.185 -2.31 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 171.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.753 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.07 -17.76 80.22 Favored Glycine 0 N--CA 1.5 2.916 0 CA-C-O 116.403 -2.331 . . . . 0.0 115.387 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.918 ' HB3' ' CB ' ' A' ' 17' ' ' MET . 1.4 pt? -84.79 -59.94 2.2 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 99.979 -4.082 . . . . 0.0 99.979 175.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.73 ' N ' ' HG ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -54.25 -18.32 3.81 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.697 1.236 . . . . 0.0 108.338 177.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.645 ' CB ' ' O ' ' A' ' 70' ' ' LEU . 69.1 t -105.25 -17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 118.328 -2.732 . . . . 0.0 105.998 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.753 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -48.28 -34.12 9.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.714 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.62 -26.45 10.86 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.785 -1.166 . . . . 0.0 108.21 174.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.663 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -89.63 49.15 1.69 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -101.02 88.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -178.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.539 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.625 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.304 0.573 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.898 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 49.2 t80 -72.02 23.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 111.903 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.567 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -89.41 -65.7 0.99 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 174.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.524 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -64.98 -40.46 95.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.772 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.07 -21.39 64.08 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 116.953 -1.899 . . . . 0.0 106.432 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.678 ' HA ' ' CZ ' ' A' ' 10' ' ' TYR . . . -53.91 -44.91 70.96 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 102.381 -3.192 . . . . 0.0 102.381 174.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.745 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.14 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.395 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.772 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -37.56 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.758 ' HB2' ' CB ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -73.3 -74.2 0.18 Allowed 'General case' 0 C--N 1.285 -2.213 0 O-C-N 119.895 -1.753 . . . . 0.0 108.088 178.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.668 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.45 -49.84 0.02 OUTLIER Glycine 0 C--N 1.28 -2.565 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tp -62.03 -68.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -59.38 -69.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 117.915 -1.514 . . . . 0.0 108.368 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.727 ' CB ' ' CB ' ' A' ' 65' ' ' MET . . . -57.66 -48.07 80.51 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -72.07 -24.83 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 116.661 -2.016 . . . . 0.0 105.564 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.65 -20.75 77.54 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.883 ' CB ' ' N ' ' A' ' 62' ' ' ALA . . . -101.96 -10.79 19.47 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.9 -1.15 . . . . 0.0 109.446 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -124.93 -66.31 0.97 Allowed 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.508 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' ILE . 17.0 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.091 -1.006 . . . . 0.0 109.398 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.556 ' HA ' ' CA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 17.6 p90 27.41 53.44 0.05 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 2.3 t80 83.58 -44.77 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 108.986 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -73.32 -0.58 2.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.122 -0.986 . . . . 0.0 108.552 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.556 ' CA ' ' HA ' ' A' ' 52' ' ' GLN . 6.5 p -53.13 -28.16 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.075 -1.016 . . . . 0.0 109.215 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.539 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.24 -41.77 94.02 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.533 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 63' ' ' ILE . . . -57.68 -20.75 40.61 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.35 -19.61 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 57' ' ' MET . 1.5 t -99.57 -69.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.697 . . . . 0.0 109.169 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.607 ' C ' ' HB3' ' A' ' 24' ' ' ALA . 16.8 m-20 -151.29 -136.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.883 ' N ' ' CB ' ' A' ' 24' ' ' ALA . . . 77.22 -70.89 0.12 Allowed 'General case' 0 C--O 1.172 -2.987 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.701 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.322 0.2 OUTLIER -17.34 -54.05 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.243 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.661 ' N ' ' O ' ' A' ' 62' ' ' ALA . 38.1 Cg_endo -70.38 -63.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.254 -2.249 . . . . 0.0 106.254 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.781 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -17.2 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 123.736 1.732 . . . . 0.0 107.904 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.77 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -56.39 -77.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.574 0 CA-C-N 111.557 -2.565 . . . . 0.0 109.352 176.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 5.3 p -78.4 -48.77 14.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 122.246 1.022 . . . . 0.0 111.469 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' A' ' 72' ' ' LEU . 3.1 t -82.98 -43.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.891 0 O-C-N 119.937 -1.727 . . . . 0.0 108.075 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -58.06 -25.68 57.17 Favored Glycine 0 CA--C 1.483 -1.919 1 N-CA-C 101.834 -4.506 . . . . 0.0 101.834 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.77 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -56.38 -58.11 9.39 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 116.157 -2.217 . . . . 0.0 105.299 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.748 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.54 18.15 55.72 Favored Glycine 0 CA--C 1.464 -3.111 0 C-N-CA 116.767 -2.635 . . . . 0.0 115.203 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.898 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.5 -49.14 3.3 Favored 'General case' 0 C--N 1.246 -3.897 1 N-CA-C 98.3 -4.704 . . . . 0.0 98.3 172.03 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.885 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -53.52 -26.72 22.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 170.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.748 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 21.2 t -85.76 -30.47 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.844 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -31.8 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 175.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.727 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.01 -31.42 7.64 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.556 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -84.75 39.06 0.73 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.021 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -92.46 -18.11 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.548 -178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.501 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.667 ' O ' ' HB1' ' A' ' 13' ' ' ALA . 6.9 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.855 ' HB2' ' CB ' ' A' ' 75' ' ' MET . 38.1 t80 -73.65 25.21 0.07 Allowed 'General case' 0 C--O 1.202 -1.443 0 O-C-N 121.073 -1.017 . . . . 0.0 111.037 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.562 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -89.14 -65.25 1.04 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -66.01 -40.03 90.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.673 ' CB ' ' HA ' ' A' ' 10' ' ' TYR . . . -69.01 -22.4 64.07 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.665 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -54.99 -44.47 74.52 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 101.947 -3.353 . . . . 0.0 101.947 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.724 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 3.1 t -60.5 -48.31 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.694 ' HG3' ' CD1' ' A' ' 72' ' ' LEU . 3.2 ptp -42.09 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.995 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.856 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.24 -70.45 0.44 Allowed 'General case' 0 C--O 1.187 -2.221 0 O-C-N 118.57 -2.581 . . . . 0.0 107.924 177.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -20.03 -56.39 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 4.3 tt -55.28 -68.08 0.22 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.848 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.0 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.102 -1.439 . . . . 0.0 107.971 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.782 ' HB3' ' HB3' ' A' ' 65' ' ' MET . . . -53.89 -70.41 0.1 Allowed 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.125 -0.984 . . . . 0.0 112.043 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -45.39 -25.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 118.883 -2.386 . . . . 0.0 106.965 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -62.89 -59.51 9.03 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.854 ' HB2' ' HG3' ' A' ' 65' ' ' MET . . . -84.07 -70.54 0.56 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 175.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -30.3 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.852 0.358 . . . . 0.0 110.54 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 24' ' ' ALA . 20.0 mm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.841 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.549 ' CA ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tt0 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CZ ' ' CG2' ' A' ' 55' ' ' ILE . 2.8 p90 16.4 -134.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 122.777 0.431 . . . . 0.0 112.077 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.536 ' HA ' ' CG ' ' A' ' 57' ' ' MET . 2.1 t80 -61.26 -26.78 67.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.065 . . . . 0.0 110.948 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.635 ' CG2' ' CZ ' ' A' ' 53' ' ' PHE . 12.2 pt -79.81 5.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.556 -1.34 . . . . 0.0 110.47 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' A' ' 52' ' ' GLN . 3.8 p -130.11 -10.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.795 -1.191 . . . . 0.0 110.922 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.551 ' CB ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -65.46 -48.41 72.76 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.61 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.42 57.63 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 106.254 -2.738 . . . . 0.0 106.254 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -90.39 -22.51 21.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.021 -0.694 . . . . 0.0 109.416 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 5.5 p -126.26 -61.18 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.966 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.736 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -53.08 -18.7 2.27 Favored 'General case' 0 CA--C 1.453 -2.77 0 C-N-CA 116.444 -2.102 . . . . 0.0 110.412 -175.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.947 ' HA ' ' HB2' ' A' ' 65' ' ' MET 0.298 . . -156.82 94.9 1.48 Allowed 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 113.683 -3.207 . . . . 0.0 116.975 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.623 ' CG2' ' HD3' ' A' ' 64' ' ' PRO . 1.3 mp -119.98 -74.21 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.73 ' HG2' ' N ' ' A' ' 65' ' ' MET 0.382 94.3 Cg_endo -82.87 -25.47 2.86 Favored 'Trans proline' 0 C--O 1.201 -1.345 0 N-CA-C 103.744 -3.214 . . . . 0.0 103.744 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.947 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 8.1 mmt -55.34 -56.46 19.8 Favored 'General case' 0 C--O 1.185 -2.335 0 CA-C-N 112.78 -2.009 . . . . 0.0 108.986 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.682 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 80.6 mt -107.94 -8.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 117.37 -1.732 . . . . 0.0 110.289 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.724 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 11.9 t -85.28 -48.84 8.69 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.982 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.3 t -86.12 -34.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 C-N-CA 116.55 -2.06 . . . . 0.0 105.693 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.879 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -64.75 -19.06 64.8 Favored Glycine 0 CA--C 1.48 -2.154 1 N-CA-C 101.99 -4.444 . . . . 0.0 101.99 171.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.8 OUTLIER -55.67 -54.93 38.17 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 102.912 -2.996 . . . . 0.0 102.912 174.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.723 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -86.7 3.66 86.85 Favored Glycine 0 N--CA 1.515 3.9 0 C-N-CA 118.752 -1.69 . . . . 0.0 114.41 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.982 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 6.8 mt -107.76 -61.74 1.53 Allowed 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 101.462 -3.533 . . . . 0.0 101.462 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 82.5 m-85 -47.41 -28.46 2.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 171.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.723 ' HB ' ' HA2' ' A' ' 71' ' ' GLY . 46.1 t -87.37 -28.78 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.855 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -31.62 -37.89 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.701 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.17 -31.76 8.11 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' N ' ' CD1' ' A' ' 76' ' ' PHE . . . -86.3 46.09 1.3 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -96.77 -30.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.578 -178.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' OXT' ' O ' ' A' ' 78' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.939 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 t80 -59.26 3.99 0.04 OUTLIER 'General case' 0 C--O 1.19 -2.027 0 O-C-N 121.468 -0.77 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.564 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 3.8 mmt -84.73 -74.84 0.37 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 118.762 -2.461 . . . . 0.0 107.085 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 15' ' ' VAL . . . -60.76 -36.35 78.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.73 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.18 -26.33 64.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.657 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . . . -50.81 -43.72 58.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 102.901 -2.999 . . . . 0.0 102.901 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 2.4 t -61.79 -51.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.73 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 2.3 tpp -40.43 -91.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.815 1.293 . . . . 0.0 110.141 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.893 ' CG ' ' O ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -67.15 -19.13 65.55 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.379 -175.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.728 ' O ' ' C ' ' A' ' 19' ' ' LEU . . . -95.42 -71.8 1.12 Allowed Glycine 0 C--O 1.194 -2.366 0 N-CA-C 107.067 -2.413 . . . . 0.0 107.067 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -31.55 -49.15 0.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 120.396 2.098 . . . . 0.0 105.761 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.611 ' O ' ' CB ' ' A' ' 61' ' ' ASP . . . -65.54 -61.04 2.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.84 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -66.0 -62.31 1.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.28 -1.368 . . . . 0.0 113.042 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.679 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -56.12 -23.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.09 -38.42 92.37 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 103.766 -3.734 . . . . 0.0 103.766 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.88 ' CB ' ' N ' ' A' ' 62' ' ' ALA . . . -89.41 3.56 51.87 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.253 -1.473 . . . . 0.0 110.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -138.29 15.51 2.79 Favored 'General case' 0 C--N 1.286 -2.173 0 O-C-N 121.709 -0.619 . . . . 0.0 109.641 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.576 ' N ' ' O ' ' A' ' 22' ' ' ILE . 26.4 pt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.932 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.524 ' CG ' HG23 ' A' ' 60' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.473 0.654 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.704 ' O ' ' N ' ' A' ' 55' ' ' ILE . 46.1 t80 -49.13 -35.25 16.06 Favored 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 118.161 -1.415 . . . . 0.0 107.907 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 56' ' ' VAL . 32.0 t80 -44.22 87.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.704 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.4 tp 38.67 26.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 54' ' ' PHE . 97.7 t -137.88 19.46 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.426 -1.422 . . . . 0.0 110.567 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.483 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -76.22 -42.99 44.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 108.931 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.49 36.18 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.74 -23.62 15.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' A' ' 61' ' ' ASP . 1.8 t -99.74 -78.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.664 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 64.1 m-20 -161.24 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 1.012 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . 87.39 -43.63 0.03 OUTLIER 'General case' 0 CA--C 1.454 -2.73 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.754 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.325 0.5 OUTLIER -28.91 -48.6 0.25 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 169.789 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.754 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 30.0 Cg_endo -66.08 -85.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 104.734 -2.833 . . . . 0.0 104.734 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 1.012 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 0.87 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.342 0 CA-C-O 123.327 1.536 . . . . 0.0 108.666 178.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.724 ' CG1' ' O ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -42.88 -84.51 0.0 OUTLIER 'Isoleucine or valine' 1 C--N 1.228 -4.682 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.054 174.688 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.698 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.8 t -81.19 -43.45 19.29 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.455 -1.403 . . . . 0.0 112.103 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.893 ' O ' ' CG ' ' A' ' 17' ' ' MET 0.256 0.6 OUTLIER -93.98 -14.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.423 0 C-N-CA 116.902 -1.919 . . . . 0.0 106.75 -178.08 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.798 ' HA2' ' CD2' ' A' ' 72' ' ' LEU . . . -68.38 -37.78 86.35 Favored Glycine 0 C--N 1.302 -1.343 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 167.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.698 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -50.5 -44.27 55.91 Favored 'General case' 0 C--O 1.183 -2.438 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 172.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.791 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -78.99 -10.07 86.52 Favored Glycine 0 N--CA 1.506 3.347 0 CA-C-O 117.0 -2.0 . . . . 0.0 115.093 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.939 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 2.4 pt? -86.39 -56.99 3.18 Favored 'General case' 0 C--N 1.284 -2.259 1 N-CA-C 98.9 -4.481 . . . . 0.0 98.9 174.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.785 ' N ' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -60.69 -14.32 20.16 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.625 1.202 . . . . 0.0 108.329 176.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.674 ' CB ' ' O ' ' A' ' 70' ' ' LEU . 98.1 t -111.94 -8.5 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 119.125 -2.234 . . . . 0.0 106.053 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.791 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -54.43 -30.03 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 100.717 -3.808 . . . . 0.0 100.717 173.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.702 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -108.95 -38.4 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.845 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . . . -67.87 1.09 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.519 -1.672 . . . . 0.0 108.845 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -51.36 -22.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.37 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 40.7 t80 -70.96 20.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.627 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.821 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.5 ttm -87.91 -65.82 0.98 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.67 -38.51 89.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -68.97 -23.47 64.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.58 -45.27 66.4 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.707 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -57.05 -55.28 21.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.81 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -33.5 -85.46 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.908 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -76.04 -73.59 0.26 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 119.718 -1.864 . . . . 0.0 107.992 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -19.23 -52.52 0.01 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.707 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.3 tt -61.61 -71.53 0.15 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.847 -1.973 . . . . 0.0 105.917 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.52 -64.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.001 -1.48 . . . . 0.0 108.832 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB2' ' SD ' ' A' ' 17' ' ' MET . . . -67.57 -56.53 9.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -57.73 -22.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 O-C-N 118.334 -2.729 . . . . 0.0 104.566 177.052 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' A' ' 21' ' ' ALA . . . -72.12 -35.31 60.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -82.84 -79.75 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . . . . . . 0 C--N 1.296 -1.722 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.643 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.322 0.8 OUTLIER . . . . . 0 C--O 1.251 1.14 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 . . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.753 ' C ' ' H ' ' A' ' 69' ' ' GLY . 41.4 Cg_endo -70.86 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 103.322 -3.376 . . . . 0.0 103.322 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 1.046 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -3.15 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 CA-C-O 124.0 1.857 . . . . 0.0 109.062 175.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.768 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -55.66 -69.67 0.13 Allowed 'Isoleucine or valine' 1 C--N 1.244 -4.021 0 CA-C-N 111.74 -2.482 . . . . 0.0 109.573 -179.934 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.672 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -81.8 -49.71 10.08 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 120.655 1.57 . . . . 0.0 110.823 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.138 HG12 ' CD2' ' A' ' 72' ' ' LEU . 4.3 t -84.43 -36.13 11.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 O-C-N 119.772 -1.83 . . . . 0.0 108.763 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 64' ' ' PRO . . . -64.08 -24.78 68.99 Favored Glycine 0 CA--C 1.481 -2.071 1 N-CA-C 100.998 -4.841 . . . . 0.0 100.998 171.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.146 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -57.02 -51.47 69.12 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 173.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.841 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -95.5 12.85 67.4 Favored Glycine 0 N--CA 1.497 2.766 0 C-N-CA 116.543 -2.741 . . . . 0.0 116.492 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.138 ' CD2' HG12 ' A' ' 68' ' ' VAL . 3.8 mm? -102.46 -47.51 4.44 Favored 'General case' 1 C--N 1.243 -4.025 1 N-CA-C 97.184 -5.117 . . . . 0.0 97.184 170.802 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.868 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -54.05 -28.15 36.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 170.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.146 HG23 ' O ' ' A' ' 70' ' ' LEU . 47.8 t -82.72 -30.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.798 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.03 -37.04 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.764 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -108.85 -30.34 8.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.976 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -85.33 40.45 0.83 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.551 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 33.1 t80 -72.86 23.57 0.06 Allowed 'General case' 0 C--O 1.196 -1.755 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.283 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.809 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 mtp -87.66 -64.9 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -66.34 -44.05 84.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -63.97 -21.89 66.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 117.067 -1.853 . . . . 0.0 106.207 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -58.82 -47.99 82.88 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 175.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -59.74 -35.2 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 1.154 ' CG ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -51.49 -86.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.691 0.758 . . . . 0.0 109.815 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.1 tpp -88.76 6.74 37.32 Favored 'General case' 0 C--N 1.288 -2.083 0 O-C-N 120.998 -1.064 . . . . 0.0 110.853 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -106.59 -51.43 0.8 Allowed Glycine 0 C--N 1.266 -3.316 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.1 tt -59.3 -50.08 75.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 17' ' ' MET . . . -61.86 -44.12 97.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.513 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 17' ' ' MET 0.264 . . -90.88 -59.76 2.09 Favored 'General case' 0 C--O 1.19 -2.048 0 C-N-CA 117.608 -1.637 . . . . 0.0 111.772 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -44.35 -31.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 118.915 -2.366 . . . . 0.0 105.544 174.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -69.26 -48.68 44.32 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 174.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.768 ' HB3' ' HG3' ' A' ' 65' ' ' MET . . . -83.93 -73.68 0.41 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.3 -1.549 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.664 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.718 HG22 ' HD3' ' A' ' 64' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.376 76.8 Cg_endo -78.9 -21.76 9.33 Favored 'Trans proline' 0 C--O 1.202 -1.299 0 N-CA-C 102.938 -3.524 . . . . 0.0 102.938 173.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.902 ' CA ' ' HB2' ' A' ' 21' ' ' ALA 0.286 1.8 mmt -81.1 -56.02 4.37 Favored 'General case' 0 C--O 1.2 -1.524 0 CA-C-N 111.102 -2.772 . . . . 0.0 108.89 -173.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.775 ' O ' HD13 ' A' ' 70' ' ' LEU . 6.6 mt -75.99 -36.63 32.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 C-N-CA 116.828 -1.949 . . . . 0.0 108.228 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.691 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.6 t -83.95 -55.05 4.44 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.79 1.281 . . . . 0.0 109.551 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' A' ' 17' ' ' MET . 6.1 t -86.63 -22.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 C-N-CA 116.46 -2.096 . . . . 0.0 107.57 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.775 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -73.17 -24.4 75.67 Favored Glycine 0 C--O 1.191 -2.55 1 N-CA-C 99.178 -5.569 . . . . 0.0 99.178 169.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.073 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 tp -56.75 -45.29 82.11 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 115.895 -2.322 . . . . 0.0 105.066 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -90.17 -2.71 73.79 Favored Glycine 0 CA--C 1.466 -3.009 0 C-N-CA 117.694 -2.193 . . . . 0.0 115.731 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.154 HD12 ' CG ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.77 -41.04 7.84 Favored 'General case' 0 C--N 1.25 -3.727 1 N-CA-C 98.705 -4.554 . . . . 0.0 98.705 173.833 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -51.1 -29.6 13.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 101.816 -3.402 . . . . 0.0 101.816 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 70' ' ' LEU . 57.3 t -81.82 -32.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.782 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -31.6 -36.75 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.806 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -108.43 -31.52 7.79 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.04 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.9 46.16 1.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.596 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.424 0.631 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.042 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 39.4 t80 -77.76 28.38 0.17 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.826 -1.149 . . . . 0.0 111.238 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.778 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 9.8 mmt -91.66 -63.79 1.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.042 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -76.73 -20.58 56.36 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.43 -43.31 64.78 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 19' ' ' LEU . 2.2 t -65.33 -51.17 67.86 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.83 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 1.5 mmt -27.29 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 CA-C-O 123.895 1.807 . . . . 0.0 106.966 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.961 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -79.41 -71.01 0.47 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 109.425 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.739 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.87 -48.45 0.02 OUTLIER Glycine 0 C--N 1.286 -2.211 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.942 HD12 HG12 ' A' ' 15' ' ' VAL . 1.9 tt -64.15 -71.47 0.17 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -60.5 -69.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.813 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.148 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -56.56 -41.7 77.32 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.756 HD13 ' HE1' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -74.04 -30.07 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 118.064 -2.898 . . . . 0.0 104.644 175.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.98 -11.86 64.11 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.636 -2.586 . . . . 0.0 106.636 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -107.68 -92.21 0.41 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.93 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . . . . . . 0 C--N 1.296 -1.761 0 O-C-N 121.416 -0.803 . . . . 0.0 109.48 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.603 ' CB ' ' CD ' ' A' ' 64' ' ' PRO 0.311 0.7 OUTLIER . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 44.4 Cg_endo -72.82 -62.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 N-CA-C 106.095 -2.31 . . . . 0.0 106.095 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 1.148 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -18.02 -56.03 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.334 0 CA-C-O 123.927 1.823 . . . . 0.0 108.299 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.756 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.91 -73.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.892 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.024 175.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.679 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 69.2 m -77.83 -50.62 11.93 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.217 1.008 . . . . 0.0 111.785 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.768 HG12 ' CD2' ' A' ' 72' ' ' LEU . 3.1 t -86.39 -28.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 O-C-N 119.681 -1.887 . . . . 0.0 109.071 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.811 ' CA ' ' HG3' ' A' ' 17' ' ' MET . . . -68.79 -25.38 75.21 Favored Glycine 0 CA--C 1.489 -1.557 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 170.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -56.86 -56.01 27.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -88.87 11.55 68.64 Favored Glycine 0 N--CA 1.514 3.899 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.425 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.883 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . 1.4 mp -109.97 -64.11 1.3 Allowed 'General case' 1 C--N 1.241 -4.123 0 N-CA-C 100.328 -3.952 . . . . 0.0 100.328 174.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.756 ' HE1' HD13 ' A' ' 22' ' ' ILE . 24.7 m-85 -47.52 -27.69 1.89 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 77' ' ' ALA . 45.6 t -88.61 -27.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.069 -1.644 . . . . 0.0 107.065 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.875 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.72 -36.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.264 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.736 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -109.04 -31.53 7.59 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.047 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.24 45.49 1.24 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.681 -1.608 . . . . 0.0 106.755 177.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.785 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.424 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' MET . 1.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.012 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 1.5 t80 -60.36 7.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.825 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.755 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -83.67 -68.58 0.7 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 119.267 -2.146 . . . . 0.0 105.868 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.14 -35.4 80.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.012 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.6 -26.12 64.29 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.17 -46.56 68.97 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.703 HG13 ' HB2' ' A' ' 19' ' ' LEU . 24.5 t -61.26 -44.51 98.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.789 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -46.28 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.67 -1.269 . . . . 0.0 110.104 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 1.094 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -65.24 -22.86 66.93 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.528 -176.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.111 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -91.15 -69.01 1.18 Allowed Glycine 0 C--O 1.191 -2.558 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.725 ' C ' ' O ' ' A' ' 18' ' ' GLY . 3.0 tp -35.25 -48.75 0.47 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.106 -2.408 . . . . 0.0 105.448 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.885 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.91 -52.86 57.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.861 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -75.77 -60.91 2.11 Favored 'General case' 0 C--O 1.193 -1.911 0 O-C-N 120.716 -1.24 . . . . 0.0 113.382 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.3 mm -51.0 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.46 -42.44 89.17 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 104.666 -3.374 . . . . 0.0 104.666 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -89.16 15.18 9.25 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 113.755 -1.222 . . . . 0.0 109.533 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.288 -2.092 0 O-C-N 121.608 -0.682 . . . . 0.0 109.747 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.791 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.328 0.3 OUTLIER . . . . . 0 C--O 1.252 1.211 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 . . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.885 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 36.5 Cg_endo -68.59 -92.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.928 0 N-CA-C 105.094 -2.695 . . . . 0.0 105.094 169.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.88 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER 5.93 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.554 0 CA-C-O 124.599 2.143 . . . . 0.0 109.876 179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.7 -78.48 0.02 OUTLIER 'Isoleucine or valine' 1 C--N 1.211 -5.416 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.073 178.904 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.701 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 m -78.83 -45.31 21.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 119.815 -1.803 . . . . 0.0 110.266 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.094 HG12 ' CG ' ' A' ' 17' ' ' MET 0.259 0.6 OUTLIER -95.34 -12.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 0 C-N-CA 116.868 -1.933 . . . . 0.0 108.152 -178.05 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.904 ' HA2' HD23 ' A' ' 72' ' ' LEU . . . -69.33 -34.26 74.38 Favored Glycine 0 CA--C 1.492 -1.396 1 N-CA-C 98.218 -5.953 . . . . 0.0 98.218 167.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -49.32 -46.66 47.06 Favored 'General case' 0 C--O 1.179 -2.639 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 171.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.27 -13.97 82.32 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-O 116.414 -2.325 . . . . 0.0 115.376 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.183 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.5 pt? -84.62 -59.06 2.48 Favored 'General case' 0 C--N 1.293 -1.853 2 CA-C-N 124.902 4.351 . . . . 0.0 99.92 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.183 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -59.73 -14.44 14.39 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.782 177.198 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.979 ' O ' HG13 ' A' ' 78' ' ' VAL . 93.5 t -109.1 -13.05 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 119.055 -2.278 . . . . 0.0 106.002 173.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.776 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -50.65 -30.92 14.74 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 174.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.825 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.79 -34.59 6.41 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.574 175.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -77.18 19.56 0.32 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.333 -1.747 . . . . 0.0 108.454 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.055 ' CD1' HD13 ' A' ' 72' ' ' LEU . 7.2 t80 -61.78 5.98 0.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.835 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.761 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -87.24 -75.97 0.38 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.519 -1.363 . . . . 0.0 107.54 177.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.12 -35.85 76.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.2 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -69.97 -31.53 69.29 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -42.51 -40.92 2.79 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 1.049 HG12 HD12 ' A' ' 19' ' ' LEU . 2.5 t -59.83 -64.83 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.93 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -13.4 -97.54 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.346 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.945 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.925 ' HB2' ' CG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.46 -84.08 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.932 ' H ' HD12 ' A' ' 72' ' ' LEU . . . -11.12 -62.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.087 -2.405 . . . . 0.0 107.087 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.049 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -56.18 -75.79 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.087 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -53.95 -67.12 0.29 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -68.44 -53.04 26.18 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.718 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -59.14 -22.72 22.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 114.241 -2.984 . . . . 0.0 104.541 177.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -72.06 -35.54 61.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.58 ' HB3' ' HG3' ' A' ' 65' ' ' MET . . . -95.48 -78.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.295 -1.802 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.892 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.1 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.759 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.371 80.8 Cg_endo -81.41 -22.4 5.72 Favored 'Trans proline' 0 C--O 1.208 -0.977 1 N-CA-C 101.441 -4.1 . . . . 0.0 101.441 173.169 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 1.045 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 1.4 mmt -77.68 -26.51 50.34 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 110.829 -2.896 . . . . 0.0 108.881 -173.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.695 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 70.0 mt -109.61 -19.48 6.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 117.786 -1.565 . . . . 0.0 107.928 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.662 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.6 m -83.2 -40.63 19.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 72' ' ' LEU . 2.9 t -95.38 -28.94 4.0 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.893 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -62.64 -26.81 68.86 Favored Glycine 0 N--CA 1.495 2.626 1 N-CA-C 100.09 -5.204 . . . . 0.0 100.09 170.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -57.45 -55.85 29.45 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.917 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.53 27.34 10.88 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 118.438 -1.839 . . . . 0.0 113.61 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.2 HD11 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -112.06 -64.53 1.28 Allowed 'General case' 1 C--N 1.242 -4.079 1 N-CA-C 98.678 -4.564 . . . . 0.0 98.678 170.617 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.758 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -57.81 -20.41 35.51 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 171.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 77' ' ' ALA . 65.8 t -100.9 -17.83 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 118.653 -2.53 . . . . 0.0 105.164 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -38.85 -38.86 0.46 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 174.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.798 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -109.53 -27.65 9.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.834 176.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.036 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 116.802 -1.959 . . . . 0.0 106.284 175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.233 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.882 0.849 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.043 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -85.09 40.07 0.8 Allowed 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 116.761 -1.976 . . . . 0.0 111.162 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.823 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.49 -63.37 1.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 101.195 -3.631 . . . . 0.0 101.195 172.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -68.87 -43.13 75.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.043 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -67.42 -17.98 64.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 116.605 -2.038 . . . . 0.0 105.931 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 1.018 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -58.01 -48.96 78.46 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.2 t -55.25 -48.09 76.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.719 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -45.34 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.865 -1.147 . . . . 0.0 110.178 178.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 1.102 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -66.39 -17.7 64.93 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.892 0.853 . . . . 0.0 112.053 -176.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.128 ' HA3' HD13 ' A' ' 72' ' ' LEU . . . -93.1 -67.91 1.09 Allowed Glycine 0 C--O 1.19 -2.624 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -35.52 -48.93 0.53 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 121.278 2.539 . . . . 0.0 105.08 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.5 -54.17 40.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.89 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -74.51 -63.78 1.17 Allowed 'General case' 0 C--O 1.189 -2.095 0 O-C-N 120.76 -1.212 . . . . 0.0 113.377 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.817 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -49.66 -27.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.0 -44.5 88.51 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 104.493 -3.443 . . . . 0.0 104.493 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -85.79 12.08 9.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.619 -1.29 . . . . 0.0 109.8 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.817 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . . . . . . 0 C--N 1.288 -2.088 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.897 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.808 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.334 1.2 mp . . . . . 0 C--O 1.251 1.172 0 N-CA-C 102.217 -3.253 . . . . 0.0 102.217 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.3 Cg_endo -67.88 -92.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 N-CA-C 105.086 -2.698 . . . . 0.0 105.086 169.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.89 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 6.26 -72.46 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 124.626 2.155 . . . . 0.0 109.794 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.24 -79.62 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.214 -5.291 0 CA-C-N 112.29 -2.232 . . . . 0.0 108.961 178.633 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 19.7 t -77.18 -46.59 22.84 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.04 -1.662 . . . . 0.0 110.336 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.102 HG12 ' CG ' ' A' ' 17' ' ' MET 0.26 0.6 OUTLIER -95.18 -11.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 C-N-CA 116.884 -1.926 . . . . 0.0 108.593 -177.62 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.49 -35.04 74.66 Favored Glycine 0 CA--C 1.498 -1.006 1 N-CA-C 97.78 -6.128 . . . . 0.0 97.78 167.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -50.62 -43.47 56.87 Favored 'General case' 0 C--O 1.185 -2.31 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 171.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.753 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.07 -17.76 80.22 Favored Glycine 0 N--CA 1.5 2.916 0 CA-C-O 116.403 -2.331 . . . . 0.0 115.387 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.175 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.4 pt? -84.79 -59.94 2.2 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 99.979 -4.082 . . . . 0.0 99.979 175.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.175 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -54.25 -18.32 3.81 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.697 1.236 . . . . 0.0 108.338 177.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 77' ' ' ALA . 69.1 t -105.25 -17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 118.328 -2.732 . . . . 0.0 105.998 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.998 ' HG3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -48.28 -34.12 9.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.714 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.62 -26.45 10.86 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.785 -1.166 . . . . 0.0 108.21 174.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.057 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -89.63 49.15 1.69 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.304 0.573 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.059 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 49.2 t80 -72.02 23.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 111.903 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.795 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -89.41 -65.7 0.99 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 174.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -64.98 -40.46 95.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.07 -21.39 64.08 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 116.953 -1.899 . . . . 0.0 106.432 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.91 -44.91 70.96 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 102.381 -3.192 . . . . 0.0 102.381 174.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.745 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.14 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.395 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.82 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -37.56 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.963 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.3 -74.2 0.18 Allowed 'General case' 0 C--N 1.285 -2.213 0 O-C-N 119.895 -1.753 . . . . 0.0 108.088 178.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.45 -49.84 0.02 OUTLIER Glycine 0 C--N 1.28 -2.565 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tp -62.03 -68.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -59.38 -69.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 117.915 -1.514 . . . . 0.0 108.368 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.13 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -57.66 -48.07 80.51 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -72.07 -24.83 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 116.661 -2.016 . . . . 0.0 105.564 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.65 -20.75 77.54 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.668 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -101.96 -10.79 19.47 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.9 -1.15 . . . . 0.0 109.446 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.289 -2.029 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.508 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.636 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.322 0.2 OUTLIER . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 . . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.659 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 38.1 Cg_endo -70.38 -63.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.254 -2.249 . . . . 0.0 106.254 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 1.13 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -17.2 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 123.736 1.732 . . . . 0.0 107.904 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.773 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -56.39 -77.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.574 0 CA-C-N 111.557 -2.565 . . . . 0.0 109.352 176.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 5.3 p -78.4 -48.77 14.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 122.246 1.022 . . . . 0.0 111.469 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.75 HG12 HD21 ' A' ' 72' ' ' LEU . 3.1 t -82.98 -43.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.891 0 O-C-N 119.937 -1.727 . . . . 0.0 108.075 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -58.06 -25.68 57.17 Favored Glycine 0 CA--C 1.483 -1.919 1 N-CA-C 101.834 -4.506 . . . . 0.0 101.834 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.131 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -56.38 -58.11 9.39 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 116.157 -2.217 . . . . 0.0 105.299 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.989 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -92.54 18.15 55.72 Favored Glycine 0 CA--C 1.464 -3.111 0 C-N-CA 116.767 -2.635 . . . . 0.0 115.203 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.989 HD23 ' C ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -107.5 -49.14 3.3 Favored 'General case' 0 C--N 1.246 -3.897 1 N-CA-C 98.3 -4.704 . . . . 0.0 98.3 172.03 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -53.52 -26.72 22.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 170.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.131 HG23 ' O ' ' A' ' 70' ' ' LEU . 21.2 t -85.76 -30.47 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.861 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -31.8 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 175.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.77 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.01 -31.42 7.64 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.931 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -84.75 39.06 0.73 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.021 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.548 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 9' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.0 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 38.1 t80 -73.65 25.21 0.07 Allowed 'General case' 0 C--O 1.202 -1.443 0 O-C-N 121.073 -1.017 . . . . 0.0 111.037 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.784 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -89.14 -65.25 1.04 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -66.01 -40.03 90.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 1.0 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.01 -22.4 64.07 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -54.99 -44.47 74.52 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 101.947 -3.353 . . . . 0.0 101.947 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.724 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 3.1 t -60.5 -48.31 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.991 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.2 ptp -42.09 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.995 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.928 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.24 -70.45 0.44 Allowed 'General case' 0 C--O 1.187 -2.221 0 O-C-N 118.57 -2.581 . . . . 0.0 107.924 177.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -20.03 -56.39 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 4.3 tt -55.28 -68.08 0.22 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.848 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.0 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.102 -1.439 . . . . 0.0 107.971 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -53.89 -70.41 0.1 Allowed 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.125 -0.984 . . . . 0.0 112.043 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -45.39 -25.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 118.883 -2.386 . . . . 0.0 106.965 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -62.89 -59.51 9.03 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.739 ' HB3' ' HG3' ' A' ' 65' ' ' MET . . . -84.07 -70.54 0.56 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.852 0.358 . . . . 0.0 110.54 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.774 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.3 mp . . . . . 0 CA--C 1.547 0.845 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.777 ' HG3' ' HE1' ' A' ' 65' ' ' MET 0.382 94.3 Cg_endo -82.87 -25.47 2.86 Favored 'Trans proline' 0 C--O 1.201 -1.345 0 N-CA-C 103.744 -3.214 . . . . 0.0 103.744 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.97 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mmt -55.34 -56.46 19.8 Favored 'General case' 0 C--O 1.185 -2.335 0 CA-C-N 112.78 -2.009 . . . . 0.0 108.986 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.682 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 80.6 mt -107.94 -8.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 117.37 -1.732 . . . . 0.0 110.289 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.724 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 11.9 t -85.28 -48.84 8.69 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.026 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.3 t -86.12 -34.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 C-N-CA 116.55 -2.06 . . . . 0.0 105.693 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.903 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -64.75 -19.06 64.8 Favored Glycine 0 CA--C 1.48 -2.154 1 N-CA-C 101.99 -4.444 . . . . 0.0 101.99 171.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.8 OUTLIER -55.67 -54.93 38.17 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 102.912 -2.996 . . . . 0.0 102.912 174.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.852 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -86.7 3.66 86.85 Favored Glycine 0 N--CA 1.515 3.9 0 C-N-CA 118.752 -1.69 . . . . 0.0 114.41 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.026 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 6.8 mt -107.76 -61.74 1.53 Allowed 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 101.462 -3.533 . . . . 0.0 101.462 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.789 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 82.5 m-85 -47.41 -28.46 2.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 171.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.071 HG13 ' O ' ' A' ' 77' ' ' ALA . 46.1 t -87.37 -28.78 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -31.62 -37.89 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.729 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.17 -31.76 8.11 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.071 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.3 46.09 1.3 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.578 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.702 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.939 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 t80 -59.26 3.99 0.04 OUTLIER 'General case' 0 C--O 1.19 -2.027 0 O-C-N 121.468 -0.77 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.704 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 mmt -84.73 -74.84 0.37 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 118.762 -2.461 . . . . 0.0 107.085 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.76 -36.35 78.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.792 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.18 -26.33 64.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -50.81 -43.72 58.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 102.901 -2.999 . . . . 0.0 102.901 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.895 HG12 HD12 ' A' ' 19' ' ' LEU . 2.4 t -61.79 -51.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.792 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 2.3 tpp -40.43 -91.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.815 1.293 . . . . 0.0 110.141 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 1.083 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -67.15 -19.13 65.55 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.379 -175.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.158 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -95.42 -71.8 1.12 Allowed Glycine 0 C--O 1.194 -2.366 0 N-CA-C 107.067 -2.413 . . . . 0.0 107.067 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -31.55 -49.15 0.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 120.396 2.098 . . . . 0.0 105.761 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.797 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -65.54 -61.04 2.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -66.0 -62.31 1.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.28 -1.368 . . . . 0.0 113.042 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.12 -23.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.09 -38.42 92.37 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 103.766 -3.734 . . . . 0.0 103.766 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -89.41 3.56 51.87 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.253 -1.473 . . . . 0.0 110.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . . . . . . 0 C--N 1.286 -2.173 0 O-C-N 121.709 -0.619 . . . . 0.0 109.641 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.032 ' HA ' HD11 ' A' ' 66' ' ' ILE 0.325 0.5 OUTLIER . . . . . 0 C--O 1.256 1.424 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 . . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.797 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 30.0 Cg_endo -66.08 -85.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 104.734 -2.833 . . . . 0.0 104.734 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.893 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 0.87 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.342 0 CA-C-O 123.327 1.536 . . . . 0.0 108.666 178.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -42.88 -84.51 0.0 OUTLIER 'Isoleucine or valine' 1 C--N 1.228 -4.682 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.054 174.688 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.698 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.8 t -81.19 -43.45 19.29 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.455 -1.403 . . . . 0.0 112.103 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 17' ' ' MET 0.256 0.6 OUTLIER -93.98 -14.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.423 0 C-N-CA 116.902 -1.919 . . . . 0.0 106.75 -178.08 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.928 ' O ' HD23 ' A' ' 72' ' ' LEU . . . -68.38 -37.78 86.35 Favored Glycine 0 C--N 1.302 -1.343 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 167.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.706 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.5 -44.27 55.91 Favored 'General case' 0 C--O 1.183 -2.438 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 172.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.791 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -78.99 -10.07 86.52 Favored Glycine 0 N--CA 1.506 3.347 0 CA-C-O 117.0 -2.0 . . . . 0.0 115.093 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.158 HD13 ' CA ' ' A' ' 18' ' ' GLY . 2.4 pt? -86.39 -56.99 3.18 Favored 'General case' 0 C--N 1.284 -2.259 1 N-CA-C 98.9 -4.481 . . . . 0.0 98.9 174.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.147 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -60.69 -14.32 20.16 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.625 1.202 . . . . 0.0 108.329 176.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.989 ' O ' HG13 ' A' ' 78' ' ' VAL . 98.1 t -111.94 -8.5 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 119.125 -2.234 . . . . 0.0 106.053 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.804 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -54.43 -30.03 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 100.717 -3.808 . . . . 0.0 100.717 173.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -108.95 -38.4 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.845 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -67.87 1.09 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.519 -1.672 . . . . 0.0 108.845 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.989 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 40.7 t80 -70.96 20.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.627 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.821 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.5 ttm -87.91 -65.82 0.98 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.67 -38.51 89.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -68.97 -23.47 64.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.58 -45.27 66.4 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.707 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -57.05 -55.28 21.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.81 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -33.5 -85.46 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.908 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -76.04 -73.59 0.26 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 119.718 -1.864 . . . . 0.0 107.992 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -19.23 -52.52 0.01 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.707 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.3 tt -61.61 -71.53 0.15 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.847 -1.973 . . . . 0.0 105.917 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.52 -64.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.001 -1.48 . . . . 0.0 108.832 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB2' ' SD ' ' A' ' 17' ' ' MET . . . -67.57 -56.53 9.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -57.73 -22.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 O-C-N 118.334 -2.729 . . . . 0.0 104.566 177.052 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' A' ' 21' ' ' ALA . . . -72.12 -35.31 60.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -82.84 -79.75 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . -40.11 -58.33 1.48 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 22' ' ' ILE . 3.5 mm . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.297 0.57 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 53' ' ' PHE . 79.8 t80 -68.32 -9.46 48.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.586 ' O ' HD12 ' A' ' 55' ' ' ILE . 50.8 t80 -45.12 -26.07 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 171.01 -20.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 56' ' ' VAL . 94.5 t -84.39 23.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.931 -1.105 . . . . 0.0 110.277 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.562 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -69.98 -40.49 75.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.851 -1.156 . . . . 0.0 109.507 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.05 -22.94 30.16 Favored Glycine 0 C--N 1.298 -1.545 0 N-CA-C 106.871 -2.492 . . . . 0.0 106.871 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -98.54 -23.37 15.55 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.711 HG12 ' HB1' ' A' ' 24' ' ' ALA . 9.5 t -57.89 -62.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 109.198 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 75.1 m-20 105.05 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 122.574 0.35 . . . . 0.0 110.553 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.948 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . -93.74 -30.12 15.04 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 116.267 -2.173 . . . . 0.0 106.921 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.688 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.322 0.8 OUTLIER -21.06 -56.03 0.08 OUTLIER Pre-proline 0 C--N 1.286 -2.156 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 172.63 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.753 ' C ' ' H ' ' A' ' 69' ' ' GLY . 41.4 Cg_endo -70.86 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 103.322 -3.376 . . . . 0.0 103.322 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 1.046 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -3.15 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 CA-C-O 124.0 1.857 . . . . 0.0 109.062 175.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.768 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -55.66 -69.67 0.13 Allowed 'Isoleucine or valine' 1 C--N 1.244 -4.021 0 CA-C-N 111.74 -2.482 . . . . 0.0 109.573 -179.934 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.672 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -81.8 -49.71 10.08 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 120.655 1.57 . . . . 0.0 110.823 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.138 HG12 ' CD2' ' A' ' 72' ' ' LEU . 4.3 t -84.43 -36.13 11.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 O-C-N 119.772 -1.83 . . . . 0.0 108.763 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 64' ' ' PRO . . . -64.08 -24.78 68.99 Favored Glycine 0 CA--C 1.481 -2.071 1 N-CA-C 100.998 -4.841 . . . . 0.0 100.998 171.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.146 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -57.02 -51.47 69.12 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 173.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.841 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -95.5 12.85 67.4 Favored Glycine 0 N--CA 1.497 2.766 0 C-N-CA 116.543 -2.741 . . . . 0.0 116.492 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.138 ' CD2' HG12 ' A' ' 68' ' ' VAL . 3.8 mm? -102.46 -47.51 4.44 Favored 'General case' 1 C--N 1.243 -4.025 1 N-CA-C 97.184 -5.117 . . . . 0.0 97.184 170.802 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.868 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -54.05 -28.15 36.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 170.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.146 HG23 ' O ' ' A' ' 70' ' ' LEU . 47.8 t -82.72 -30.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.798 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.03 -37.04 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.764 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -108.85 -30.34 8.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.976 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -85.33 40.45 0.83 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -94.85 37.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.551 -178.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.521 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 33.1 t80 -72.86 23.57 0.06 Allowed 'General case' 0 C--O 1.196 -1.755 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.283 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.809 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 mtp -87.66 -64.9 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -66.34 -44.05 84.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -63.97 -21.89 66.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 117.067 -1.853 . . . . 0.0 106.207 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -58.82 -47.99 82.88 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 175.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -59.74 -35.2 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 1.154 ' CG ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -51.49 -86.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.691 0.758 . . . . 0.0 109.815 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.1 tpp -88.76 6.74 37.32 Favored 'General case' 0 C--N 1.288 -2.083 0 O-C-N 120.998 -1.064 . . . . 0.0 110.853 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -106.59 -51.43 0.8 Allowed Glycine 0 C--N 1.266 -3.316 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.1 tt -59.3 -50.08 75.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 17' ' ' MET . . . -61.86 -44.12 97.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.513 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 17' ' ' MET 0.264 . . -90.88 -59.76 2.09 Favored 'General case' 0 C--O 1.19 -2.048 0 C-N-CA 117.608 -1.637 . . . . 0.0 111.772 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -44.35 -31.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 118.915 -2.366 . . . . 0.0 105.544 174.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -69.26 -48.68 44.32 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 174.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.856 ' HB1' ' N ' ' A' ' 62' ' ' ALA . . . -83.93 -73.68 0.41 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -47.13 -49.07 22.86 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.664 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 25' ' ' ALA . 3.1 tt . . . . . 0 N--CA 1.494 1.734 0 O-C-N 120.705 -1.247 . . . . 0.0 109.755 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' CZ ' ' CG1' ' A' ' 55' ' ' ILE . 16.3 p90 27.55 54.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.571 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 3.8 t80 84.19 -46.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' CG1' ' CZ ' ' A' ' 53' ' ' PHE . 39.8 mm -69.58 -4.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HA ' ' N ' ' A' ' 52' ' ' GLN . 4.6 p -45.78 -32.81 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 0.0 108.892 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.598 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -83.23 -38.91 21.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' MET . . . -51.82 -24.58 13.68 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 57' ' ' MET . 0.4 OUTLIER -103.85 -23.45 13.38 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.619 HG12 ' CB ' ' A' ' 24' ' ' ALA . 3.4 t -99.44 -77.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 108.971 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.005 ' O ' HD12 ' A' ' 63' ' ' ILE . 4.6 m-20 -166.17 -104.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.593 -1.317 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.856 ' N ' ' HB1' ' A' ' 24' ' ' ALA . . . 57.71 40.9 26.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.005 HD12 ' O ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -131.74 -63.28 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 111.003 -2.817 . . . . 0.0 104.269 -178.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.376 76.8 Cg_endo -78.9 -21.76 9.33 Favored 'Trans proline' 0 C--O 1.202 -1.299 0 N-CA-C 102.938 -3.524 . . . . 0.0 102.938 173.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.902 ' CA ' ' HB2' ' A' ' 21' ' ' ALA 0.286 1.8 mmt -81.1 -56.02 4.37 Favored 'General case' 0 C--O 1.2 -1.524 0 CA-C-N 111.102 -2.772 . . . . 0.0 108.89 -173.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.775 ' O ' HD13 ' A' ' 70' ' ' LEU . 6.6 mt -75.99 -36.63 32.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 C-N-CA 116.828 -1.949 . . . . 0.0 108.228 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.691 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.6 t -83.95 -55.05 4.44 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.79 1.281 . . . . 0.0 109.551 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' A' ' 17' ' ' MET . 6.1 t -86.63 -22.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 C-N-CA 116.46 -2.096 . . . . 0.0 107.57 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.775 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -73.17 -24.4 75.67 Favored Glycine 0 C--O 1.191 -2.55 1 N-CA-C 99.178 -5.569 . . . . 0.0 99.178 169.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.073 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 tp -56.75 -45.29 82.11 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 115.895 -2.322 . . . . 0.0 105.066 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -90.17 -2.71 73.79 Favored Glycine 0 CA--C 1.466 -3.009 0 C-N-CA 117.694 -2.193 . . . . 0.0 115.731 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.154 HD12 ' CG ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.77 -41.04 7.84 Favored 'General case' 0 C--N 1.25 -3.727 1 N-CA-C 98.705 -4.554 . . . . 0.0 98.705 173.833 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -51.1 -29.6 13.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 101.816 -3.402 . . . . 0.0 101.816 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 70' ' ' LEU . 57.3 t -81.82 -32.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.782 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -31.6 -36.75 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.806 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -108.43 -31.52 7.79 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.04 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.9 46.16 1.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -99.7 77.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.596 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.499 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.424 0.631 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.042 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 39.4 t80 -77.76 28.38 0.17 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.826 -1.149 . . . . 0.0 111.238 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.778 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 9.8 mmt -91.66 -63.79 1.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.042 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -76.73 -20.58 56.36 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.43 -43.31 64.78 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 19' ' ' LEU . 2.2 t -65.33 -51.17 67.86 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.83 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 1.5 mmt -27.29 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 CA-C-O 123.895 1.807 . . . . 0.0 106.966 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.961 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -79.41 -71.01 0.47 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 109.425 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.739 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.87 -48.45 0.02 OUTLIER Glycine 0 C--N 1.286 -2.211 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.942 HD12 HG12 ' A' ' 15' ' ' VAL . 1.9 tt -64.15 -71.47 0.17 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -60.5 -69.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.813 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.148 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -56.56 -41.7 77.32 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.756 HD13 ' HE1' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -74.04 -30.07 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 118.064 -2.898 . . . . 0.0 104.644 175.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.866 ' O ' HD12 ' A' ' 59' ' ' LEU . . . -68.98 -11.86 64.11 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.636 -2.586 . . . . 0.0 106.636 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -107.68 -92.21 0.41 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.93 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . -41.69 -34.95 0.68 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.416 -0.803 . . . . 0.0 109.48 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.773 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.765 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.557 ' HA ' ' CA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 22.3 p90 28.41 53.46 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 1.3 t80 83.74 -45.73 0.11 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.294 -0.879 . . . . 0.0 108.736 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.647 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.03 -4.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.87 HG13 ' H ' ' A' ' 58' ' ' GLY . 9.9 p -51.31 -26.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 108.965 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.606 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 14.8 mmt 63.42 29.29 15.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.87 ' H ' HG13 ' A' ' 56' ' ' VAL . . . 44.67 29.43 1.92 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -174.18 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 172.38 -44.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.992 0.901 . . . . 0.0 109.173 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 36.0 m-20 -159.29 -111.24 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.288 1.042 . . . . 0.0 108.714 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.014 ' N ' ' HB1' ' A' ' 24' ' ' ALA . . . 89.15 -53.73 0.03 OUTLIER 'General case' 0 C--O 1.181 -2.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.704 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.311 0.7 OUTLIER -18.36 -55.96 0.05 OUTLIER Pre-proline 0 C--N 1.285 -2.221 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.102 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 44.4 Cg_endo -72.82 -62.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 N-CA-C 106.095 -2.31 . . . . 0.0 106.095 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 1.148 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -18.02 -56.03 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.334 0 CA-C-O 123.927 1.823 . . . . 0.0 108.299 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.815 HG13 ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.91 -73.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.892 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.024 175.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.679 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 69.2 m -77.83 -50.62 11.93 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.217 1.008 . . . . 0.0 111.785 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.768 HG12 ' CD2' ' A' ' 72' ' ' LEU . 3.1 t -86.39 -28.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 O-C-N 119.681 -1.887 . . . . 0.0 109.071 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.811 ' CA ' ' HG3' ' A' ' 17' ' ' MET . . . -68.79 -25.38 75.21 Favored Glycine 0 CA--C 1.489 -1.557 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 170.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -56.86 -56.01 27.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -88.87 11.55 68.64 Favored Glycine 0 N--CA 1.514 3.899 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.425 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.883 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . 1.4 mp -109.97 -64.11 1.3 Allowed 'General case' 1 C--N 1.241 -4.123 0 N-CA-C 100.328 -3.952 . . . . 0.0 100.328 174.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.756 ' HE1' HD13 ' A' ' 22' ' ' ILE . 24.7 m-85 -47.52 -27.69 1.89 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 77' ' ' ALA . 45.6 t -88.61 -27.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.069 -1.644 . . . . 0.0 107.065 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.875 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.72 -36.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.264 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.736 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -109.04 -31.53 7.59 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.047 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.24 45.49 1.24 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.681 -1.608 . . . . 0.0 106.755 177.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.785 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -95.63 52.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.424 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.462 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' MET . 1.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.012 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 1.5 t80 -60.36 7.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.825 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.755 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -83.67 -68.58 0.7 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 119.267 -2.146 . . . . 0.0 105.868 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.14 -35.4 80.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.012 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.6 -26.12 64.29 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.17 -46.56 68.97 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.703 HG13 ' HB2' ' A' ' 19' ' ' LEU . 24.5 t -61.26 -44.51 98.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.789 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -46.28 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.67 -1.269 . . . . 0.0 110.104 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 1.094 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -65.24 -22.86 66.93 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.528 -176.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.111 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -91.15 -69.01 1.18 Allowed Glycine 0 C--O 1.191 -2.558 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.725 ' C ' ' O ' ' A' ' 18' ' ' GLY . 3.0 tp -35.25 -48.75 0.47 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.106 -2.408 . . . . 0.0 105.448 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.885 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.91 -52.86 57.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.861 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -75.77 -60.91 2.11 Favored 'General case' 0 C--O 1.193 -1.911 0 O-C-N 120.716 -1.24 . . . . 0.0 113.382 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.3 mm -51.0 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.46 -42.44 89.17 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 104.666 -3.374 . . . . 0.0 104.666 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.019 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -89.16 15.18 9.25 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 113.755 -1.222 . . . . 0.0 109.533 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -164.06 39.14 0.08 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.608 -0.682 . . . . 0.0 109.747 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ILE . 21.1 tt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.593 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.588 0.708 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 52' ' ' GLN . 6.3 t80 -61.87 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.617 -1.302 . . . . 0.0 108.941 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.806 ' O ' HD12 ' A' ' 55' ' ' ILE . 3.2 m-30 47.69 25.47 0.69 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.298 -1.501 . . . . 0.0 106.976 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 54' ' ' PHE . 2.3 mt 87.64 41.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 56' ' ' VAL . 87.8 t 62.41 29.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.609 -1.307 . . . . 0.0 110.357 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.595 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -77.85 -41.99 35.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.648 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 52' ' ' GLN . . . -55.44 -22.39 30.85 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 106.602 -2.599 . . . . 0.0 106.602 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.503 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 0.3 OUTLIER -101.24 -21.55 14.88 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.817 HG12 ' N ' ' A' ' 61' ' ' ASP . 2.2 t -101.0 -81.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.881 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 17.9 m-20 -158.23 -140.04 0.07 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.019 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . 85.09 -31.45 0.06 Allowed 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.791 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.328 0.3 OUTLIER -34.6 -48.58 0.95 Allowed Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 168.899 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.885 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 36.5 Cg_endo -68.59 -92.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.928 0 N-CA-C 105.094 -2.695 . . . . 0.0 105.094 169.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.98 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 5.93 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.554 0 CA-C-O 124.599 2.143 . . . . 0.0 109.876 179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.7 -78.48 0.02 OUTLIER 'Isoleucine or valine' 1 C--N 1.211 -5.416 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.073 178.904 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.701 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 m -78.83 -45.31 21.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 119.815 -1.803 . . . . 0.0 110.266 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.094 HG12 ' CG ' ' A' ' 17' ' ' MET 0.259 0.6 OUTLIER -95.34 -12.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 0 C-N-CA 116.868 -1.933 . . . . 0.0 108.152 -178.05 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.904 ' HA2' HD23 ' A' ' 72' ' ' LEU . . . -69.33 -34.26 74.38 Favored Glycine 0 CA--C 1.492 -1.396 1 N-CA-C 98.218 -5.953 . . . . 0.0 98.218 167.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -49.32 -46.66 47.06 Favored 'General case' 0 C--O 1.179 -2.639 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 171.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.27 -13.97 82.32 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-O 116.414 -2.325 . . . . 0.0 115.376 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.183 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.5 pt? -84.62 -59.06 2.48 Favored 'General case' 0 C--N 1.293 -1.853 2 CA-C-N 124.902 4.351 . . . . 0.0 99.92 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.183 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -59.73 -14.44 14.39 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.782 177.198 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.979 ' O ' HG13 ' A' ' 78' ' ' VAL . 93.5 t -109.1 -13.05 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 119.055 -2.278 . . . . 0.0 106.002 173.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.776 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -50.65 -30.92 14.74 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 174.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.825 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.79 -34.59 6.41 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.574 175.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -77.18 19.56 0.32 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.333 -1.747 . . . . 0.0 108.454 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -68.41 -43.6 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.48 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.055 ' CD1' HD13 ' A' ' 72' ' ' LEU . 7.2 t80 -61.78 5.98 0.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.835 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.761 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -87.24 -75.97 0.38 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.519 -1.363 . . . . 0.0 107.54 177.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.12 -35.85 76.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.2 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -69.97 -31.53 69.29 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -42.51 -40.92 2.79 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 1.049 HG12 HD12 ' A' ' 19' ' ' LEU . 2.5 t -59.83 -64.83 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.93 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -13.4 -97.54 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.346 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.945 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.925 ' HB2' ' CG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.46 -84.08 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.932 ' H ' HD12 ' A' ' 72' ' ' LEU . . . -11.12 -62.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.087 -2.405 . . . . 0.0 107.087 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.049 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -56.18 -75.79 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.087 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -53.95 -67.12 0.29 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -68.44 -53.04 26.18 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.803 HD12 HD13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -59.14 -22.72 22.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 114.241 -2.984 . . . . 0.0 104.541 177.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -72.06 -35.54 61.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.819 ' HA ' HG13 ' A' ' 60' ' ' VAL . . . -95.48 -78.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.927 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -43.81 -22.16 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.892 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.803 HD13 HD12 ' A' ' 22' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.497 1.895 0 O-C-N 120.176 -1.578 . . . . 0.0 109.806 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.639 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 5.8 pt20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.602 0.715 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.954 ' HA ' HG12 ' A' ' 56' ' ' VAL . 3.7 t80 -58.66 -170.04 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.747 -1.581 . . . . 0.0 108.249 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.679 ' C ' HG22 ' A' ' 55' ' ' ILE . 10.1 t80 86.99 -7.4 0.67 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.679 HG22 ' C ' ' A' ' 54' ' ' PHE . 1.7 tt 150.81 0.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.682 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 53' ' ' PHE . 1.9 p -46.59 -39.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 120.037 -1.665 . . . . 0.0 108.128 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.691 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -88.98 -25.56 21.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.129 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 57' ' ' MET . . . -51.54 -27.82 19.5 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.507 -3.037 . . . . 0.0 105.507 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -107.43 -26.98 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 24' ' ' ALA . 94.4 t -104.17 -114.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.687 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 154.0 -91.09 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.927 -1.108 . . . . 0.0 109.399 178.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.092 ' HB1' ' CD1' ' A' ' 66' ' ' ILE . . . 47.11 32.87 2.14 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 124.174 1.94 . . . . 0.0 106.01 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.1 mt -109.71 -66.58 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.131 0 CA-C-N 111.822 -2.445 . . . . 0.0 104.496 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.759 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.371 80.8 Cg_endo -81.41 -22.4 5.72 Favored 'Trans proline' 0 C--O 1.208 -0.977 1 N-CA-C 101.441 -4.1 . . . . 0.0 101.441 173.169 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 1.045 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 1.4 mmt -77.68 -26.51 50.34 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 110.829 -2.896 . . . . 0.0 108.881 -173.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.092 ' CD1' ' HB1' ' A' ' 62' ' ' ALA . 70.0 mt -109.61 -19.48 6.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 117.786 -1.565 . . . . 0.0 107.928 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.662 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.6 m -83.2 -40.63 19.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 72' ' ' LEU . 2.9 t -95.38 -28.94 4.0 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.893 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -62.64 -26.81 68.86 Favored Glycine 0 N--CA 1.495 2.626 1 N-CA-C 100.09 -5.204 . . . . 0.0 100.09 170.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -57.45 -55.85 29.45 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.917 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.53 27.34 10.88 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 118.438 -1.839 . . . . 0.0 113.61 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.2 HD11 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -112.06 -64.53 1.28 Allowed 'General case' 1 C--N 1.242 -4.079 1 N-CA-C 98.678 -4.564 . . . . 0.0 98.678 170.617 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.758 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -57.81 -20.41 35.51 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 171.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 77' ' ' ALA . 65.8 t -100.9 -17.83 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 118.653 -2.53 . . . . 0.0 105.164 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -38.85 -38.86 0.46 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 174.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.798 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -109.53 -27.65 9.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.834 176.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.036 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 116.802 -1.959 . . . . 0.0 106.284 175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -91.28 -44.22 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.233 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.841 -1.076 . . . . 0.0 109.545 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.882 0.849 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.043 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -85.09 40.07 0.8 Allowed 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 116.761 -1.976 . . . . 0.0 111.162 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.823 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.49 -63.37 1.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 101.195 -3.631 . . . . 0.0 101.195 172.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -68.87 -43.13 75.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.043 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -67.42 -17.98 64.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 116.605 -2.038 . . . . 0.0 105.931 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 1.018 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -58.01 -48.96 78.46 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.2 t -55.25 -48.09 76.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.719 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -45.34 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.865 -1.147 . . . . 0.0 110.178 178.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 1.102 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -66.39 -17.7 64.93 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.892 0.853 . . . . 0.0 112.053 -176.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.128 ' HA3' HD13 ' A' ' 72' ' ' LEU . . . -93.1 -67.91 1.09 Allowed Glycine 0 C--O 1.19 -2.624 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -35.52 -48.93 0.53 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 121.278 2.539 . . . . 0.0 105.08 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.5 -54.17 40.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.89 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -74.51 -63.78 1.17 Allowed 'General case' 0 C--O 1.189 -2.095 0 O-C-N 120.76 -1.212 . . . . 0.0 113.377 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.001 ' CG2' HD13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -49.66 -27.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.0 -44.5 88.51 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 104.493 -3.443 . . . . 0.0 104.493 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.064 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -85.79 12.08 9.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.619 -1.29 . . . . 0.0 109.8 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' C ' HD12 ' A' ' 26' ' ' ILE . . . -141.04 9.9 2.14 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.897 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.001 HD13 ' CG2' ' A' ' 22' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 109.249 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.828 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 55' ' ' ILE . 29.5 p90 -10.74 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' N ' ' CG ' ' A' ' 53' ' ' PHE . 40.4 t80 -139.06 -40.01 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.666 -1.271 . . . . 0.0 108.122 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 52' ' ' GLN . 5.8 tt -63.09 -10.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 57' ' ' MET . 8.6 p -61.79 -40.37 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.295 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.657 ' HG2' HG13 ' A' ' 56' ' ' VAL . 1.5 mtm -79.82 -41.13 27.04 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.33 -23.0 32.42 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -99.97 -23.42 14.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.795 HG12 ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -96.97 -74.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.825 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 25.0 m-20 -160.51 -137.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.064 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . 83.64 -34.12 0.07 Allowed 'General case' 0 CA--C 1.473 -1.998 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.808 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.334 1.2 mp -33.55 -49.08 0.73 Allowed Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 102.217 -3.253 . . . . 0.0 102.217 168.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.3 Cg_endo -67.88 -92.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 N-CA-C 105.086 -2.698 . . . . 0.0 105.086 169.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 1.026 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 6.26 -72.46 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 124.626 2.155 . . . . 0.0 109.794 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.24 -79.62 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.214 -5.291 0 CA-C-N 112.29 -2.232 . . . . 0.0 108.961 178.633 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 19.7 t -77.18 -46.59 22.84 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.04 -1.662 . . . . 0.0 110.336 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.102 HG12 ' CG ' ' A' ' 17' ' ' MET 0.26 0.6 OUTLIER -95.18 -11.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 C-N-CA 116.884 -1.926 . . . . 0.0 108.593 -177.62 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.49 -35.04 74.66 Favored Glycine 0 CA--C 1.498 -1.006 1 N-CA-C 97.78 -6.128 . . . . 0.0 97.78 167.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -50.62 -43.47 56.87 Favored 'General case' 0 C--O 1.185 -2.31 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 171.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.753 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.07 -17.76 80.22 Favored Glycine 0 N--CA 1.5 2.916 0 CA-C-O 116.403 -2.331 . . . . 0.0 115.387 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.175 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.4 pt? -84.79 -59.94 2.2 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 99.979 -4.082 . . . . 0.0 99.979 175.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.175 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -54.25 -18.32 3.81 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.697 1.236 . . . . 0.0 108.338 177.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 77' ' ' ALA . 69.1 t -105.25 -17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 118.328 -2.732 . . . . 0.0 105.998 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.998 ' HG3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -48.28 -34.12 9.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.714 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.62 -26.45 10.86 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.785 -1.166 . . . . 0.0 108.21 174.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.057 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -89.63 49.15 1.69 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -101.02 88.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -178.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.539 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.304 0.573 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.059 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 49.2 t80 -72.02 23.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 111.903 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.795 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -89.41 -65.7 0.99 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 174.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -64.98 -40.46 95.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.07 -21.39 64.08 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 116.953 -1.899 . . . . 0.0 106.432 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.91 -44.91 70.96 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 102.381 -3.192 . . . . 0.0 102.381 174.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.745 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.14 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.395 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.82 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -37.56 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.963 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.3 -74.2 0.18 Allowed 'General case' 0 C--N 1.285 -2.213 0 O-C-N 119.895 -1.753 . . . . 0.0 108.088 178.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.45 -49.84 0.02 OUTLIER Glycine 0 C--N 1.28 -2.565 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tp -62.03 -68.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.944 ' HB1' ' CG ' ' A' ' 61' ' ' ASP . . . -59.38 -69.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 117.915 -1.514 . . . . 0.0 108.368 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.13 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -57.66 -48.07 80.51 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -72.07 -24.83 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 116.661 -2.016 . . . . 0.0 105.564 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.65 -20.75 77.54 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.132 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -101.96 -10.79 19.47 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.9 -1.15 . . . . 0.0 109.446 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -124.93 -66.31 0.97 Allowed 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.508 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 22' ' ' ILE . 17.0 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.091 -1.006 . . . . 0.0 109.398 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.565 ' HA ' ' CA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 17.6 p90 27.41 53.44 0.05 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 2.3 t80 83.58 -44.77 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 108.986 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -73.32 -0.58 2.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.122 -0.986 . . . . 0.0 108.552 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' CA ' ' HA ' ' A' ' 52' ' ' GLN . 6.5 p -53.13 -28.16 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.075 -1.016 . . . . 0.0 109.215 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.565 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.24 -41.77 94.02 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.533 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.685 ' HA2' HD12 ' A' ' 63' ' ' ILE . . . -57.68 -20.75 40.61 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.35 -19.61 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 61' ' ' ASP . 1.5 t -99.57 -69.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.697 . . . . 0.0 109.169 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.944 ' CG ' ' HB1' ' A' ' 20' ' ' ALA . 16.8 m-20 -151.29 -136.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.132 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . 77.22 -70.89 0.12 Allowed 'General case' 0 C--O 1.172 -2.987 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.701 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.322 0.2 OUTLIER -17.34 -54.05 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.243 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.661 ' N ' ' O ' ' A' ' 62' ' ' ALA . 38.1 Cg_endo -70.38 -63.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.254 -2.249 . . . . 0.0 106.254 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 1.13 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -17.2 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 123.736 1.732 . . . . 0.0 107.904 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.778 HG13 ' O ' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -56.39 -77.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.574 0 CA-C-N 111.557 -2.565 . . . . 0.0 109.352 176.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 5.3 p -78.4 -48.77 14.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 122.246 1.022 . . . . 0.0 111.469 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.75 HG12 HD21 ' A' ' 72' ' ' LEU . 3.1 t -82.98 -43.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.891 0 O-C-N 119.937 -1.727 . . . . 0.0 108.075 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -58.06 -25.68 57.17 Favored Glycine 0 CA--C 1.483 -1.919 1 N-CA-C 101.834 -4.506 . . . . 0.0 101.834 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.131 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -56.38 -58.11 9.39 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 116.157 -2.217 . . . . 0.0 105.299 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.989 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -92.54 18.15 55.72 Favored Glycine 0 CA--C 1.464 -3.111 0 C-N-CA 116.767 -2.635 . . . . 0.0 115.203 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.989 HD23 ' C ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -107.5 -49.14 3.3 Favored 'General case' 0 C--N 1.246 -3.897 1 N-CA-C 98.3 -4.704 . . . . 0.0 98.3 172.03 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -53.52 -26.72 22.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 170.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.131 HG23 ' O ' ' A' ' 70' ' ' LEU . 21.2 t -85.76 -30.47 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.861 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -31.8 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 175.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.77 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.01 -31.42 7.64 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.931 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -84.75 39.06 0.73 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.021 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -92.46 -18.11 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.548 -178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.501 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 9' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.0 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 38.1 t80 -73.65 25.21 0.07 Allowed 'General case' 0 C--O 1.202 -1.443 0 O-C-N 121.073 -1.017 . . . . 0.0 111.037 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.784 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -89.14 -65.25 1.04 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -66.01 -40.03 90.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.0 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.01 -22.4 64.07 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -54.99 -44.47 74.52 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 101.947 -3.353 . . . . 0.0 101.947 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.724 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 3.1 t -60.5 -48.31 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.991 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.2 ptp -42.09 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.995 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.928 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.24 -70.45 0.44 Allowed 'General case' 0 C--O 1.187 -2.221 0 O-C-N 118.57 -2.581 . . . . 0.0 107.924 177.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -20.03 -56.39 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 4.3 tt -55.28 -68.08 0.22 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.848 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.0 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.102 -1.439 . . . . 0.0 107.971 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -53.89 -70.41 0.1 Allowed 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.125 -0.984 . . . . 0.0 112.043 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -45.39 -25.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 118.883 -2.386 . . . . 0.0 106.965 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -62.89 -59.51 9.03 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -84.07 -70.54 0.56 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 175.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -30.3 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.852 0.358 . . . . 0.0 110.54 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.766 HG22 ' O ' ' A' ' 26' ' ' ILE . 20.0 mm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.841 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.562 ' CA ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tt0 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.774 ' CE2' HG23 ' A' ' 55' ' ' ILE . 2.8 p90 16.4 -134.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 122.777 0.431 . . . . 0.0 112.077 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' HA ' ' CG ' ' A' ' 57' ' ' MET . 2.1 t80 -61.26 -26.78 67.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.065 . . . . 0.0 110.948 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.774 HG23 ' CE2' ' A' ' 53' ' ' PHE . 12.2 pt -79.81 5.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.556 -1.34 . . . . 0.0 110.47 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 60' ' ' VAL . 3.8 p -130.11 -10.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.795 -1.191 . . . . 0.0 110.922 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.56 ' CG ' ' HA ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -65.46 -48.41 72.76 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.61 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.42 57.63 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 106.254 -2.738 . . . . 0.0 106.254 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -90.39 -22.51 21.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.021 -0.694 . . . . 0.0 109.416 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.776 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.5 p -126.26 -61.18 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.966 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.745 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -53.08 -18.7 2.27 Favored 'General case' 0 CA--C 1.453 -2.77 0 C-N-CA 116.444 -2.102 . . . . 0.0 110.412 -175.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.932 ' HA ' ' HB2' ' A' ' 65' ' ' MET 0.298 . . -156.82 94.9 1.48 Allowed 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 113.683 -3.207 . . . . 0.0 116.975 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.774 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.3 mp -119.98 -74.21 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.777 ' HG3' ' HE1' ' A' ' 65' ' ' MET 0.382 94.3 Cg_endo -82.87 -25.47 2.86 Favored 'Trans proline' 0 C--O 1.201 -1.345 0 N-CA-C 103.744 -3.214 . . . . 0.0 103.744 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.97 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mmt -55.34 -56.46 19.8 Favored 'General case' 0 C--O 1.185 -2.335 0 CA-C-N 112.78 -2.009 . . . . 0.0 108.986 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.734 HD12 ' CB ' ' A' ' 62' ' ' ALA . 80.6 mt -107.94 -8.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 117.37 -1.732 . . . . 0.0 110.289 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.724 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 11.9 t -85.28 -48.84 8.69 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.026 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.3 t -86.12 -34.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 C-N-CA 116.55 -2.06 . . . . 0.0 105.693 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.903 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -64.75 -19.06 64.8 Favored Glycine 0 CA--C 1.48 -2.154 1 N-CA-C 101.99 -4.444 . . . . 0.0 101.99 171.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.8 OUTLIER -55.67 -54.93 38.17 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 102.912 -2.996 . . . . 0.0 102.912 174.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.852 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -86.7 3.66 86.85 Favored Glycine 0 N--CA 1.515 3.9 0 C-N-CA 118.752 -1.69 . . . . 0.0 114.41 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.026 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 6.8 mt -107.76 -61.74 1.53 Allowed 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 101.462 -3.533 . . . . 0.0 101.462 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.789 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 82.5 m-85 -47.41 -28.46 2.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 171.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.071 HG13 ' O ' ' A' ' 77' ' ' ALA . 46.1 t -87.37 -28.78 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -31.62 -37.89 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.729 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.17 -31.76 8.11 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.071 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.3 46.09 1.3 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -96.77 -30.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.578 -178.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 78' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.702 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.939 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 t80 -59.26 3.99 0.04 OUTLIER 'General case' 0 C--O 1.19 -2.027 0 O-C-N 121.468 -0.77 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.704 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 mmt -84.73 -74.84 0.37 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 118.762 -2.461 . . . . 0.0 107.085 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.76 -36.35 78.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.792 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.18 -26.33 64.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -50.81 -43.72 58.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 102.901 -2.999 . . . . 0.0 102.901 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.895 HG12 HD12 ' A' ' 19' ' ' LEU . 2.4 t -61.79 -51.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.792 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 2.3 tpp -40.43 -91.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.815 1.293 . . . . 0.0 110.141 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 1.083 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -67.15 -19.13 65.55 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.379 -175.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.158 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -95.42 -71.8 1.12 Allowed Glycine 0 C--O 1.194 -2.366 0 N-CA-C 107.067 -2.413 . . . . 0.0 107.067 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -31.55 -49.15 0.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 120.396 2.098 . . . . 0.0 105.761 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.797 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -65.54 -61.04 2.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -66.0 -62.31 1.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.28 -1.368 . . . . 0.0 113.042 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.12 -23.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.09 -38.42 92.37 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 103.766 -3.734 . . . . 0.0 103.766 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.049 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -89.41 3.56 51.87 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.253 -1.473 . . . . 0.0 110.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . -138.29 15.51 2.79 Favored 'General case' 0 C--N 1.286 -2.173 0 O-C-N 121.709 -0.619 . . . . 0.0 109.641 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.602 HG22 ' OE1' ' A' ' 52' ' ' GLN . 26.4 pt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.932 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.826 ' HB3' HG11 ' A' ' 60' ' ' VAL . 7.5 mp0 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.473 0.654 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.704 ' O ' ' N ' ' A' ' 55' ' ' ILE . 46.1 t80 -49.13 -35.25 16.06 Favored 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 118.161 -1.415 . . . . 0.0 107.907 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.695 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.0 t80 -44.22 87.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.704 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.4 tp 38.67 26.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 56' ' ' VAL . 97.7 t -137.88 19.46 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.426 -1.422 . . . . 0.0 110.567 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.512 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -76.22 -42.99 44.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 108.931 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.49 36.18 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.74 -23.62 15.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 52' ' ' GLN . 1.8 t -99.74 -78.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.816 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 64.1 m-20 -161.24 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.088 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . 87.39 -43.63 0.03 OUTLIER 'General case' 0 CA--C 1.454 -2.73 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.032 ' HA ' HD11 ' A' ' 66' ' ' ILE 0.325 0.5 OUTLIER -28.91 -48.6 0.25 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 169.789 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.797 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 30.0 Cg_endo -66.08 -85.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 104.734 -2.833 . . . . 0.0 104.734 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 1.088 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 0.87 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.342 0 CA-C-O 123.327 1.536 . . . . 0.0 108.666 178.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -42.88 -84.51 0.0 OUTLIER 'Isoleucine or valine' 1 C--N 1.228 -4.682 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.054 174.688 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.698 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.8 t -81.19 -43.45 19.29 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.455 -1.403 . . . . 0.0 112.103 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 17' ' ' MET 0.256 0.6 OUTLIER -93.98 -14.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.423 0 C-N-CA 116.902 -1.919 . . . . 0.0 106.75 -178.08 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.928 ' O ' HD23 ' A' ' 72' ' ' LEU . . . -68.38 -37.78 86.35 Favored Glycine 0 C--N 1.302 -1.343 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 167.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.706 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.5 -44.27 55.91 Favored 'General case' 0 C--O 1.183 -2.438 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 172.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.791 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -78.99 -10.07 86.52 Favored Glycine 0 N--CA 1.506 3.347 0 CA-C-O 117.0 -2.0 . . . . 0.0 115.093 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.158 HD13 ' CA ' ' A' ' 18' ' ' GLY . 2.4 pt? -86.39 -56.99 3.18 Favored 'General case' 0 C--N 1.284 -2.259 1 N-CA-C 98.9 -4.481 . . . . 0.0 98.9 174.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.147 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -60.69 -14.32 20.16 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.625 1.202 . . . . 0.0 108.329 176.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.989 ' O ' HG13 ' A' ' 78' ' ' VAL . 98.1 t -111.94 -8.5 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 119.125 -2.234 . . . . 0.0 106.053 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.804 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -54.43 -30.03 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 100.717 -3.808 . . . . 0.0 100.717 173.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -108.95 -38.4 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.845 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -67.87 1.09 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.519 -1.672 . . . . 0.0 108.845 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.989 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -51.36 -22.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.37 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 40.7 t80 -70.96 20.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.627 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.821 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.5 ttm -87.91 -65.82 0.98 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.67 -38.51 89.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -68.97 -23.47 64.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.58 -45.27 66.4 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.707 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -57.05 -55.28 21.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.81 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -33.5 -85.46 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.908 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -76.04 -73.59 0.26 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 119.718 -1.864 . . . . 0.0 107.992 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -19.23 -52.52 0.01 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.707 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.3 tt -61.61 -71.53 0.15 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.847 -1.973 . . . . 0.0 105.917 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.52 -64.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.001 -1.48 . . . . 0.0 108.832 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB2' ' SD ' ' A' ' 17' ' ' MET . . . -67.57 -56.53 9.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -57.73 -22.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 O-C-N 118.334 -2.729 . . . . 0.0 104.566 177.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' A' ' 21' ' ' ALA . . . -72.12 -35.31 60.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.715 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -82.84 -79.75 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . . . . . . 0 C--N 1.296 -1.722 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.643 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.322 0.8 OUTLIER . . . . . 0 C--O 1.251 1.14 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.753 ' C ' ' H ' ' A' ' 69' ' ' GLY . 41.4 Cg_endo -70.86 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 103.322 -3.376 . . . . 0.0 103.322 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 1.046 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -3.15 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 CA-C-O 124.0 1.857 . . . . 0.0 109.062 175.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.768 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -55.66 -69.67 0.13 Allowed 'Isoleucine or valine' 1 C--N 1.244 -4.021 0 CA-C-N 111.74 -2.482 . . . . 0.0 109.573 -179.934 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.672 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -81.8 -49.71 10.08 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 120.655 1.57 . . . . 0.0 110.823 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.138 HG12 ' CD2' ' A' ' 72' ' ' LEU . 4.3 t -84.43 -36.13 11.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 O-C-N 119.772 -1.83 . . . . 0.0 108.763 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 64' ' ' PRO . . . -64.08 -24.78 68.99 Favored Glycine 0 CA--C 1.481 -2.071 1 N-CA-C 100.998 -4.841 . . . . 0.0 100.998 171.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.146 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -57.02 -51.47 69.12 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 173.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.841 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -95.5 12.85 67.4 Favored Glycine 0 N--CA 1.497 2.766 0 C-N-CA 116.543 -2.741 . . . . 0.0 116.492 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.138 ' CD2' HG12 ' A' ' 68' ' ' VAL . 3.8 mm? -102.46 -47.51 4.44 Favored 'General case' 1 C--N 1.243 -4.025 1 N-CA-C 97.184 -5.117 . . . . 0.0 97.184 170.802 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.868 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -54.05 -28.15 36.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 170.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.146 HG23 ' O ' ' A' ' 70' ' ' LEU . 47.8 t -82.72 -30.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.798 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.03 -37.04 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.764 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -108.85 -30.34 8.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.976 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -85.33 40.45 0.83 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.551 -178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 33.1 t80 -72.86 23.57 0.06 Allowed 'General case' 0 C--O 1.196 -1.755 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.283 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.809 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 mtp -87.66 -64.9 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -66.34 -44.05 84.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -63.97 -21.89 66.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 117.067 -1.853 . . . . 0.0 106.207 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -58.82 -47.99 82.88 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 175.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -59.74 -35.2 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 1.154 ' CG ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -51.49 -86.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.691 0.758 . . . . 0.0 109.815 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.1 tpp -88.76 6.74 37.32 Favored 'General case' 0 C--N 1.288 -2.083 0 O-C-N 120.998 -1.064 . . . . 0.0 110.853 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -106.59 -51.43 0.8 Allowed Glycine 0 C--N 1.266 -3.316 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.1 tt -59.3 -50.08 75.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 17' ' ' MET . . . -61.86 -44.12 97.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.513 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 17' ' ' MET 0.264 . . -90.88 -59.76 2.09 Favored 'General case' 0 C--O 1.19 -2.048 0 C-N-CA 117.608 -1.637 . . . . 0.0 111.772 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -44.35 -31.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 118.915 -2.366 . . . . 0.0 105.544 174.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -69.26 -48.68 44.32 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 174.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.768 ' HB3' ' HG3' ' A' ' 65' ' ' MET . . . -83.93 -73.68 0.41 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.3 -1.549 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.664 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.718 HG22 ' HD3' ' A' ' 64' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.376 76.8 Cg_endo -78.9 -21.76 9.33 Favored 'Trans proline' 0 C--O 1.202 -1.299 0 N-CA-C 102.938 -3.524 . . . . 0.0 102.938 173.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.902 ' CA ' ' HB2' ' A' ' 21' ' ' ALA 0.286 1.8 mmt -81.1 -56.02 4.37 Favored 'General case' 0 C--O 1.2 -1.524 0 CA-C-N 111.102 -2.772 . . . . 0.0 108.89 -173.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.775 ' O ' HD13 ' A' ' 70' ' ' LEU . 6.6 mt -75.99 -36.63 32.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 C-N-CA 116.828 -1.949 . . . . 0.0 108.228 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.691 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.6 t -83.95 -55.05 4.44 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.79 1.281 . . . . 0.0 109.551 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' A' ' 17' ' ' MET . 6.1 t -86.63 -22.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 C-N-CA 116.46 -2.096 . . . . 0.0 107.57 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.775 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -73.17 -24.4 75.67 Favored Glycine 0 C--O 1.191 -2.55 1 N-CA-C 99.178 -5.569 . . . . 0.0 99.178 169.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.073 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 tp -56.75 -45.29 82.11 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 115.895 -2.322 . . . . 0.0 105.066 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -90.17 -2.71 73.79 Favored Glycine 0 CA--C 1.466 -3.009 0 C-N-CA 117.694 -2.193 . . . . 0.0 115.731 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.154 HD12 ' CG ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.77 -41.04 7.84 Favored 'General case' 0 C--N 1.25 -3.727 1 N-CA-C 98.705 -4.554 . . . . 0.0 98.705 173.833 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -51.1 -29.6 13.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 101.816 -3.402 . . . . 0.0 101.816 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 70' ' ' LEU . 57.3 t -81.82 -32.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.782 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -31.6 -36.75 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.806 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -108.43 -31.52 7.79 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.04 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.9 46.16 1.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.596 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.424 0.631 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.042 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 39.4 t80 -77.76 28.38 0.17 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.826 -1.149 . . . . 0.0 111.238 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.778 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 9.8 mmt -91.66 -63.79 1.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.042 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -76.73 -20.58 56.36 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.43 -43.31 64.78 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 19' ' ' LEU . 2.2 t -65.33 -51.17 67.86 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.83 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 1.5 mmt -27.29 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 CA-C-O 123.895 1.807 . . . . 0.0 106.966 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.961 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -79.41 -71.01 0.47 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 109.425 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.739 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.87 -48.45 0.02 OUTLIER Glycine 0 C--N 1.286 -2.211 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.942 HD12 HG12 ' A' ' 15' ' ' VAL . 1.9 tt -64.15 -71.47 0.17 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -60.5 -69.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.813 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.148 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -56.56 -41.7 77.32 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.756 HD13 ' HE1' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -74.04 -30.07 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 118.064 -2.898 . . . . 0.0 104.644 175.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.98 -11.86 64.11 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.636 -2.586 . . . . 0.0 106.636 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -107.68 -92.21 0.41 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.93 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . . . . . . 0 C--N 1.296 -1.761 0 O-C-N 121.416 -0.803 . . . . 0.0 109.48 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.603 ' CB ' ' CD ' ' A' ' 64' ' ' PRO 0.311 0.7 OUTLIER . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 44.4 Cg_endo -72.82 -62.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 N-CA-C 106.095 -2.31 . . . . 0.0 106.095 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 1.148 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -18.02 -56.03 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.334 0 CA-C-O 123.927 1.823 . . . . 0.0 108.299 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.756 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -59.91 -73.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.892 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.024 175.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.679 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 69.2 m -77.83 -50.62 11.93 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.217 1.008 . . . . 0.0 111.785 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.768 HG12 ' CD2' ' A' ' 72' ' ' LEU . 3.1 t -86.39 -28.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 O-C-N 119.681 -1.887 . . . . 0.0 109.071 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.811 ' CA ' ' HG3' ' A' ' 17' ' ' MET . . . -68.79 -25.38 75.21 Favored Glycine 0 CA--C 1.489 -1.557 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 170.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -56.86 -56.01 27.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -88.87 11.55 68.64 Favored Glycine 0 N--CA 1.514 3.899 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.425 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.883 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . 1.4 mp -109.97 -64.11 1.3 Allowed 'General case' 1 C--N 1.241 -4.123 0 N-CA-C 100.328 -3.952 . . . . 0.0 100.328 174.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.756 ' HE1' HD13 ' A' ' 22' ' ' ILE . 24.7 m-85 -47.52 -27.69 1.89 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 77' ' ' ALA . 45.6 t -88.61 -27.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.069 -1.644 . . . . 0.0 107.065 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.875 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.72 -36.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.264 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.736 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -109.04 -31.53 7.59 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.047 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.24 45.49 1.24 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.681 -1.608 . . . . 0.0 106.755 177.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.785 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.424 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' MET . 1.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.012 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 1.5 t80 -60.36 7.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.825 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.755 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -83.67 -68.58 0.7 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 119.267 -2.146 . . . . 0.0 105.868 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.14 -35.4 80.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.012 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.6 -26.12 64.29 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.17 -46.56 68.97 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.703 HG13 ' HB2' ' A' ' 19' ' ' LEU . 24.5 t -61.26 -44.51 98.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.789 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -46.28 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.67 -1.269 . . . . 0.0 110.104 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 1.094 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -65.24 -22.86 66.93 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.528 -176.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.111 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -91.15 -69.01 1.18 Allowed Glycine 0 C--O 1.191 -2.558 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.725 ' C ' ' O ' ' A' ' 18' ' ' GLY . 3.0 tp -35.25 -48.75 0.47 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.106 -2.408 . . . . 0.0 105.448 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.885 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.91 -52.86 57.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.861 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -75.77 -60.91 2.11 Favored 'General case' 0 C--O 1.193 -1.911 0 O-C-N 120.716 -1.24 . . . . 0.0 113.382 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.3 mm -51.0 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.46 -42.44 89.17 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 104.666 -3.374 . . . . 0.0 104.666 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -89.16 15.18 9.25 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 113.755 -1.222 . . . . 0.0 109.533 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.288 -2.092 0 O-C-N 121.608 -0.682 . . . . 0.0 109.747 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.791 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.328 0.3 OUTLIER . . . . . 0 C--O 1.252 1.211 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.885 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 36.5 Cg_endo -68.59 -92.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.928 0 N-CA-C 105.094 -2.695 . . . . 0.0 105.094 169.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.88 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER 5.93 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.554 0 CA-C-O 124.599 2.143 . . . . 0.0 109.876 179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.7 -78.48 0.02 OUTLIER 'Isoleucine or valine' 1 C--N 1.211 -5.416 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.073 178.904 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.701 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 m -78.83 -45.31 21.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 119.815 -1.803 . . . . 0.0 110.266 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.094 HG12 ' CG ' ' A' ' 17' ' ' MET 0.259 0.6 OUTLIER -95.34 -12.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 0 C-N-CA 116.868 -1.933 . . . . 0.0 108.152 -178.05 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.904 ' HA2' HD23 ' A' ' 72' ' ' LEU . . . -69.33 -34.26 74.38 Favored Glycine 0 CA--C 1.492 -1.396 1 N-CA-C 98.218 -5.953 . . . . 0.0 98.218 167.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -49.32 -46.66 47.06 Favored 'General case' 0 C--O 1.179 -2.639 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 171.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.27 -13.97 82.32 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-O 116.414 -2.325 . . . . 0.0 115.376 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.183 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.5 pt? -84.62 -59.06 2.48 Favored 'General case' 0 C--N 1.293 -1.853 2 CA-C-N 124.902 4.351 . . . . 0.0 99.92 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.183 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -59.73 -14.44 14.39 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.782 177.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.979 ' O ' HG13 ' A' ' 78' ' ' VAL . 93.5 t -109.1 -13.05 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 119.055 -2.278 . . . . 0.0 106.002 173.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.776 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -50.65 -30.92 14.74 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 174.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.825 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.79 -34.59 6.41 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.574 175.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -77.18 19.56 0.32 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.333 -1.747 . . . . 0.0 108.454 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.055 ' CD1' HD13 ' A' ' 72' ' ' LEU . 7.2 t80 -61.78 5.98 0.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.835 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.761 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -87.24 -75.97 0.38 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.519 -1.363 . . . . 0.0 107.54 177.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.12 -35.85 76.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.2 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -69.97 -31.53 69.29 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -42.51 -40.92 2.79 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 1.049 HG12 HD12 ' A' ' 19' ' ' LEU . 2.5 t -59.83 -64.83 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.93 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -13.4 -97.54 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.346 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.945 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.925 ' HB2' ' CG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.46 -84.08 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.932 ' H ' HD12 ' A' ' 72' ' ' LEU . . . -11.12 -62.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.087 -2.405 . . . . 0.0 107.087 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.049 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -56.18 -75.79 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -53.95 -67.12 0.29 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -68.44 -53.04 26.18 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.718 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -59.14 -22.72 22.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 114.241 -2.984 . . . . 0.0 104.541 177.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -72.06 -35.54 61.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.58 ' HB3' ' HG3' ' A' ' 65' ' ' MET . . . -95.48 -78.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.295 -1.802 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.892 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.1 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.759 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.371 80.8 Cg_endo -81.41 -22.4 5.72 Favored 'Trans proline' 0 C--O 1.208 -0.977 1 N-CA-C 101.441 -4.1 . . . . 0.0 101.441 173.169 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 1.045 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 1.4 mmt -77.68 -26.51 50.34 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 110.829 -2.896 . . . . 0.0 108.881 -173.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.695 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 70.0 mt -109.61 -19.48 6.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 117.786 -1.565 . . . . 0.0 107.928 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.662 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.6 m -83.2 -40.63 19.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 72' ' ' LEU . 2.9 t -95.38 -28.94 4.0 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.893 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -62.64 -26.81 68.86 Favored Glycine 0 N--CA 1.495 2.626 1 N-CA-C 100.09 -5.204 . . . . 0.0 100.09 170.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -57.45 -55.85 29.45 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.917 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.53 27.34 10.88 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 118.438 -1.839 . . . . 0.0 113.61 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.2 HD11 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -112.06 -64.53 1.28 Allowed 'General case' 1 C--N 1.242 -4.079 1 N-CA-C 98.678 -4.564 . . . . 0.0 98.678 170.617 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.758 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -57.81 -20.41 35.51 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 171.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 77' ' ' ALA . 65.8 t -100.9 -17.83 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 118.653 -2.53 . . . . 0.0 105.164 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -38.85 -38.86 0.46 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 174.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.798 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -109.53 -27.65 9.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.834 176.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.036 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 116.802 -1.959 . . . . 0.0 106.284 175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.233 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.882 0.849 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.043 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -85.09 40.07 0.8 Allowed 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 116.761 -1.976 . . . . 0.0 111.162 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.823 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.49 -63.37 1.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 101.195 -3.631 . . . . 0.0 101.195 172.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -68.87 -43.13 75.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.043 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -67.42 -17.98 64.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 116.605 -2.038 . . . . 0.0 105.931 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 1.018 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -58.01 -48.96 78.46 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.2 t -55.25 -48.09 76.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.719 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -45.34 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.865 -1.147 . . . . 0.0 110.178 178.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 1.102 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -66.39 -17.7 64.93 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.892 0.853 . . . . 0.0 112.053 -176.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.128 ' HA3' HD13 ' A' ' 72' ' ' LEU . . . -93.1 -67.91 1.09 Allowed Glycine 0 C--O 1.19 -2.624 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -35.52 -48.93 0.53 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 121.278 2.539 . . . . 0.0 105.08 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.5 -54.17 40.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.89 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -74.51 -63.78 1.17 Allowed 'General case' 0 C--O 1.189 -2.095 0 O-C-N 120.76 -1.212 . . . . 0.0 113.377 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.817 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -49.66 -27.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.0 -44.5 88.51 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 104.493 -3.443 . . . . 0.0 104.493 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -85.79 12.08 9.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.619 -1.29 . . . . 0.0 109.8 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.817 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . . . . . . 0 C--N 1.288 -2.088 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.897 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.808 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.334 1.2 mp . . . . . 0 C--O 1.251 1.172 0 N-CA-C 102.217 -3.253 . . . . 0.0 102.217 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.3 Cg_endo -67.88 -92.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 N-CA-C 105.086 -2.698 . . . . 0.0 105.086 169.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.89 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 6.26 -72.46 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 124.626 2.155 . . . . 0.0 109.794 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.24 -79.62 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.214 -5.291 0 CA-C-N 112.29 -2.232 . . . . 0.0 108.961 178.633 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 19.7 t -77.18 -46.59 22.84 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.04 -1.662 . . . . 0.0 110.336 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.102 HG12 ' CG ' ' A' ' 17' ' ' MET 0.26 0.6 OUTLIER -95.18 -11.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 C-N-CA 116.884 -1.926 . . . . 0.0 108.593 -177.62 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.49 -35.04 74.66 Favored Glycine 0 CA--C 1.498 -1.006 1 N-CA-C 97.78 -6.128 . . . . 0.0 97.78 167.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -50.62 -43.47 56.87 Favored 'General case' 0 C--O 1.185 -2.31 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 171.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.753 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.07 -17.76 80.22 Favored Glycine 0 N--CA 1.5 2.916 0 CA-C-O 116.403 -2.331 . . . . 0.0 115.387 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.175 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.4 pt? -84.79 -59.94 2.2 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 99.979 -4.082 . . . . 0.0 99.979 175.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.175 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -54.25 -18.32 3.81 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.697 1.236 . . . . 0.0 108.338 177.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 77' ' ' ALA . 69.1 t -105.25 -17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 118.328 -2.732 . . . . 0.0 105.998 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.998 ' HG3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -48.28 -34.12 9.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.714 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.62 -26.45 10.86 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.785 -1.166 . . . . 0.0 108.21 174.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.057 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -89.63 49.15 1.69 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.304 0.573 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.059 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 49.2 t80 -72.02 23.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 111.903 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.795 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -89.41 -65.7 0.99 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 174.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -64.98 -40.46 95.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.07 -21.39 64.08 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 116.953 -1.899 . . . . 0.0 106.432 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.91 -44.91 70.96 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 102.381 -3.192 . . . . 0.0 102.381 174.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.745 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.14 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.395 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.82 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -37.56 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.963 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.3 -74.2 0.18 Allowed 'General case' 0 C--N 1.285 -2.213 0 O-C-N 119.895 -1.753 . . . . 0.0 108.088 178.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.45 -49.84 0.02 OUTLIER Glycine 0 C--N 1.28 -2.565 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.745 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tp -62.03 -68.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.635 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -59.38 -69.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 117.915 -1.514 . . . . 0.0 108.368 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.13 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -57.66 -48.07 80.51 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -72.07 -24.83 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 116.661 -2.016 . . . . 0.0 105.564 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.65 -20.75 77.54 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.668 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -101.96 -10.79 19.47 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.9 -1.15 . . . . 0.0 109.446 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 C--N 1.289 -2.029 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.508 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.636 HG22 ' HD3' ' A' ' 64' ' ' PRO 0.322 0.2 OUTLIER . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.659 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 38.1 Cg_endo -70.38 -63.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.254 -2.249 . . . . 0.0 106.254 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 1.13 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -17.2 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 123.736 1.732 . . . . 0.0 107.904 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.773 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -56.39 -77.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.574 0 CA-C-N 111.557 -2.565 . . . . 0.0 109.352 176.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 5.3 p -78.4 -48.77 14.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 122.246 1.022 . . . . 0.0 111.469 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.75 HG12 HD21 ' A' ' 72' ' ' LEU . 3.1 t -82.98 -43.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.891 0 O-C-N 119.937 -1.727 . . . . 0.0 108.075 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -58.06 -25.68 57.17 Favored Glycine 0 CA--C 1.483 -1.919 1 N-CA-C 101.834 -4.506 . . . . 0.0 101.834 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.131 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -56.38 -58.11 9.39 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 116.157 -2.217 . . . . 0.0 105.299 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.989 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -92.54 18.15 55.72 Favored Glycine 0 CA--C 1.464 -3.111 0 C-N-CA 116.767 -2.635 . . . . 0.0 115.203 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.989 HD23 ' C ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -107.5 -49.14 3.3 Favored 'General case' 0 C--N 1.246 -3.897 1 N-CA-C 98.3 -4.704 . . . . 0.0 98.3 172.03 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -53.52 -26.72 22.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 170.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.131 HG23 ' O ' ' A' ' 70' ' ' LEU . 21.2 t -85.76 -30.47 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.861 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -31.8 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 175.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.77 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.01 -31.42 7.64 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.931 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -84.75 39.06 0.73 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.021 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.548 -178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 9' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.0 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 38.1 t80 -73.65 25.21 0.07 Allowed 'General case' 0 C--O 1.202 -1.443 0 O-C-N 121.073 -1.017 . . . . 0.0 111.037 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.784 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -89.14 -65.25 1.04 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -66.01 -40.03 90.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 1.0 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.01 -22.4 64.07 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -54.99 -44.47 74.52 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 101.947 -3.353 . . . . 0.0 101.947 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.724 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 3.1 t -60.5 -48.31 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.991 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.2 ptp -42.09 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.995 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.928 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.24 -70.45 0.44 Allowed 'General case' 0 C--O 1.187 -2.221 0 O-C-N 118.57 -2.581 . . . . 0.0 107.924 177.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -20.03 -56.39 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 4.3 tt -55.28 -68.08 0.22 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.848 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.0 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.102 -1.439 . . . . 0.0 107.971 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -53.89 -70.41 0.1 Allowed 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.125 -0.984 . . . . 0.0 112.043 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -45.39 -25.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 118.883 -2.386 . . . . 0.0 106.965 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -62.89 -59.51 9.03 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.739 ' HB3' ' HG3' ' A' ' 65' ' ' MET . . . -84.07 -70.54 0.56 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 120.852 0.358 . . . . 0.0 110.54 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.774 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.3 mp . . . . . 0 CA--C 1.547 0.845 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.777 ' HG3' ' HE1' ' A' ' 65' ' ' MET 0.382 94.3 Cg_endo -82.87 -25.47 2.86 Favored 'Trans proline' 0 C--O 1.201 -1.345 0 N-CA-C 103.744 -3.214 . . . . 0.0 103.744 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.97 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mmt -55.34 -56.46 19.8 Favored 'General case' 0 C--O 1.185 -2.335 0 CA-C-N 112.78 -2.009 . . . . 0.0 108.986 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.682 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 80.6 mt -107.94 -8.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 117.37 -1.732 . . . . 0.0 110.289 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.724 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 11.9 t -85.28 -48.84 8.69 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.026 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.3 t -86.12 -34.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 C-N-CA 116.55 -2.06 . . . . 0.0 105.693 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.903 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -64.75 -19.06 64.8 Favored Glycine 0 CA--C 1.48 -2.154 1 N-CA-C 101.99 -4.444 . . . . 0.0 101.99 171.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.8 OUTLIER -55.67 -54.93 38.17 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 102.912 -2.996 . . . . 0.0 102.912 174.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.852 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -86.7 3.66 86.85 Favored Glycine 0 N--CA 1.515 3.9 0 C-N-CA 118.752 -1.69 . . . . 0.0 114.41 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.026 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 6.8 mt -107.76 -61.74 1.53 Allowed 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 101.462 -3.533 . . . . 0.0 101.462 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.789 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 82.5 m-85 -47.41 -28.46 2.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 171.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.071 HG13 ' O ' ' A' ' 77' ' ' ALA . 46.1 t -87.37 -28.78 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -31.62 -37.89 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.729 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.17 -31.76 8.11 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.071 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.3 46.09 1.3 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.578 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.702 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.939 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 t80 -59.26 3.99 0.04 OUTLIER 'General case' 0 C--O 1.19 -2.027 0 O-C-N 121.468 -0.77 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.704 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 mmt -84.73 -74.84 0.37 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 118.762 -2.461 . . . . 0.0 107.085 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.76 -36.35 78.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.792 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.18 -26.33 64.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -50.81 -43.72 58.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 102.901 -2.999 . . . . 0.0 102.901 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.895 HG12 HD12 ' A' ' 19' ' ' LEU . 2.4 t -61.79 -51.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.792 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 2.3 tpp -40.43 -91.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.815 1.293 . . . . 0.0 110.141 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 1.083 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -67.15 -19.13 65.55 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.379 -175.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.158 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -95.42 -71.8 1.12 Allowed Glycine 0 C--O 1.194 -2.366 0 N-CA-C 107.067 -2.413 . . . . 0.0 107.067 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -31.55 -49.15 0.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 120.396 2.098 . . . . 0.0 105.761 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.797 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -65.54 -61.04 2.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -66.0 -62.31 1.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.28 -1.368 . . . . 0.0 113.042 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.12 -23.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.09 -38.42 92.37 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 103.766 -3.734 . . . . 0.0 103.766 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -89.41 3.56 51.87 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.253 -1.473 . . . . 0.0 110.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . . . . . . 0 C--N 1.286 -2.173 0 O-C-N 121.709 -0.619 . . . . 0.0 109.641 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.032 ' HA ' HD11 ' A' ' 66' ' ' ILE 0.325 0.5 OUTLIER . . . . . 0 C--O 1.256 1.424 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.797 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 30.0 Cg_endo -66.08 -85.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 104.734 -2.833 . . . . 0.0 104.734 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.893 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER 0.87 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.342 0 CA-C-O 123.327 1.536 . . . . 0.0 108.666 178.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -42.88 -84.51 0.0 OUTLIER 'Isoleucine or valine' 1 C--N 1.228 -4.682 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.054 174.688 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.698 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.8 t -81.19 -43.45 19.29 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.455 -1.403 . . . . 0.0 112.103 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 17' ' ' MET 0.256 0.6 OUTLIER -93.98 -14.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.423 0 C-N-CA 116.902 -1.919 . . . . 0.0 106.75 -178.08 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.928 ' O ' HD23 ' A' ' 72' ' ' LEU . . . -68.38 -37.78 86.35 Favored Glycine 0 C--N 1.302 -1.343 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 167.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.706 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.5 -44.27 55.91 Favored 'General case' 0 C--O 1.183 -2.438 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 172.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.791 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -78.99 -10.07 86.52 Favored Glycine 0 N--CA 1.506 3.347 0 CA-C-O 117.0 -2.0 . . . . 0.0 115.093 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.158 HD13 ' CA ' ' A' ' 18' ' ' GLY . 2.4 pt? -86.39 -56.99 3.18 Favored 'General case' 0 C--N 1.284 -2.259 1 N-CA-C 98.9 -4.481 . . . . 0.0 98.9 174.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.147 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -60.69 -14.32 20.16 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.625 1.202 . . . . 0.0 108.329 176.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.989 ' O ' HG13 ' A' ' 78' ' ' VAL . 98.1 t -111.94 -8.5 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 119.125 -2.234 . . . . 0.0 106.053 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.804 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -54.43 -30.03 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 100.717 -3.808 . . . . 0.0 100.717 173.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -108.95 -38.4 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.845 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -67.87 1.09 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.519 -1.672 . . . . 0.0 108.845 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.989 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 40.7 t80 -70.96 20.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.627 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.821 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.5 ttm -87.91 -65.82 0.98 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.76 -2.681 . . . . 0.0 103.76 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.67 -38.51 89.51 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -68.97 -23.47 64.13 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.58 -45.27 66.4 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 101.736 -3.431 . . . . 0.0 101.736 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.707 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -57.05 -55.28 21.29 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.185 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 174.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.81 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -33.5 -85.46 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.611 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.908 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -76.04 -73.59 0.26 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 119.718 -1.864 . . . . 0.0 107.992 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -19.23 -52.52 0.01 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 107.875 -2.09 . . . . 0.0 107.875 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.707 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.3 tt -61.61 -71.53 0.15 Allowed 'General case' 0 C--N 1.293 -1.852 0 O-C-N 119.847 -1.973 . . . . 0.0 105.917 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.52 -64.84 0.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.001 -1.48 . . . . 0.0 108.832 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB2' ' SD ' ' A' ' 17' ' ' MET . . . -67.57 -56.53 9.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -57.73 -22.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 O-C-N 118.334 -2.729 . . . . 0.0 104.566 177.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' A' ' 21' ' ' ALA . . . -72.12 -35.31 60.94 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -82.84 -79.75 0.18 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.046 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . -40.11 -58.33 1.48 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 22' ' ' ILE . 3.5 mm . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 56' ' ' VAL . 1.7 tt0 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.297 0.57 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 53' ' ' PHE . 79.8 t80 -68.32 -9.46 48.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 118.949 -1.1 . . . . 0.0 109.472 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.586 ' O ' HD12 ' A' ' 55' ' ' ILE . 50.8 t80 -45.12 -26.07 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER 171.01 -20.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 56' ' ' VAL . 94.5 t -84.39 23.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.931 -1.105 . . . . 0.0 110.277 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.562 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -69.98 -40.49 75.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.851 -1.156 . . . . 0.0 109.507 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.05 -22.94 30.16 Favored Glycine 0 C--N 1.298 -1.545 0 N-CA-C 106.871 -2.492 . . . . 0.0 106.871 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -98.54 -23.37 15.55 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.711 HG12 ' HB1' ' A' ' 24' ' ' ALA . 9.5 t -57.89 -62.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 109.198 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.752 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 75.1 m-20 105.05 16.11 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 122.574 0.35 . . . . 0.0 110.553 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.948 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . -93.74 -30.12 15.04 Favored 'General case' 0 C--N 1.278 -2.519 0 C-N-CA 116.267 -2.173 . . . . 0.0 106.921 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.688 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.322 0.8 OUTLIER -21.06 -56.03 0.08 OUTLIER Pre-proline 0 C--N 1.286 -2.156 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 172.63 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.753 ' C ' ' H ' ' A' ' 69' ' ' GLY . 41.4 Cg_endo -70.86 -76.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 103.322 -3.376 . . . . 0.0 103.322 173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 1.046 ' CG ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -3.15 -73.08 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 CA-C-O 124.0 1.857 . . . . 0.0 109.062 175.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.768 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -55.66 -69.67 0.13 Allowed 'Isoleucine or valine' 1 C--N 1.244 -4.021 0 CA-C-N 111.74 -2.482 . . . . 0.0 109.573 -179.934 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.672 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -81.8 -49.71 10.08 Favored 'General case' 0 N--CA 1.504 2.261 0 CA-C-N 120.655 1.57 . . . . 0.0 110.823 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.138 HG12 ' CD2' ' A' ' 72' ' ' LEU . 4.3 t -84.43 -36.13 11.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 O-C-N 119.772 -1.83 . . . . 0.0 108.763 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.753 ' H ' ' C ' ' A' ' 64' ' ' PRO . . . -64.08 -24.78 68.99 Favored Glycine 0 CA--C 1.481 -2.071 1 N-CA-C 100.998 -4.841 . . . . 0.0 100.998 171.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.146 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -57.02 -51.47 69.12 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 173.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.841 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -95.5 12.85 67.4 Favored Glycine 0 N--CA 1.497 2.766 0 C-N-CA 116.543 -2.741 . . . . 0.0 116.492 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.138 ' CD2' HG12 ' A' ' 68' ' ' VAL . 3.8 mm? -102.46 -47.51 4.44 Favored 'General case' 1 C--N 1.243 -4.025 1 N-CA-C 97.184 -5.117 . . . . 0.0 97.184 170.802 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.868 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -54.05 -28.15 36.86 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 170.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.146 HG23 ' O ' ' A' ' 70' ' ' LEU . 47.8 t -82.72 -30.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 171.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.798 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.03 -37.04 0.02 OUTLIER 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 176.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.764 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -108.85 -30.34 8.18 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.976 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -85.33 40.45 0.83 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -94.85 37.78 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.551 -178.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.521 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 33.1 t80 -72.86 23.57 0.06 Allowed 'General case' 0 C--O 1.196 -1.755 0 C-N-CA 118.826 -1.15 . . . . 0.0 111.283 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.809 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 mtp -87.66 -64.9 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 103.227 -2.879 . . . . 0.0 103.227 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.803 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -66.34 -44.05 84.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 173.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -63.97 -21.89 66.68 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 117.067 -1.853 . . . . 0.0 106.207 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -58.82 -47.99 82.88 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 175.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -59.74 -35.2 58.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 1.154 ' CG ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -51.49 -86.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.691 0.758 . . . . 0.0 109.815 178.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.908 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.1 tpp -88.76 6.74 37.32 Favored 'General case' 0 C--N 1.288 -2.083 0 O-C-N 120.998 -1.064 . . . . 0.0 110.853 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.678 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -106.59 -51.43 0.8 Allowed Glycine 0 C--N 1.266 -3.316 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 2.1 tt -59.3 -50.08 75.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 102.155 -3.276 . . . . 0.0 102.155 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 17' ' ' MET . . . -61.86 -44.12 97.47 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.513 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 17' ' ' MET 0.264 . . -90.88 -59.76 2.09 Favored 'General case' 0 C--O 1.19 -2.048 0 C-N-CA 117.608 -1.637 . . . . 0.0 111.772 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.678 ' N ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -44.35 -31.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 118.915 -2.366 . . . . 0.0 105.544 174.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -69.26 -48.68 44.32 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 174.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.856 ' HB1' ' N ' ' A' ' 62' ' ' ALA . . . -83.93 -73.68 0.41 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -47.13 -49.07 22.86 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.664 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 25' ' ' ALA . 3.1 tt . . . . . 0 N--CA 1.494 1.734 0 O-C-N 120.705 -1.247 . . . . 0.0 109.755 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' C ' ' CD1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' CZ ' ' CG1' ' A' ' 55' ' ' ILE . 16.3 p90 27.55 54.87 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.571 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 3.8 t80 84.19 -46.35 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' CG1' ' CZ ' ' A' ' 53' ' ' PHE . 39.8 mm -69.58 -4.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HA ' ' N ' ' A' ' 52' ' ' GLN . 4.6 p -45.78 -32.81 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.212 -0.93 . . . . 0.0 108.892 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.598 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -83.23 -38.91 21.61 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' MET . . . -51.82 -24.58 13.68 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.449 ' N ' ' C ' ' A' ' 57' ' ' MET . 0.4 OUTLIER -103.85 -23.45 13.38 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.619 HG12 ' CB ' ' A' ' 24' ' ' ALA . 3.4 t -99.44 -77.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 108.971 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.005 ' O ' HD12 ' A' ' 63' ' ' ILE . 4.6 m-20 -166.17 -104.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.593 -1.317 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.856 ' N ' ' HB1' ' A' ' 24' ' ' ALA . . . 57.71 40.9 26.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 -176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.005 HD12 ' O ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -131.74 -63.28 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.437 0 CA-C-N 111.003 -2.817 . . . . 0.0 104.269 -178.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.376 76.8 Cg_endo -78.9 -21.76 9.33 Favored 'Trans proline' 0 C--O 1.202 -1.299 0 N-CA-C 102.938 -3.524 . . . . 0.0 102.938 173.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.902 ' CA ' ' HB2' ' A' ' 21' ' ' ALA 0.286 1.8 mmt -81.1 -56.02 4.37 Favored 'General case' 0 C--O 1.2 -1.524 0 CA-C-N 111.102 -2.772 . . . . 0.0 108.89 -173.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.775 ' O ' HD13 ' A' ' 70' ' ' LEU . 6.6 mt -75.99 -36.63 32.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 C-N-CA 116.828 -1.949 . . . . 0.0 108.228 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.691 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.6 t -83.95 -55.05 4.44 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 122.79 1.281 . . . . 0.0 109.551 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.84 HG12 ' HE2' ' A' ' 17' ' ' MET . 6.1 t -86.63 -22.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 C-N-CA 116.46 -2.096 . . . . 0.0 107.57 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.775 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -73.17 -24.4 75.67 Favored Glycine 0 C--O 1.191 -2.55 1 N-CA-C 99.178 -5.569 . . . . 0.0 99.178 169.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.073 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 tp -56.75 -45.29 82.11 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 115.895 -2.322 . . . . 0.0 105.066 173.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -90.17 -2.71 73.79 Favored Glycine 0 CA--C 1.466 -3.009 0 C-N-CA 117.694 -2.193 . . . . 0.0 115.731 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.154 HD12 ' CG ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.77 -41.04 7.84 Favored 'General case' 0 C--N 1.25 -3.727 1 N-CA-C 98.705 -4.554 . . . . 0.0 98.705 173.833 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 1.0 OUTLIER -51.1 -29.6 13.71 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 101.816 -3.402 . . . . 0.0 101.816 168.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.073 HG23 ' O ' ' A' ' 70' ' ' LEU . 57.3 t -81.82 -32.7 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 171.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.782 ' N ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -31.6 -36.75 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.806 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -108.43 -31.52 7.79 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.04 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.9 46.16 1.34 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 177.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -99.7 77.68 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.596 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.499 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.424 0.631 . . . . 0.0 109.502 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.042 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 39.4 t80 -77.76 28.38 0.17 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 118.826 -1.149 . . . . 0.0 111.238 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.778 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 9.8 mmt -91.66 -63.79 1.2 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.042 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -76.73 -20.58 56.36 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -52.43 -43.31 64.78 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 173.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 19' ' ' LEU . 2.2 t -65.33 -51.17 67.86 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.83 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 1.5 mmt -27.29 -87.69 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.213 0 CA-C-O 123.895 1.807 . . . . 0.0 106.966 177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.961 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -79.41 -71.01 0.47 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 109.425 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.739 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.87 -48.45 0.02 OUTLIER Glycine 0 C--N 1.286 -2.211 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.942 HD12 HG12 ' A' ' 15' ' ' VAL . 1.9 tt -64.15 -71.47 0.17 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -60.5 -69.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.026 -1.47 . . . . 0.0 108.813 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.148 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -56.56 -41.7 77.32 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.756 HD13 ' HE1' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -74.04 -30.07 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 118.064 -2.898 . . . . 0.0 104.644 175.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.866 ' O ' HD12 ' A' ' 59' ' ' LEU . . . -68.98 -11.86 64.11 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.636 -2.586 . . . . 0.0 106.636 173.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 21' ' ' ALA . . . -107.68 -92.21 0.41 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.93 ' HB2' ' CG ' ' A' ' 65' ' ' MET . . . -41.69 -34.95 0.68 Allowed 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.416 -0.803 . . . . 0.0 109.48 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.773 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.765 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.557 ' HA ' ' CA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 22.3 p90 28.41 53.46 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 120.663 0.268 . . . . 0.0 111.654 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 1.3 t80 83.74 -45.73 0.11 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.294 -0.879 . . . . 0.0 108.736 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.647 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -70.03 -4.12 3.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.87 HG13 ' H ' ' A' ' 58' ' ' GLY . 9.9 p -51.31 -26.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 108.965 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.606 ' HG3' ' HA ' ' A' ' 61' ' ' ASP . 14.8 mmt 63.42 29.29 15.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.671 -0.643 . . . . 0.0 110.168 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.87 ' H ' HG13 ' A' ' 56' ' ' VAL . . . 44.67 29.43 1.92 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -174.18 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -177.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 172.38 -44.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.992 0.901 . . . . 0.0 109.173 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 36.0 m-20 -159.29 -111.24 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.288 1.042 . . . . 0.0 108.714 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.014 ' N ' ' HB1' ' A' ' 24' ' ' ALA . . . 89.15 -53.73 0.03 OUTLIER 'General case' 0 C--O 1.181 -2.507 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.704 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.311 0.7 OUTLIER -18.36 -55.96 0.05 OUTLIER Pre-proline 0 C--N 1.285 -2.221 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.102 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 44.4 Cg_endo -72.82 -62.6 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.717 0 N-CA-C 106.095 -2.31 . . . . 0.0 106.095 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 1.148 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -18.02 -56.03 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.334 0 CA-C-O 123.927 1.823 . . . . 0.0 108.299 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.815 HG13 ' O ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.91 -73.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.246 -3.892 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.024 175.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.679 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 69.2 m -77.83 -50.62 11.93 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.217 1.008 . . . . 0.0 111.785 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.768 HG12 ' CD2' ' A' ' 72' ' ' LEU . 3.1 t -86.39 -28.97 5.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 O-C-N 119.681 -1.887 . . . . 0.0 109.071 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.811 ' CA ' ' HG3' ' A' ' 17' ' ' MET . . . -68.79 -25.38 75.21 Favored Glycine 0 CA--C 1.489 -1.557 1 N-CA-C 99.94 -5.264 . . . . 0.0 99.94 170.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.2 OUTLIER -56.86 -56.01 27.03 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.92 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -88.87 11.55 68.64 Favored Glycine 0 N--CA 1.514 3.899 0 C-N-CA 118.946 -1.597 . . . . 0.0 113.425 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.883 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . 1.4 mp -109.97 -64.11 1.3 Allowed 'General case' 1 C--N 1.241 -4.123 0 N-CA-C 100.328 -3.952 . . . . 0.0 100.328 174.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.756 ' HE1' HD13 ' A' ' 22' ' ' ILE . 24.7 m-85 -47.52 -27.69 1.89 Allowed 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 77' ' ' ALA . 45.6 t -88.61 -27.63 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.069 -1.644 . . . . 0.0 107.065 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.875 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -32.72 -36.26 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.264 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 174.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.736 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -109.04 -31.53 7.59 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.047 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.24 45.49 1.24 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.681 -1.608 . . . . 0.0 106.755 177.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.785 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -95.63 52.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.424 -178.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.462 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' MET . 1.6 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.012 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 1.5 t80 -60.36 7.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.576 -0.702 . . . . 0.0 110.825 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.755 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -83.67 -68.58 0.7 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 119.267 -2.146 . . . . 0.0 105.868 175.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -63.14 -35.4 80.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.012 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.6 -26.12 64.29 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.17 -46.56 68.97 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.703 HG13 ' HB2' ' A' ' 19' ' ' LEU . 24.5 t -61.26 -44.51 98.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.789 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -46.28 -91.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.67 -1.269 . . . . 0.0 110.104 178.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 1.094 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -65.24 -22.86 66.93 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.528 -176.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.111 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -91.15 -69.01 1.18 Allowed Glycine 0 C--O 1.191 -2.558 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.725 ' C ' ' O ' ' A' ' 18' ' ' GLY . 3.0 tp -35.25 -48.75 0.47 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 119.106 -2.408 . . . . 0.0 105.448 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.885 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.91 -52.86 57.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 174.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.861 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -75.77 -60.91 2.11 Favored 'General case' 0 C--O 1.193 -1.911 0 O-C-N 120.716 -1.24 . . . . 0.0 113.382 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.3 mm -51.0 -27.1 5.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.46 -42.44 89.17 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 104.666 -3.374 . . . . 0.0 104.666 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.019 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -89.16 15.18 9.25 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 113.755 -1.222 . . . . 0.0 109.533 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -164.06 39.14 0.08 Allowed 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.608 -0.682 . . . . 0.0 109.747 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.595 ' N ' ' O ' ' A' ' 22' ' ' ILE . 21.1 tt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.593 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.588 0.708 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' O ' ' O ' ' A' ' 52' ' ' GLN . 6.3 t80 -61.87 -132.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.617 -1.302 . . . . 0.0 108.941 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.806 ' O ' HD12 ' A' ' 55' ' ' ILE . 3.2 m-30 47.69 25.47 0.69 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.298 -1.501 . . . . 0.0 106.976 -178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 54' ' ' PHE . 2.3 mt 87.64 41.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.94 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 56' ' ' VAL . 87.8 t 62.41 29.73 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.609 -1.307 . . . . 0.0 110.357 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.595 ' HB2' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -77.85 -41.99 35.05 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.648 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 52' ' ' GLN . . . -55.44 -22.39 30.85 Favored Glycine 0 C--N 1.296 -1.656 0 N-CA-C 106.602 -2.599 . . . . 0.0 106.602 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.503 ' N ' ' HG2' ' A' ' 52' ' ' GLN . 0.3 OUTLIER -101.24 -21.55 14.88 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.817 HG12 ' N ' ' A' ' 61' ' ' ASP . 2.2 t -101.0 -81.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.881 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 17.9 m-20 -158.23 -140.04 0.07 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.019 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . 85.09 -31.45 0.06 Allowed 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.791 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.328 0.3 OUTLIER -34.6 -48.58 0.95 Allowed Pre-proline 0 C--N 1.289 -2.06 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 168.899 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.885 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 36.5 Cg_endo -68.59 -92.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.928 0 N-CA-C 105.094 -2.695 . . . . 0.0 105.094 169.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.98 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 5.93 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.554 0 CA-C-O 124.599 2.143 . . . . 0.0 109.876 179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.7 -78.48 0.02 OUTLIER 'Isoleucine or valine' 1 C--N 1.211 -5.416 0 CA-C-N 112.306 -2.224 . . . . 0.0 109.073 178.904 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.701 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.1 m -78.83 -45.31 21.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 119.815 -1.803 . . . . 0.0 110.266 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.094 HG12 ' CG ' ' A' ' 17' ' ' MET 0.259 0.6 OUTLIER -95.34 -12.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 0 C-N-CA 116.868 -1.933 . . . . 0.0 108.152 -178.05 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.904 ' HA2' HD23 ' A' ' 72' ' ' LEU . . . -69.33 -34.26 74.38 Favored Glycine 0 CA--C 1.492 -1.396 1 N-CA-C 98.218 -5.953 . . . . 0.0 98.218 167.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -49.32 -46.66 47.06 Favored 'General case' 0 C--O 1.179 -2.639 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 171.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.27 -13.97 82.32 Favored Glycine 0 N--CA 1.507 3.425 0 CA-C-O 116.414 -2.325 . . . . 0.0 115.376 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.183 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.5 pt? -84.62 -59.06 2.48 Favored 'General case' 0 C--N 1.293 -1.853 2 CA-C-N 124.902 4.351 . . . . 0.0 99.92 175.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.183 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -59.73 -14.44 14.39 Favored 'General case' 0 C--N 1.287 -2.112 0 C-N-CA 118.511 -1.276 . . . . 0.0 108.782 177.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.979 ' O ' HG13 ' A' ' 78' ' ' VAL . 93.5 t -109.1 -13.05 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 119.055 -2.278 . . . . 0.0 106.002 173.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.776 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -50.65 -30.92 14.74 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 174.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.825 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.79 -34.59 6.41 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.574 175.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -77.18 19.56 0.32 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 117.333 -1.747 . . . . 0.0 108.454 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.979 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -68.41 -43.6 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.48 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.055 ' CD1' HD13 ' A' ' 72' ' ' LEU . 7.2 t80 -61.78 5.98 0.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.13 -0.981 . . . . 0.0 110.835 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.761 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -87.24 -75.97 0.38 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 120.519 -1.363 . . . . 0.0 107.54 177.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.12 -35.85 76.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.2 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -69.97 -31.53 69.29 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 11' ' ' MET . . . -42.51 -40.92 2.79 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 1.049 HG12 HD12 ' A' ' 19' ' ' LEU . 2.5 t -59.83 -64.83 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 172.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.93 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -13.4 -97.54 0.0 OUTLIER 'General case' 1 N--CA 1.546 4.346 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 173.945 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.925 ' HB2' ' CG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.46 -84.08 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 176.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.932 ' H ' HD12 ' A' ' 72' ' ' LEU . . . -11.12 -62.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.087 -2.405 . . . . 0.0 107.087 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.049 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -56.18 -75.79 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 174.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -53.95 -67.12 0.29 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -68.44 -53.04 26.18 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.803 HD12 HD13 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -59.14 -22.72 22.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 C-N-CA 114.241 -2.984 . . . . 0.0 104.541 177.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -72.06 -35.54 61.03 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 174.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.819 ' HA ' HG13 ' A' ' 60' ' ' VAL . . . -95.48 -78.15 0.46 Allowed 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.927 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . . . -43.81 -22.16 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.892 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.803 HD13 HD12 ' A' ' 22' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.497 1.895 0 O-C-N 120.176 -1.578 . . . . 0.0 109.806 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.639 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 5.8 pt20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.602 0.715 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.954 ' HA ' HG12 ' A' ' 56' ' ' VAL . 3.7 t80 -58.66 -170.04 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.747 -1.581 . . . . 0.0 108.249 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.679 ' C ' HG22 ' A' ' 55' ' ' ILE . 10.1 t80 86.99 -7.4 0.67 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -175.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.679 HG22 ' C ' ' A' ' 54' ' ' PHE . 1.7 tt 150.81 0.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.682 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' A' ' 53' ' ' PHE . 1.9 p -46.59 -39.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 120.037 -1.665 . . . . 0.0 108.128 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.691 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -88.98 -25.56 21.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.129 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 57' ' ' MET . . . -51.54 -27.82 19.5 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 105.507 -3.037 . . . . 0.0 105.507 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 57' ' ' MET . 0.3 OUTLIER -107.43 -26.98 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 177.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 24' ' ' ALA . 94.4 t -104.17 -114.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.687 ' HB2' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 154.0 -91.09 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.927 -1.108 . . . . 0.0 109.399 178.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.092 ' HB1' ' CD1' ' A' ' 66' ' ' ILE . . . 47.11 32.87 2.14 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 124.174 1.94 . . . . 0.0 106.01 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.1 mt -109.71 -66.58 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.131 0 CA-C-N 111.822 -2.445 . . . . 0.0 104.496 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.759 ' HD3' HG22 ' A' ' 63' ' ' ILE 0.371 80.8 Cg_endo -81.41 -22.4 5.72 Favored 'Trans proline' 0 C--O 1.208 -0.977 1 N-CA-C 101.441 -4.1 . . . . 0.0 101.441 173.169 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 1.045 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 1.4 mmt -77.68 -26.51 50.34 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-N 110.829 -2.896 . . . . 0.0 108.881 -173.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.092 ' CD1' ' HB1' ' A' ' 62' ' ' ALA . 70.0 mt -109.61 -19.48 6.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 117.786 -1.565 . . . . 0.0 107.928 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.662 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 1.6 m -83.2 -40.63 19.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 72' ' ' LEU . 2.9 t -95.38 -28.94 4.0 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.893 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -62.64 -26.81 68.86 Favored Glycine 0 N--CA 1.495 2.626 1 N-CA-C 100.09 -5.204 . . . . 0.0 100.09 170.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 0.5 OUTLIER -57.45 -55.85 29.45 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 173.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.917 ' HA2' ' HB ' ' A' ' 74' ' ' VAL . . . -92.53 27.34 10.88 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 118.438 -1.839 . . . . 0.0 113.61 178.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.2 HD11 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -112.06 -64.53 1.28 Allowed 'General case' 1 C--N 1.242 -4.079 1 N-CA-C 98.678 -4.564 . . . . 0.0 98.678 170.617 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.758 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -57.81 -20.41 35.51 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 171.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 77' ' ' ALA . 65.8 t -100.9 -17.83 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 118.653 -2.53 . . . . 0.0 105.164 171.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -38.85 -38.86 0.46 Allowed 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 174.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.798 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -109.53 -27.65 9.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.834 176.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.036 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -87.08 40.24 0.9 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 116.802 -1.959 . . . . 0.0 106.284 175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -91.28 -44.22 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.233 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.841 -1.076 . . . . 0.0 109.545 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.882 0.849 . . . . 0.0 109.586 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.043 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -85.09 40.07 0.8 Allowed 'General case' 0 C--O 1.19 -2.065 0 C-N-CA 116.761 -1.976 . . . . 0.0 111.162 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.823 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -92.49 -63.37 1.24 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 101.195 -3.631 . . . . 0.0 101.195 172.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -68.87 -43.13 75.98 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 103.38 -2.822 . . . . 0.0 103.38 171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.043 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -67.42 -17.98 64.92 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 116.605 -2.038 . . . . 0.0 105.931 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 1.018 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -58.01 -48.96 78.46 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 174.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.657 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.2 t -55.25 -48.09 76.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 175.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.719 ' HB3' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -45.34 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.865 -1.147 . . . . 0.0 110.178 178.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 1.102 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -66.39 -17.7 64.93 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.892 0.853 . . . . 0.0 112.053 -176.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.128 ' HA3' HD13 ' A' ' 72' ' ' LEU . . . -93.1 -67.91 1.09 Allowed Glycine 0 C--O 1.19 -2.624 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -35.52 -48.93 0.53 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 121.278 2.539 . . . . 0.0 105.08 178.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.767 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -63.5 -54.17 40.56 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.89 ' CB ' ' HA ' ' A' ' 65' ' ' MET . . . -74.51 -63.78 1.17 Allowed 'General case' 0 C--O 1.189 -2.095 0 O-C-N 120.76 -1.212 . . . . 0.0 113.377 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.001 ' CG2' HD13 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -49.66 -27.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.0 -44.5 88.51 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 104.493 -3.443 . . . . 0.0 104.493 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.064 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -85.79 12.08 9.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 113.619 -1.29 . . . . 0.0 109.8 176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' C ' HD12 ' A' ' 26' ' ' ILE . . . -141.04 9.9 2.14 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.897 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.001 HD13 ' CG2' ' A' ' 22' ' ' ILE . 2.9 mp . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.007 -1.058 . . . . 0.0 109.249 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.828 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 55' ' ' ILE . 29.5 p90 -10.74 -53.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' N ' ' CG ' ' A' ' 53' ' ' PHE . 40.4 t80 -139.06 -40.01 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.666 -1.271 . . . . 0.0 108.122 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 52' ' ' GLN . 5.8 tt -63.09 -10.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.657 HG13 ' HG2' ' A' ' 57' ' ' MET . 8.6 p -61.79 -40.37 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.13 -0.981 . . . . 0.0 109.295 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.657 ' HG2' HG13 ' A' ' 56' ' ' VAL . 1.5 mtm -79.82 -41.13 27.04 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.33 -23.0 32.42 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -99.97 -23.42 14.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.795 HG12 ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -96.97 -74.13 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.825 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 25.0 m-20 -160.51 -137.21 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.064 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . 83.64 -34.12 0.07 Allowed 'General case' 0 CA--C 1.473 -1.998 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.808 ' N ' ' HD2' ' A' ' 64' ' ' PRO 0.334 1.2 mp -33.55 -49.08 0.73 Allowed Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 102.217 -3.253 . . . . 0.0 102.217 168.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HD2' ' N ' ' A' ' 63' ' ' ILE . 36.3 Cg_endo -67.88 -92.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 N-CA-C 105.086 -2.698 . . . . 0.0 105.086 169.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 1.026 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 6.26 -72.46 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 124.626 2.155 . . . . 0.0 109.794 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -59.24 -79.62 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.214 -5.291 0 CA-C-N 112.29 -2.232 . . . . 0.0 108.961 178.633 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.689 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 19.7 t -77.18 -46.59 22.84 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.04 -1.662 . . . . 0.0 110.336 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.102 HG12 ' CG ' ' A' ' 17' ' ' MET 0.26 0.6 OUTLIER -95.18 -11.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 C-N-CA 116.884 -1.926 . . . . 0.0 108.593 -177.62 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -69.49 -35.04 74.66 Favored Glycine 0 CA--C 1.498 -1.006 1 N-CA-C 97.78 -6.128 . . . . 0.0 97.78 167.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -50.62 -43.47 56.87 Favored 'General case' 0 C--O 1.185 -2.31 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 171.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.753 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -75.07 -17.76 80.22 Favored Glycine 0 N--CA 1.5 2.916 0 CA-C-O 116.403 -2.331 . . . . 0.0 115.387 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.175 HD21 ' CZ ' ' A' ' 73' ' ' TYR . 1.4 pt? -84.79 -59.94 2.2 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 99.979 -4.082 . . . . 0.0 99.979 175.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.175 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -54.25 -18.32 3.81 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 122.697 1.236 . . . . 0.0 108.338 177.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.057 HG13 ' O ' ' A' ' 77' ' ' ALA . 69.1 t -105.25 -17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 118.328 -2.732 . . . . 0.0 105.998 173.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.998 ' HG3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -48.28 -34.12 9.89 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.714 ' CD1' ' CE2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -107.62 -26.45 10.86 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.785 -1.166 . . . . 0.0 108.21 174.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.057 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -89.63 49.15 1.69 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.938 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -101.02 88.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -178.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.539 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.304 0.573 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.059 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 49.2 t80 -72.02 23.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.132 -0.98 . . . . 0.0 111.903 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.795 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -89.41 -65.7 0.99 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 102.889 -3.004 . . . . 0.0 102.889 174.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.726 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -64.98 -40.46 95.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 103.407 -2.812 . . . . 0.0 103.407 172.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.059 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.07 -21.39 64.08 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 116.953 -1.899 . . . . 0.0 106.432 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.809 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -53.91 -44.91 70.96 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 102.381 -3.192 . . . . 0.0 102.381 174.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.745 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.14 -45.93 97.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.395 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 174.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.82 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -37.56 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.613 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 176.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.963 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -73.3 -74.2 0.18 Allowed 'General case' 0 C--N 1.285 -2.213 0 O-C-N 119.895 -1.753 . . . . 0.0 108.088 178.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -23.45 -49.84 0.02 OUTLIER Glycine 0 C--N 1.28 -2.565 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.745 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tp -62.03 -68.82 0.29 Allowed 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.944 ' HB1' ' CG ' ' A' ' 61' ' ' ASP . . . -59.38 -69.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 117.915 -1.514 . . . . 0.0 108.368 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.13 ' HB1' ' CB ' ' A' ' 65' ' ' MET . . . -57.66 -48.07 80.51 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.719 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -72.07 -24.83 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 C-N-CA 116.661 -2.016 . . . . 0.0 105.564 177.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.65 -20.75 77.54 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.132 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -101.96 -10.79 19.47 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 113.9 -1.15 . . . . 0.0 109.446 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -124.93 -66.31 0.97 Allowed 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.508 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' HA ' HG23 ' A' ' 22' ' ' ILE . 17.0 mt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.091 -1.006 . . . . 0.0 109.398 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.565 ' HA ' ' CA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 55' ' ' ILE . 17.6 p90 27.41 53.44 0.05 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' CB ' ' O ' ' A' ' 53' ' ' PHE . 2.3 t80 83.58 -44.77 0.11 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 108.986 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 0.7 OUTLIER -73.32 -0.58 2.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.122 -0.986 . . . . 0.0 108.552 178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.565 ' CA ' ' HA ' ' A' ' 52' ' ' GLN . 6.5 p -53.13 -28.16 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.075 -1.016 . . . . 0.0 109.215 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.565 ' HA ' ' HB ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.24 -41.77 94.02 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.533 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.685 ' HA2' HD12 ' A' ' 63' ' ' ILE . . . -57.68 -20.75 40.61 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.35 -19.61 16.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 61' ' ' ASP . 1.5 t -99.57 -69.28 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.584 -0.697 . . . . 0.0 109.169 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.944 ' CG ' ' HB1' ' A' ' 20' ' ' ALA . 16.8 m-20 -151.29 -136.08 0.07 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.132 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . . . 77.22 -70.89 0.12 Allowed 'General case' 0 C--O 1.172 -2.987 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.701 ' C ' ' O ' ' A' ' 62' ' ' ALA 0.322 0.2 OUTLIER -17.34 -54.05 0.04 OUTLIER Pre-proline 0 C--N 1.289 -2.022 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 173.243 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.661 ' N ' ' O ' ' A' ' 62' ' ' ALA . 38.1 Cg_endo -70.38 -63.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.455 0 N-CA-C 106.254 -2.249 . . . . 0.0 106.254 173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 1.13 ' CB ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -17.2 -57.79 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 123.736 1.732 . . . . 0.0 107.904 178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.778 HG13 ' O ' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -56.39 -77.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.574 0 CA-C-N 111.557 -2.565 . . . . 0.0 109.352 176.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 5.3 p -78.4 -48.77 14.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 122.246 1.022 . . . . 0.0 111.469 -178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.75 HG12 HD21 ' A' ' 72' ' ' LEU . 3.1 t -82.98 -43.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.891 0 O-C-N 119.937 -1.727 . . . . 0.0 108.075 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 65' ' ' MET . . . -58.06 -25.68 57.17 Favored Glycine 0 CA--C 1.483 -1.919 1 N-CA-C 101.834 -4.506 . . . . 0.0 101.834 172.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.131 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.3 OUTLIER -56.38 -58.11 9.39 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 116.157 -2.217 . . . . 0.0 105.299 173.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.989 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -92.54 18.15 55.72 Favored Glycine 0 CA--C 1.464 -3.111 0 C-N-CA 116.767 -2.635 . . . . 0.0 115.203 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.989 HD23 ' C ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -107.5 -49.14 3.3 Favored 'General case' 0 C--N 1.246 -3.897 1 N-CA-C 98.3 -4.704 . . . . 0.0 98.3 172.03 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.818 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -53.52 -26.72 22.14 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 170.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.131 HG23 ' O ' ' A' ' 70' ' ' LEU . 21.2 t -85.76 -30.47 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 170.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.861 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -31.8 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.277 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 175.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.77 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -109.01 -31.42 7.64 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 175.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.931 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -84.75 39.06 0.73 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.021 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -92.46 -18.11 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.548 -178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.501 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 9' ' ' LEU . 6.9 mt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.0 ' HA ' ' HB3' ' A' ' 13' ' ' ALA . 38.1 t80 -73.65 25.21 0.07 Allowed 'General case' 0 C--O 1.202 -1.443 0 O-C-N 121.073 -1.017 . . . . 0.0 111.037 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.784 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 0.1 OUTLIER -89.14 -65.25 1.04 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 174.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -66.01 -40.03 90.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.0 ' HB3' ' HA ' ' A' ' 10' ' ' TYR . . . -69.01 -22.4 64.07 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.852 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -54.99 -44.47 74.52 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 101.947 -3.353 . . . . 0.0 101.947 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.724 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 3.1 t -60.5 -48.31 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 174.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.991 ' SD ' HD22 ' A' ' 72' ' ' LEU . 3.2 ptp -42.09 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 117.509 -1.676 . . . . 0.0 108.995 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.928 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -76.24 -70.45 0.44 Allowed 'General case' 0 C--O 1.187 -2.221 0 O-C-N 118.57 -2.581 . . . . 0.0 107.924 177.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.729 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -20.03 -56.39 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 4.3 tt -55.28 -68.08 0.22 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.848 ' N ' ' O ' ' A' ' 17' ' ' MET . . . -52.0 -74.08 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.102 -1.439 . . . . 0.0 107.971 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.97 ' HB2' ' HA ' ' A' ' 65' ' ' MET . . . -53.89 -70.41 0.1 Allowed 'General case' 0 N--CA 1.516 2.826 0 O-C-N 121.125 -0.984 . . . . 0.0 112.043 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -45.39 -25.03 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 118.883 -2.386 . . . . 0.0 106.965 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -62.89 -59.51 9.03 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.776 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -84.07 -70.54 0.56 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 175.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' ' O ' ' A' ' 21' ' ' ALA . . . -30.3 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 120.852 0.358 . . . . 0.0 110.54 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.766 HG22 ' O ' ' A' ' 26' ' ' ILE . 20.0 mm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 120.974 -1.079 . . . . 0.0 109.841 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.562 ' CA ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tt0 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.774 ' CE2' HG23 ' A' ' 55' ' ' ILE . 2.8 p90 16.4 -134.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 122.777 0.431 . . . . 0.0 112.077 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' HA ' ' CG ' ' A' ' 57' ' ' MET . 2.1 t80 -61.26 -26.78 67.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.065 . . . . 0.0 110.948 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.774 HG23 ' CE2' ' A' ' 53' ' ' PHE . 12.2 pt -79.81 5.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.556 -1.34 . . . . 0.0 110.47 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 60' ' ' VAL . 3.8 p -130.11 -10.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.795 -1.191 . . . . 0.0 110.922 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.56 ' CG ' ' HA ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -65.46 -48.41 72.76 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 119.209 -0.996 . . . . 0.0 108.61 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.69 -17.42 57.63 Favored Glycine 0 N--CA 1.481 1.657 0 N-CA-C 106.254 -2.738 . . . . 0.0 106.254 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -90.39 -22.51 21.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 122.021 -0.694 . . . . 0.0 109.416 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.776 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.5 p -126.26 -61.18 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.966 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.745 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -53.08 -18.7 2.27 Favored 'General case' 0 CA--C 1.453 -2.77 0 C-N-CA 116.444 -2.102 . . . . 0.0 110.412 -175.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.932 ' HA ' ' HB2' ' A' ' 65' ' ' MET 0.298 . . -156.82 94.9 1.48 Allowed 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 113.683 -3.207 . . . . 0.0 116.975 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.774 HG22 ' HD3' ' A' ' 64' ' ' PRO . 1.3 mp -119.98 -74.21 0.01 OUTLIER Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.777 ' HG3' ' HE1' ' A' ' 65' ' ' MET 0.382 94.3 Cg_endo -82.87 -25.47 2.86 Favored 'Trans proline' 0 C--O 1.201 -1.345 0 N-CA-C 103.744 -3.214 . . . . 0.0 103.744 174.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.97 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mmt -55.34 -56.46 19.8 Favored 'General case' 0 C--O 1.185 -2.335 0 CA-C-N 112.78 -2.009 . . . . 0.0 108.986 -173.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.734 HD12 ' CB ' ' A' ' 62' ' ' ALA . 80.6 mt -107.94 -8.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 117.37 -1.732 . . . . 0.0 110.289 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.724 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 11.9 t -85.28 -48.84 8.69 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 103.177 -2.897 . . . . 0.0 103.177 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.026 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.3 t -86.12 -34.28 8.05 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 C-N-CA 116.55 -2.06 . . . . 0.0 105.693 175.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.903 ' HA3' ' O ' ' A' ' 65' ' ' MET . . . -64.75 -19.06 64.8 Favored Glycine 0 CA--C 1.48 -2.154 1 N-CA-C 101.99 -4.444 . . . . 0.0 101.99 171.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.724 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 0.8 OUTLIER -55.67 -54.93 38.17 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 102.912 -2.996 . . . . 0.0 102.912 174.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.852 ' C ' HD23 ' A' ' 72' ' ' LEU . . . -86.7 3.66 86.85 Favored Glycine 0 N--CA 1.515 3.9 0 C-N-CA 118.752 -1.69 . . . . 0.0 114.41 177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.026 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 6.8 mt -107.76 -61.74 1.53 Allowed 'General case' 0 C--N 1.252 -3.674 0 N-CA-C 101.462 -3.533 . . . . 0.0 101.462 174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.789 ' HA ' ' CD2' ' A' ' 10' ' ' TYR . 82.5 m-85 -47.41 -28.46 2.12 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 171.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.071 HG13 ' O ' ' A' ' 77' ' ' ALA . 46.1 t -87.37 -28.78 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -31.62 -37.89 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 174.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.729 ' N ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -107.17 -31.76 8.11 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.071 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -86.3 46.09 1.3 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.843 HG13 HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -96.77 -30.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.578 -178.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 78' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.469 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.702 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.939 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 1.8 t80 -59.26 3.99 0.04 OUTLIER 'General case' 0 C--O 1.19 -2.027 0 O-C-N 121.468 -0.77 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.704 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 3.8 mmt -84.73 -74.84 0.37 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 118.762 -2.461 . . . . 0.0 107.085 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 15' ' ' VAL . . . -60.76 -36.35 78.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.792 ' CA ' ' HB3' ' A' ' 16' ' ' MET . . . -69.18 -26.33 64.79 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -50.81 -43.72 58.94 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 102.901 -2.999 . . . . 0.0 102.901 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.895 HG12 HD12 ' A' ' 19' ' ' LEU . 2.4 t -61.79 -51.18 75.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.792 ' HB3' ' CA ' ' A' ' 13' ' ' ALA . 2.3 tpp -40.43 -91.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.815 1.293 . . . . 0.0 110.141 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 1.083 ' CG ' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -67.15 -19.13 65.55 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.379 -175.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.158 ' CA ' HD13 ' A' ' 72' ' ' LEU . . . -95.42 -71.8 1.12 Allowed Glycine 0 C--O 1.194 -2.366 0 N-CA-C 107.067 -2.413 . . . . 0.0 107.067 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -31.55 -49.15 0.15 Allowed 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 120.396 2.098 . . . . 0.0 105.761 177.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.797 ' HB1' ' HG3' ' A' ' 64' ' ' PRO . . . -65.54 -61.04 2.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.893 ' HB1' ' HA ' ' A' ' 65' ' ' MET . . . -66.0 -62.31 1.57 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.28 -1.368 . . . . 0.0 113.042 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER -56.12 -23.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 19' ' ' LEU . . . -67.09 -38.42 92.37 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 103.766 -3.734 . . . . 0.0 103.766 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.049 ' HB1' ' HB2' ' A' ' 62' ' ' ALA . . . -89.41 3.56 51.87 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.253 -1.473 . . . . 0.0 110.888 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 22' ' ' ILE . . . -138.29 15.51 2.79 Favored 'General case' 0 C--N 1.286 -2.173 0 O-C-N 121.709 -0.619 . . . . 0.0 109.641 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.752 HG22 ' NE2' ' A' ' 52' ' ' GLN . 26.4 pt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.932 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.826 ' HB3' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.473 0.654 . . . . 0.0 109.459 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.704 ' O ' ' N ' ' A' ' 55' ' ' ILE . 46.1 t80 -49.13 -35.25 16.06 Favored 'General case' 0 C--O 1.204 -1.334 0 C-N-CA 118.161 -1.415 . . . . 0.0 107.907 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.695 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.0 t80 -44.22 87.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.704 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.4 tp 38.67 26.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 56' ' ' VAL . 97.7 t -137.88 19.46 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.426 -1.422 . . . . 0.0 110.567 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.512 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -76.22 -42.99 44.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.136 -0.978 . . . . 0.0 108.931 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.49 36.18 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 106.595 -2.602 . . . . 0.0 106.595 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.74 -23.62 15.84 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.826 HG11 ' HB3' ' A' ' 52' ' ' GLN . 1.8 t -99.74 -78.85 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.816 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . 64.1 m-20 -161.24 -136.64 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.088 ' HA ' ' HB2' ' A' ' 65' ' ' MET . . . 87.39 -43.63 0.03 OUTLIER 'General case' 0 CA--C 1.454 -2.73 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.032 ' HA ' HD11 ' A' ' 66' ' ' ILE 0.325 0.5 OUTLIER -28.91 -48.6 0.25 Allowed Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 169.789 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.797 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 30.0 Cg_endo -66.08 -85.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.244 0 N-CA-C 104.734 -2.833 . . . . 0.0 104.734 169.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 1.088 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER 0.87 -79.97 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.342 0 CA-C-O 123.327 1.536 . . . . 0.0 108.666 178.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -42.88 -84.51 0.0 OUTLIER 'Isoleucine or valine' 1 C--N 1.228 -4.682 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.054 174.688 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.698 ' O ' ' CB ' ' A' ' 70' ' ' LEU . 3.8 t -81.19 -43.45 19.29 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.455 -1.403 . . . . 0.0 112.103 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 17' ' ' MET 0.256 0.6 OUTLIER -93.98 -14.52 8.13 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.423 0 C-N-CA 116.902 -1.919 . . . . 0.0 106.75 -178.08 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.928 ' O ' HD23 ' A' ' 72' ' ' LEU . . . -68.38 -37.78 86.35 Favored Glycine 0 C--N 1.302 -1.343 1 N-CA-C 97.662 -6.175 . . . . 0.0 97.662 167.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.706 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -50.5 -44.27 55.91 Favored 'General case' 0 C--O 1.183 -2.438 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 172.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.791 ' O ' ' N ' ' A' ' 75' ' ' MET . . . -78.99 -10.07 86.52 Favored Glycine 0 N--CA 1.506 3.347 0 CA-C-O 117.0 -2.0 . . . . 0.0 115.093 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.158 HD13 ' CA ' ' A' ' 18' ' ' GLY . 2.4 pt? -86.39 -56.99 3.18 Favored 'General case' 0 C--N 1.284 -2.259 1 N-CA-C 98.9 -4.481 . . . . 0.0 98.9 174.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.147 ' CZ ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -60.69 -14.32 20.16 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.625 1.202 . . . . 0.0 108.329 176.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.989 ' O ' HG13 ' A' ' 78' ' ' VAL . 98.1 t -111.94 -8.5 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 119.125 -2.234 . . . . 0.0 106.053 173.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.804 ' CB ' ' HB2' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -54.43 -30.03 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 100.717 -3.808 . . . . 0.0 100.717 173.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -108.95 -38.4 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.845 176.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.854 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . . . -67.87 1.09 2.81 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 117.519 -1.672 . . . . 0.0 108.845 178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.989 HG13 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -51.36 -22.78 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.647 -0.658 . . . . 0.0 109.496 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.37 179.98 . . . . . . . . 0 0 . 1 stop_ save_